Document,Phrase,RakeVal,SimVal
0,predict risk allows healthcare providers,23.555555555555557,0.13763638958334923
0,hf present particular concerns according,21.333333333333336,0.0777988001704216
0,assessed using prediction model risk,20.72222222222222,0.06924197152256965
0,identify risk prediction models conducted,17.12222222222222,0.09658324345946312
0,left ventricular ejection fraction,16.0,0.06285456009209156
0,105 distinct predictor variables,15.666666666666666,0.03999088890850544
0,distinct risk prediction variables,14.722222222222221,0.06918284250423312
0,characteristics including male sex,14.5,0.042833952233195305
0,24 %) external validation,14.0,0.09607840701937675
0,"9 ), hf hospitalizations",13.833333333333334,0.14424603308240572
0,58 models assessed 55,13.733333333333333,0.08501061052083969
0,"17 ), cardiovascular death",13.0,0.3477906510233879
0,risk prediction models,10.455555555555556,0.12669244656960169
0,identify common variables,10.333333333333332,0.047371236607432365
0,identify hf risk,10.055555555555555,0.11752037828167279
0,19 %) models,9.9,0.10839370638132095
0,terminal prohormone brain,9.0,0.10691695908705394
0,systolic blood pressure,9.0,0.19706550737222037
0,patients might benefit,9.0,0.17430907239516577
0,machine learning tools,9.0,0.017356942718227703
0,handling missing data,9.0,0.029383260756731033
0,blood urea nitrogen,9.0,0.08491628368695577
0,systematic literature review,8.5,0.11429194112618764
0,assess statistical approach,8.5,0.0682396503786246
0,publications reported detail,8.25,0.061810540656248726
0,58 identified risk,8.222222222222221,0.14875178039073944
0,overall low rob,8.0,0.036160012086232506
0,bias assessment tool,7.5,0.02515859839816888
0,prediction models,6.9,0.09293749555945396
0,assess risk,6.055555555555555,0.1279876697808504
0,cardiovascular death,6.0,0.3477906510233879
0,"hf ),",5.833333333333334,0.1109897643327713
0,prediction publications,5.75,0.0990343950688839
0,outcomes assessed,5.666666666666666,0.14744332060217857
0,40 risk,5.555555555555555,0.19420234858989716
0,ranked according,5.5,0.03414288908243179
0,"15 ),",5.0,0
0,hf hospitalization,4.833333333333334,0.18449676781892776
0,rob assessment,4.5,0.046648452058434486
0,literature databases,4.5,0.148965522646904
0,5 publications,4.25,0.06551873870193958
0,40 publications,4.25,0.12058750540018082
0,rob ).,4.0,0.009379956871271133
0,registration number,4.0,0.019475161097943783
0,primary outcomes,4.0,0.15430442243814468
0,predictors included,4.0,0.09621145948767662
0,potential utility,4.0,0.09313226863741875
0,nyha class,4.0,0.02183631807565689
0,novel approaches,4.0,0.0687826182693243
0,natriuretic peptide,4.0,0.1839265078306198
0,may 2018,4.0,-0.009713593870401382
0,march 2013,4.0,-0.027591872960329056
0,mainly due,4.0,0.016958811786025763
0,justify clinical,4.0,0.25655319821089506
0,hospital setting,4.0,0.23481094278395176
0,heart rate,4.0,0.20280320569872856
0,heart failure,4.0,0.2074820026755333
0,generally better,4.0,0.03557589091360569
0,economic value,4.0,0.04851515172049403
0,duplicated citations,4.0,0.02788121998310089
0,crd42018100709 ).,4.0,0
0,composite endpoints,4.0,0.09084805846214294
0,certain therapies,4.0,0.19523299857974052
0,cause mortality,4.0,0.18113460391759872
0,4720 non,4.0,0.06398928165435791
0,28 %).,4.0,0
0,probast ).,3.5,0
0,discriminatory ability,3.5,0.016360502690076828
0,deemed relevant,3.5,0.06971338763833046
0,14 ).,3.5,0
0,conducted,3.0,0.055469855666160583
0,hf,2.8333333333333335,0.1109897643327713
0,58,2.6666666666666665,0
0,validation,2.5,0.09198760986328125
0,including,2.5,0.06332606077194214
0,rob,2.0,0.009379956871271133
0,identified,2.0,0.10330121219158173
0,bias,2.0,0.01831863634288311
0,relevant,1.5,0.09132666885852814
0,probast,1.5,0
0,ability,1.5,-0.022223003208637238
0,14,1.5,0
0,yet,1.0,-0.03675409406423569
0,within,1.0,0.06455390155315399
0,understand,1.0,-0.004381440579891205
0,total,1.0,0.003683900460600853
0,studies,1.0,0.24976284801959991
0,sodium,1.0,0.11925020068883896
0,slr,1.0,0.0981777086853981
0,searched,1.0,0.027823450043797493
0,robustness,1.0,0.028073906898498535
0,results,1.0,0.0652550756931305
0,registered,1.0,0.016251616179943085
0,prospero,1.0,0
0,propose,1.0,0.06627984344959259
0,predicting,1.0,0.043349962681531906
0,payers,1.0,0.18115882575511932
0,n,1.0,-0.021267158910632133
0,methods,1.0,0.024640876799821854
0,majority,1.0,0.026061898097395897
0,lack,1.0,0.0400080606341362
0,incorporation,1.0,0.05103994905948639
0,id,1.0,0.0023845192044973373
0,extent,1.0,0.017291061580181122
0,diabetes,1.0,0.31405115127563477
0,determined,1.0,-0.03170712664723396
0,demands,1.0,0.033390387892723083
0,creatinine,1.0,0.20824791491031647
0,conclusions,1.0,0.07628431916236877
0,co,1.0,0.08638649433851242
0,calibration,1.0,0.21323038637638092
0,bmi,1.0,0.0934591069817543
0,based,1.0,0.08516917377710342
0,background,1.0,0.03833860531449318
0,application,1.0,0.023733139038085938
0,age,1.0,0.10348664224147797
0,adults,1.0,0.051906388252973557
0,4,1.0,-8.371472358703613e-05
0,3,1.0,0.019742561504244804
0,26,1.0,0
0,2,1.0,0.03300613537430763
0,11,1.0,0
0,1,1.0,-0.001867588609457016
0,approach evaluated anonymized cardiac images,23.666666666666668,0.17590658068656922
0,advanced machine learning methods,16.0,0.05202275887131691
0,reproducible cardiac pathological assessment,15.666666666666666,0.253646831959486
0,fully automatic processing pipeline,15.666666666666666,0.07228710362687707
0,cardiac cine sequencing provides,15.666666666666666,0.24283761950209737
0,independent test set using,15.5,0.015956244431436062
0,initial processing element consists,15.166666666666666,0.03378185909241438
0,20 patients per group,14.5,0.17405342496931553
0,ary pathology classification accuracy,14.333333333333334,0.14713991759344935
0,final processing element,10.166666666666666,0.023160612831513088
0,cardiac pathology classifier,10.0,0.4012519071499507
0,quantify cardiac measures,9.666666666666666,0.21810053630421558
0,manual cardiac evaluation,9.666666666666666,0.26817435150345165
0,training data set,9.5,0.07900424053271611
0,1 healthy group,9.5,0.05025427540143331
0,4 pathology groups,9.333333333333334,0.1706454207499822
0,"rv ), respectively",9.0,0.06496892496943474
0,performance results demonstrate,9.0,0.04285929352045059
0,enabling improved extraction,9.0,0.055905758713682495
0,cardiovascular disease staging,8.5,0.25692620997627574
0,"lv ), myocardium",8.0,0.16202591359615326
0,combining semantic segmentation,8.0,0.05596125001708666
0,disease classification,5.5,0.09134924225509167
0,100 patients,5.0,0.4592966139316559
0,wise segmentation,4.0,0.06757503096014261
0,ventricular cavities,4.0,0.19728557020425797
0,university hospital,4.0,0.32684318721294403
0,structure segmentation,4.0,0.08185387216508389
0,right ventricle,4.0,0.08423669962212443
0,observer bias,4.0,0.04053699877113104
0,morphological features,4.0,0.1226752009242773
0,left ventricle,4.0,0.1010191198438406
0,important functional,4.0,0.11301657184958458
0,ejection fraction,4.0,-0.013899685814976692
0,deliver accurate,4.0,0.03067811205983162
0,trained model,3.5,0.08922233246266842
0,segmentation,2.0,0.13467922806739807
0,myocardium,2.0,0.27229008078575134
0,model,1.5,0.05463607236742973
0,voxel,1.0,0.22100672125816345
0,utilized,1.0,0.03543274104595184
0,recorded,1.0,0.01999819651246071
0,presented,1.0,0.10993251949548721
0,potential,1.0,0.06813585013151169
0,method,1.0,0.016362402588129044
0,expense,1.0,0.08347275108098984
0,examined,1.0,0.1701224148273468
0,efficient,1.0,0.10318800061941147
0,dijon,1.0,0.010735955089330673
0,curtails,1.0,0.028310272842645645
0,basis,1.0,-0.04432522505521774
0,940,1.0,0
0,90,1.0,0
0,886,1.0,0
0,849,1.0,0
0,5,1.0,0.010449972003698349
0,0,1.0,0.04786166548728943
0,term data demonstrating improved outcomes,25.0,0.10536950230598449
0,determine lesion functional significance,16.0,0.1012946218252182
0,beyond fractional flow reserve,16.0,0.04637357534375042
0,"ffrct ), invasive angiography",14.25,0.3308231234550476
0,guided percutaneous coronary intervention,13.722222222222221,0.22295109555125237
0,evaluating coronary stenosis physiology,13.722222222222221,0.2790856324136257
0,coronary physiological assessment remains,12.222222222222221,0.1741553032770753
0,invasive coronary ct,9.722222222222221,0.23524800688028336
0,coronary physiological assessment,9.222222222222221,0.23429864148298898
0,coronary artery disease,9.222222222222221,0.2953575849533081
0,acute coronary syndromes,9.222222222222221,0.348122239112854
0,technical aspects involved,9.0,0.05736500769853592
0,rest without hyperemia,9.0,0.0856664205590884
0,residual ischemia post,9.0,0.10443652172883351
0,optical coherence tomography,9.0,0.16895723839600882
0,interventional cardiology toolbox,9.0,0.5282939846316973
0,improve patient care,9.0,0.25580136477947235
0,hyperemic pressure ratios,9.0,0.10968661680817604
0,exciting technological future,9.0,0.09376745671033859
0,enable detailed pre,9.0,0.046365381528933845
0,artificial intelligence algorithms,9.0,0.11491399258375168
0,alternative ffr approaches,9.0,0.055263230577111244
0,assess coronary physiology,8.722222222222221,0.2895762088398139
0,refine clinical practice,8.0,0.21875642985105515
0,"ffr ), non",7.75,0.06398928165435791
0,physiological assessment,6.0,0.12038403004407883
0,coronary physiology,5.722222222222222,0.40347781777381897
0,remains underutilized,5.0,0.05646817572414875
0,"ffroct ),",4.75,0
0,"ffrangio ),",4.75,0
0,current practice,4.5,0.09676923789083958
0,clinical scenarios,4.5,0.2632120056077838
0,well established,4.0,0.07649984396994114
0,serial lesions,4.0,0.08666558656841516
0,robust tools,4.0,0.012099930085241795
0,related arteries,4.0,0.1908680871129036
0,recent findings,4.0,0.12625432386994362
0,left main,4.0,0.046499328687787056
0,latest developments,4.0,0.08507654257118702
0,indispensable tool,4.0,0.005240730941295624
0,including non,4.0,0.06365767121315002
0,essential component,4.0,0.018949024379253387
0,especially helpful,4.0,0.08433499187231064
0,despite long,4.0,-0.004904087632894516
0,catheterization laboratory,4.0,0.39266934990882874
0,also emerging,4.0,0.08303185738623142
0,additional advances,4.0,0.09927589446306229
0,stable cad,3.666666666666667,0.040095262229442596
0,multivessel cad,3.666666666666667,0.12174112349748611
0,review outlines,3.5,0.06390692293643951
0,physiology,2.5,0.3448277711868286
0,intervention,2.5,0.06027820706367493
0,non,2.0,0.06398928165435791
0,cad,1.6666666666666667,0.008538410067558289
0,review,1.5,0.06275224685668945
0,virtual,1.0,-0.016268359497189522
0,today,1.0,0.028057290241122246
0,realized,1.0,-0.013345438987016678
0,purpose,1.0,-0.006926483474671841
0,procedure,1.0,0.2543809711933136
0,pci,1.0,0.06185466796159744
0,nhpr,1.0,0
0,infarct,1.0,0.29678159952163696
0,indications,1.0,0.12957578897476196
0,however,1.0,-0.011453256011009216
0,focusing,1.0,0.07314138859510422
0,field,1.0,0.11301998794078827
0,benefits,1.0,0.05126548931002617
0,addition,1.0,0.1140233725309372
0,abound,1.0,0.029980715364217758
0,"ai ), although well established",23.0,0.055529759265482426
0,editorial review highlights progress,16.0,0.055371860042214394
0,common clinical conditions,8.0,0.21186517924070358
0,many areas,4.0,0.10166110098361969
0,everyday life,4.0,0.03412359766662121
0,artificial intelligence,4.0,0.1279079094529152
0,ai,3.0,0.07966839522123337
0,conditions,2.0,0.047392018139362335
0,trials,1.0,0.12281295657157898
0,trialed,1.0,0.007933016866445541
0,suggests,1.0,0.041627660393714905
0,recently,1.0,0.026306796818971634
0,management,1.0,0.23943668603897095
0,improvements,1.0,0.08724521100521088
0,hypertension,1.0,0.364623486995697
0,diagnosis,1.0,0.24688632786273956
0,date,1.0,-0.02209126204252243
0,"unsorted cortical tissue ), liver",23.5,0.13676342368125916
0,"neurodegenerative ataxia ), slowing",16.5,0.09183459045986335
0,pick disease type c,16.0,0.05154294241219759
0,optimized dual aavs enable,12.833333333333334,0.05696753909190496
0,therapeutically relevant efficiencies,9.0,0.12600423892339072
0,targeted point mutations,9.0,0.0671967143813769
0,relevant cell types,9.0,0.08464814225832622
0,mouse brain tissue,9.0,0.11349478860696156
0,genetic diseases depends,9.0,0.1369860221942266
0,aav packaging capacity,9.0,0.06035717390477657
0,"38 %), retina",9.0,0.1610647439956665
0,"38 %), heart",9.0,0.30470412969589233
0,optimized delivery vectors,8.833333333333334,0.06485484788815181
0,base editing corrects,8.8,0.03478117287158966
0,length base editors,8.466666666666667,0.020101820429166157
0,adenine base editors,8.466666666666667,0.005505541960398356
0,delivery via adeno,8.333333333333334,0.09841644763946533
0,vivo base editing,7.8,0.09603611379861832
0,base editors,5.466666666666667,0.005307380110025406
0,dual aavs,5.333333333333334,0.05582564324140549
0,mouse brain,5.0,0.08274193853139877
0,therapeutic interest,4.0,0.1769992895424366
0,split cytosine,4.0,0.029614080674946308
0,splicing inteins,4.0,0.03305492177605629
0,skeletal muscle,4.0,0.10633536614477634
0,multiple tissues,4.0,0.09319684654474258
0,increasing lifespan,4.0,0.05654631368815899
0,efficient introduction,4.0,0.062367403879761696
0,causes niemann,4.0,0.0955091118812561
0,associated viruses,4.0,0.06252634525299072
0,also show,4.0,0.02594495750963688
0,9 %).,4.0,-0.015072595328092575
0,20 %),4.0,0
0,delivery,2.3333333333333335,0.08233281970024109
0,aavs,2.3333333333333335,0
0,vivo,2.0,0.22206149995326996
0,use,1.0,0.0033735278993844986
0,treatment,1.0,0.27399298548698425
0,trans,1.0,0.035792045295238495
0,success,1.0,0.02648092433810234
0,study,1.0,0.2376001477241516
0,report,1.0,0.05636989697813988
0,reconstituted,1.0,0.051905177533626556
0,precludes,1.0,-0.0305861197412014
0,neurodegeneration,1.0,0.20730683207511902
0,mutation,1.0,0.07678423076868057
0,limited,1.0,0.009723823517560959
0,full,1.0,0.008461154997348785
0,facilitate,1.0,0.07707814872264862
0,dosages,1.0,0.16614286601543427
0,deliver,1.0,0.048547469079494476
0,application,1.0,0.023733139038085938
0,ability,1.0,-0.022223003208637238
0,59,1.0,0
0,current literature exists regarding,16.0,0.07642204780131578
0,also cause significant lesions,14.5,0.09312801156193018
0,less commonly affected species,14.0,0.03716933075338602
0,human arboviral neuroinvasive disease,13.833333333333334,0.1755093988031149
0,west nile virus infection,13.25,0.075938087888062
0,prior human wnv infection,12.283333333333335,0.0854246977251023
0,west nile virus,10.0,0.04166504368185997
0,commonly affected birds,10.0,0.006251970926920573
0,also briefly discussed,9.5,0.05715696637829145
0,human infection involve,9.083333333333334,0.11089861144622166
0,viral pathogenesis derived,9.0,0.05232189502567053
0,severe systemic disease,9.0,0.12626137087742487
0,renal injury leading,9.0,0.1803122895459334
0,central nervous system,9.0,0.09717598309119542
0,experimental animal models,8.0,0.12631584952274957
0,wnv infection,5.45,0.12057871744036674
0,virus propagation,5.0,0.008435415104031563
0,major cause,5.0,0.08084611594676971
0,avian species,5.0,0.059786129742860794
0,animal models,5.0,0.10543617233633995
0,human animals,4.833333333333334,0.06385773420333862
0,neurologic disease,4.5,0.20460288226604462
0,human non,4.5,0.07672946527600288
0,human vertebrates,4.333333333333334,0.0828995481133461
0,wnv pathology,4.2,0.27686580643057823
0,wnv maintenance,4.2,0.11021209880709648
0,vertebrate host,4.0,0.08990686014294624
0,review summarizes,4.0,0.05325387790799141
0,prominent manifestation,4.0,0.07033965550363064
0,pathology seen,4.0,0.2737777568399906
0,pathology caused,4.0,0.2596761416643858
0,particularly diverse,4.0,0.10571541264653206
0,natural infections,4.0,0.13648249581456184
0,known findings,4.0,0.12461254186928272
0,knowledge gaps,4.0,0.06761082634329796
0,knowledge gains,4.0,0.021418079733848572
0,host animals,4.0,0.03248347342014313
0,future directions,4.0,0.06682271603494883
0,susceptible non,3.666666666666667,0.06416111439466476
0,neurotropic nature,3.5,-0.0009654052555561066
0,wnv,2.2,0.0624002143740654
0,non,1.6666666666666667,0.06398928165435791
0,vertebrates,1.5,0.07632944732904434
0,neurologic,1.5,0.24617043137550354
0,nature,1.5,-0.06284593045711517
0,well,1.0,0.09099400043487549
0,transmission,1.0,0.07843247056007385
0,time,1.0,0.05442593991756439
0,similarly,1.0,0.015414413064718246
0,serve,1.0,0.044177670031785965
0,research,1.0,0.27731871604919434
0,relationship,1.0,0.0036004912108182907
0,ranging,1.0,-0.015200847759842873
0,occur,1.0,0.06010684743523598
0,kidneys,1.0,0.14581722021102905
0,intestinal,1.0,0.14243550598621368
0,humans,1.0,0.06040411442518234
0,however,1.0,-0.011453256011009216
0,horses,1.0,0.05137117952108383
0,heart,1.0,0.30470412969589233
0,gap,1.0,0.07254616916179657
0,eyes,1.0,0.0620502233505249
0,death,1.0,0.12083880603313446
0,continues,1.0,-0.03620941564440727
0,cardiac,1.0,0.619275689125061
0,alligators,1.0,0.003468889743089676
0,addressed,1.0,0.10165482014417648
0,sensors record blood volume variations,24.0,0.08834755159914494
0,challenges towards clinical applications,16.0,0.1738534076139331
0,deep learning approaches used,15.0,0.03189744148403406
0,cardiac rhythm disorder associated,14.0,0.24421579390764236
0,af detection using ppg,11.5,0.07864008843898773
0,implement optical sensors,10.0,0.1003437452018261
0,possible using low,9.5,0.012498260786135992
0,patient management tools,9.0,0.21142581291496754
0,new wearable devices,9.0,0.14939591040213904
0,leading risk factor,9.0,0.09249850610891978
0,large prospective trials,9.0,0.08907155940930049
0,grade wearable devices,9.0,0.08568766713142395
0,enabling transformative diagnostic,9.0,0.18593546686073145
0,devices would allow,9.0,0.08195636545618375
0,today possible thanks,8.5,0.00540257307390372
0,secondary stroke prevention,8.333333333333334,0.204373300075531
0,cardiac rhythm,6.0,0.39142943918704987
0,ppg )-,5.0,0.12077879160642624
0,machine learning,5.0,0.03610682301223278
0,af detection,5.0,0.11775946244597435
0,early detection,4.666666666666666,0.10575852356851101
0,today equip,4.5,0.04264319594949484
0,prevent stroke,4.333333333333334,0.1360683385282755
0,cardioembolic stroke,4.333333333333334,0.2529298663139343
0,user activity,4.0,0.04194623976945877
0,thorough account,4.0,0.012766440398991108
0,technology known,4.0,0.12273937650024891
0,signal processing,4.0,0.08321457356214523
0,physiological parameters,4.0,0.10987468808889389
0,increased morbidity,4.0,0.1984947919845581
0,heart rate,4.0,0.20280320569872856
0,early screening,4.0,0.09201321564614773
0,cost easy,4.0,0.007938457652926445
0,atrial fibrillation,4.0,0.26550570130348206
0,continuous monitoring,3.5,0.08128756657242775
0,af,2.3333333333333335,0.058493904769420624
0,monitoring,1.5,0.158101424574852
0,©,1.0,0.024751247838139534
0,work,1.0,0.06322342157363892
0,wearables,1.0,0.09958787262439728
0,therapy,1.0,0.29505598545074463
0,summary,1.0,0.08503544330596924
0,studies,1.0,0.24976284801959991
0,sleep,1.0,0.16289515793323517
0,review,1.0,0.06275224685668945
0,recently,1.0,0.026306796818971634
0,primary,1.0,0.07534971833229065
0,presented,1.0,0.10993251949548721
0,photoplethysmography,1.0,0
0,mortality,1.0,0.27426618337631226
0,majority,1.0,0.026061898097395897
0,limitations,1.0,0.020679235458374023
0,introduced,1.0,0.0400276780128479
0,initiation,1.0,0.09276364743709564
0,inform,1.0,0.01317903958261013
0,health,1.0,0.31966903805732727
0,followed,1.0,0.06544908136129379
0,fitness,1.0,0.18124014139175415
0,extracted,1.0,0.012193005532026291
0,evidenced,1.0,-0.023355547338724136
0,discussion,1.0,0.10436347126960754
0,crucial,1.0,0.045712754130363464
0,consumer,1.0,0.12918971478939056
0,cases,1.0,0.1337328851222992
0,capable,1.0,0.04132876545190811
0,body,1.0,0.014940984547138214
0,author,1.0,0.1725224107503891
0,2020,1.0,0
0,source r package flowmapr via,25.0,0.02748046233318746
0,mouse embryonic stem cells differentiating,24.5,0.041282980144023894
0,cell technologies present new opportunities,23.625,0.11003904938697814
0,gui )- based software tool,21.5,0.059671323746442795
0,vitro stem cell differentiation,16.125,0.10967454873025417
0,change across time points,15.666666666666666,0.04481137450784445
0,identify unique cell populations,15.625,0.07011363562196493
0,uses graph layout analysis,14.571428571428571,0.04619096498936415
0,previously published scrnaseq dataset,14.5,0.084927332897981
0,cell time course datasets,14.291666666666666,0.08688928745687008
0,sequential time ordering,9.666666666666666,0.040717649894456066
0,cell signaling dynamics,9.625,0.07717842360337575
0,cell rna sequencing,9.625,0.14709154143929482
0,cell datasets obtained,9.625,0.08115091112752755
0,cell analysis methods,9.196428571428571,0.07716615870594978
0,visualize cellular trajectories,9.0,0.08103281383713086
0,three germ layers,9.0,0.015514960512518883
0,resulting datasets makes,9.0,0.040843154614170395
0,one particular challenge,9.0,0.06298240336279075
0,many dynamic processes,9.0,0.05819833775361379
0,graphical user interface,9.0,0.03447173535823822
0,perform comprehensive analysis,7.571428571428571,0.09863713632027309
0,map analysis side,6.571428571428571,0.06406636163592339
0,based commands,5.5,0.1051076091825962
0,experimental datasets,5.0,0.1543521136045456
0,map analysis,4.571428571428571,0.08488576486706734
0,step analysis,4.071428571428571,0.05773446336388588
0,vivo development,4.0,0.20071841031312943
0,protocol takes,4.0,0.08096887031570077
0,mass cytometry,4.0,0.12563294544816017
0,map algorithm,4.0,0.06980007514357567
0,drug resistance,4.0,0.07900293543934822
0,detailed description,4.0,0.01719026267528534
0,complex nature,4.0,0.008451268076896667
0,biological discovery,4.0,0.11704317480325699
0,5 h,4.0,0.019505219534039497
0,30 min,4.0,0.07128780335187912
0,perform flow,3.8,0.08166857808828354
0,flow cytometry,3.8,0.14311635494232178
0,developed flow,3.8,0.09296619892120361
0,map approach,3.5,0.04827821999788284
0,dimensional single,3.5,0.048512762412428856
0,demonstrate flow,3.3,0.04625438153743744
0,gui,3.0,0.04591921716928482
0,analysis,2.5714285714285716,0.10335448384284973
0,scrnaseq,2.5,0
0,side,2.0,0.022427555173635483
0,perform,2.0,0.09922076761722565
0,map,2.0,0.06641704589128494
0,flow,1.8,0.06411638855934143
0,step,1.5,0.012114442884922028
0,single,1.5,0.015469912439584732
0,demonstrate,1.5,0.028392374515533447
0,approach,1.5,0.030139394104480743
0,using,1.0,-0.04173736274242401
0,use,1.0,0.0033735278993844986
0,track,1.0,0.04564104974269867
0,text,1.0,0.04602084308862686
0,synthetic,1.0,0.00509323924779892
0,provide,1.0,0.01998533308506012
0,open,1.0,0.04772356525063515
0,oncogenesis,1.0,0.18533475697040558
0,mesoderm,1.0,0.12716028094291687
0,including,1.0,0.06332606077194214
0,illustrate,1.0,-0.009545623324811459
0,high,1.0,0.06070782244205475
0,facilitate,1.0,0.07707814872264862
0,experiments,1.0,0.11820036172866821
0,endoderm,1.0,0.15505863726139069
0,emergence,1.0,0.041484735906124115
0,ectoderm,1.0,0.1283458173274994
0,complete,1.0,-0.01845567114651203
0,comparison,1.0,0.11286726593971252
0,challenging,1.0,0.0013546105474233627
0,applied,1.0,0.006987035274505615
0,advantageous,1.0,0.10459944605827332
0,addition,1.0,0.1140233725309372
0,1,1.0,-0.001867588609457016
0,yet available methods using pcr,23.166666666666668,-0.0036433180794119835
0,virus detection using msspe arboviral,20.46666666666667,0.09966944623738527
0,enriching targeted rna viral sequences,18.166666666666664,0.02730653714388609
0,(± 16 %) increase,16.0,0.06259705126285553
0,successfully enriched using msspe,15.466666666666669,0.02615826080242793
0,additional target enrichment step,15.333333333333334,0.05413145758211613
0,haemorrhagic fever viral panels,15.166666666666666,0.05390750081278384
0,simultaneously retaining metagenomic sensitivity,13.666666666666666,0.08221469447016716
0,spiked primer enrichment,9.333333333333334,-0.001618103434642156
0,median tenfold enrichment,9.333333333333334,0.09705824156602223
0,yellow fever viruses,9.166666666666666,0.008568771493931612
0,spectrum pathogen detection,9.0,0.10307461271683376
0,portable nanopore sequencers,9.0,0.11907924214998881
0,sensitivity pathogen identification,8.666666666666666,0.0676748404900233
0,14 different viruses,8.666666666666666,0.045714251697063446
0,developed metagenomic sequencing,8.333333333333334,0.16355501115322113
0,method directly applicable,8.0,0.04245349392294884
0,viral outbreaks,5.666666666666666,0.03406250849366188
0,specifically targeted,5.5,0.06474586948752403
0,specific pcr,5.5,0.08915150165557861
0,metagenomic next,5.0,0.12817152589559555
0,"msspe ),",4.8,0
0,evaluated msspe,4.8,0.1149546355009079
0,infecting viruses,4.666666666666666,0.021462706848978996
0,shotgun sequencing,4.333333333333334,0.095013995654881
0,generation sequencing,4.333333333333334,0.12652655690908432
0,titre infections,4.0,0.15311158820986748
0,proved useful,4.0,0.04149645706638694
0,plasma samples,4.0,0.11209489591419697
0,narrow scope,4.0,0.03682776726782322
0,mngs alone,4.0,0.04610326886177063
0,"mngs ),",4.0,0
0,mean 47,4.0,0.07771239429712296
0,lengthy protocols,4.0,0.1216435506939888
0,infected patients,4.0,0.2552550472319126
0,including powassan,4.0,0.06332606077194214
0,genomic surveillance,4.0,0.19439147785305977
0,genome coverage,4.0,0.09967924654483795
0,generally needed,4.0,0.02674674242734909
0,field use,4.0,0.058196757920086384
0,either benchtop,4.0,0.11202492192387581
0,diagnostic laboratory,4.0,0.3936236500740051
0,demonstrating 95,4.0,0.04213862493634224
0,clinical samples,4.0,0.27576604671776295
0,capture probes,4.0,0.07700442895293236
0,low cost,3.5,0.04937576688826084
0,high cost,3.5,0.047133004292845726
0,sequences,3.0,0.03171074762940407
0,rna,3.0,0
0,detection,3.0,0.17702502012252808
0,msspe,2.8,0
0,sensitivity,2.6666666666666665,0.0724399983882904
0,method,2.0,0.016362402588129044
0,low,1.5,0.06519334763288498
0,high,1.5,0.06070782244205475
0,zika,1.0,0
0,yielding,1.0,0.021416712552309036
0,usutu,1.0,0
0,simple,1.0,-0.0471973717212677
0,priori,1.0,0.06202193722128868
0,pathogens,1.0,0.09530304372310638
0,notably,1.0,0.056873396039009094
0,making,1.0,-0.03939424455165863
0,limited,1.0,0.009723823517560959
0,fast,1.0,0.029178690165281296
0,emerging,1.0,0.12356212735176086
0,ebola,1.0,0.021312974393367767
0,dna,1.0,-0.015949951484799385
0,deployable,1.0,0.03742877021431923
0,dengue,1.0,0.12166149169206619
0,cross,1.0,0.1382628083229065
0,contamination,1.0,0.02167564444243908
0,comparable,1.0,0.07046344876289368
0,co,1.0,0.08638649433851242
0,chikungunya,1.0,0.12630540132522583
0,broad,1.0,0.06394508481025696
0,breadth,1.0,0.07947862148284912
0,accuracy,1.0,0.05023651197552681
0,random forest classification algorithm revealed,23.0,0.023757678642868995
0,dnam markers across three tissues,18.733333333333334,0.0709637813270092
0,three different sample sources,16.5,0.041682141716592014
0,peripheral blood mononuclear cells,15.666666666666666,0.16128713637590408
0,central airway epithelial cells,15.166666666666666,0.12305069155991077
0,rapgef3 gene might interact,15.0,0.06221134463946024
0,based dnam signatures exerted,14.166666666666666,0.01980481979747613
0,"87 ), 8 loci",13.666666666666666,0.05253671761602163
0,specific dnam markers classify,13.566666666666666,0.04337199653188387
0,"pbmc -, nec -,",13.0,0.11377857625484467
0,wide dna methylation levels,12.5,0.05782374134287238
0,nasal epithelial cells,10.166666666666666,0.1074996069073677
0,asthma across tissues,10.166666666666666,0.1304762860139211
0,machine learning algorithm,10.0,0.048465583473443985
0,lower classification error,10.0,0.029133873681227367
0,based dnam markers,9.566666666666666,0.06165548413991928
0,associated methylation markers,9.4,0.0851381594936053
0,overlap analysis across,9.166666666666666,0.08697239061196645
0,unique pathophysiological processes,8.5,0.09294130156437556
0,top 100 asthma,8.5,0.13267496787011623
0,obtained 74 subjects,8.333333333333334,0.06826585438102484
0,bag errors using,8.0,-0.02964676295717557
0,predict asthma risk,7.0,0.148760624229908
0,specific markers,6.4,0.06364664807915688
0,dna methylation,6.0,0.0501743545755744
0,dnam levels,5.666666666666666,0.04464932531118393
0,analysis based,5.5,0.09426182880997658
0,cdh6 gene,5.0,0.13568075001239777
0,4 loci,5.0,0.05771397054195404
0,"99 ),",4.666666666666666,0
0,pathway levels,4.5,0.0496255848556757
0,pathological processes,4.5,0.11578480899333954
0,jointly predict,4.5,0.03758827969431877
0,efficacy levels,4.5,0.11919186636805534
0,697 subjects,4.333333333333334,0.13721111416816711
0,15 subjects,4.333333333333334,0.13721111416816711
0,"necs ),",4.166666666666666,0
0,results using,4.0,0.011758856475353241
0,pivotal role,4.0,0.06431124173104763
0,pathological changes,4.0,0.08055469393730164
0,optimal subset,4.0,0.10311964154243469
0,measured using,4.0,0.01618562638759613
0,may play,4.0,0.02951589785516262
0,key role,4.0,0.05408843792974949
0,investigate shared,4.0,0.04026031494140625
0,diagnostic performance,4.0,0.26163750514388084
0,current study,4.0,0.1360595915466547
0,cpg sites,4.0,0.05223437398672104
0,also discovered,4.0,0.029014802537858486
0,41 controls,4.0,0.05869656428694725
0,14 controls,4.0,0.05869656428694725
0,0002 ).,4.0,0
0,locus interaction,3.666666666666667,0.05765111744403839
0,locus effects,3.666666666666667,0.0617215633392334
0,pbmcs ).,3.5,0
0,cell junction,3.5,0.08838457986712456
0,97 controls,3.5,0.05869656428694725
0,dnam,3.1666666666666665,0
0,pbmc,2.5,0
0,nec,2.5,0.11377857625484467
0,asthma,2.5,0.2230728715658188
0,using,2.0,-0.04173736274242401
0,risk,2.0,0.19420234858989716
0,locus,1.6666666666666667,0.08330907672643661
0,pbmcs,1.5,0
0,necs,1.5,0
0,cell,1.5,0.10350311547517776
0,97,1.5,0
0,warranted,1.0,0.049046266824007034
0,value,1.0,0.012530318461358547
0,tissue,1.0,0.17500048875808716
0,suggests,1.0,0.041627660393714905
0,studied,1.0,0.20383524894714355
0,respectively,1.0,0.08458003401756287
0,research,1.0,0.27731871604919434
0,profiles,1.0,0.015331141650676727
0,p,1.0,0.11820723116397858
0,multi,1.0,0.048057474195957184
0,goal,1.0,0.06500711292028427
0,found,1.0,0.03727259859442711
0,focused,1.0,0.060328997671604156
0,evaluate,1.0,0.08850531280040741
0,epigenome,1.0,0.2085411250591278
0,dataset,1.0,0.1345919519662857
0,curve,1.0,-0.04778170958161354
0,context,1.0,0.04743277281522751
0,compare,1.0,0.09237030148506165
0,classifiers,1.0,0.01899723708629608
0,auc,1.0,-0.016484811902046204
0,area,1.0,0.1299571692943573
0,aecs,1.0,0
0,aec,1.0,0
0,additionally,1.0,0.012068133801221848
0,0,1.0,0.04786166548728943
0,automatically detect nocturnal hypoglycemia using,22.666666666666668,0.07286923974752427
0,visualisation method enabling clinicians,16.0,0.15729086908201376
0,tight glucose monitoring reduces,15.5,0.10141230933368206
0,raw ecg signal recorded,14.0,0.08821557089686394
0,blood glucose levels,9.5,0.12890821943680444
0,previous studies based,9.0,0.12067770461241405
0,monitored 24 hours,9.0,0.09647073224186897
0,14 consecutive days,9.0,-0.003653779625892639
0,crucial diabetic patients,8.0,0.2570076634486516
0,ecg signal,6.0,0.18263478577136993
0,diabetic patients,5.0,0.3626551181077957
0,hypoglycemia affects,4.666666666666666,0.10820268839597702
0,wearable devices,4.0,0.17093516886234283
0,subjects failed,4.0,0.06553647574037313
0,strong inter,4.0,0.060590051114559174
0,specific conditions,4.0,0.06827175989747047
0,significantly associated,4.0,0.10379760712385178
0,results advance,4.0,0.0595612283796072
0,learning methods,4.0,0.026072733104228973
0,intelligibility problem,4.0,0.04237242182716727
0,hypoglycemic event,4.0,0.09281031414866447
0,healthy subjects,4.0,0.1198251061141491
0,healthy individuals,4.0,0.07825295999646187
0,"g .,",4.0,0.02275453880429268
0,deploy electrocardiogram,4.0,0.17002745997160673
0,artificial intelligence,4.0,0.1279079094529152
0,subject heterogeneity,3.5,0.08142948150634766
0,hypoglycemia,2.6666666666666665,0.166548490524292
0,subject,1.5,0.022654160857200623
0,wave,1.0,0.00466490164399147
0,visualise,1.0,0
0,tracking,1.0,0.03154240548610687
0,time,1.0,0.05442593991756439
0,st,1.0,-0.026569277048110962
0,series,1.0,0.054160453379154205
0,seizure,1.0,0.036535464227199554
0,risk,1.0,0.19420234858989716
0,result,1.0,0.009511183947324753
0,real,1.0,0.02762891724705696
0,present,1.0,0.0756206065416336
0,part,1.0,0.037912048399448395
0,overcoming,1.0,0.02182142436504364
0,non,1.0,0.06398928165435791
0,irritability,1.0,0.03948258236050606
0,invasive,1.0,0.19703441858291626
0,interval,1.0,0.14205302298069
0,important,1.0,0.07185453921556473
0,however,1.0,-0.011453256011009216
0,heartbeats,1.0,0.22334828972816467
0,heart,1.0,0.30470412969589233
0,fluctuations,1.0,0.0738903284072876
0,feasibility,1.0,0.11239571869373322
0,fatal,1.0,0.10084082186222076
0,even,1.0,0.015417572110891342
0,especially,1.0,0.09752822667360306
0,electrophysiology,1.0,0.6528501510620117
0,e,1.0,0.042460739612579346
0,due,1.0,-0.005625979043543339
0,deep,1.0,0.045967910438776016
0,confusion,1.0,0.014717166312038898
0,complications,1.0,0.2546522915363312
0,cohort,1.0,0.15340903401374817
0,ai,1.0,0.07966839522123337
0,additionally,1.0,0.012068133801221848
0,copyright © 2019 elsevier inc,25.0,0.014825990734001001
0,induced cardiac toxicity among patients,18.88888888888889,0.2611809652298689
0,repeat ann analysis using dosimetry,17.166666666666664,0.10916580557823181
0,undergone stereotactic ablative radiotherapy,15.0,0.2738480754196644
0,dose neutral structure confirmed,14.666666666666666,0.01576175494119525
0,including cardiac dosimetry parameters,14.38888888888889,0.2722908668220043
0,stage nsclc undergoing sabr,12.0,0.10231232643127441
0,modulate confounding behaviors,9.0,0.04818002010385195
0,locally advanced non,9.0,0.06425461297233899
0,cell lung cancer,9.0,0.19772735486427942
0,artificial neural network,9.0,0.10054086024562518
0,74 input features,9.0,0.008707460947334766
0,3 years vs,9.0,0.05054249055683613
0,cardiac radiation dosimetry,8.63888888888889,0.3874152998129527
0,15 cardiac substructures,8.38888888888889,0.37395475804805756
0,significantly longer os,8.0,0.06576568509141605
0,cardiac radiation dose,7.805555555555555,0.2923531432946523
0,4 years ).,7.5,0.02528901770710945
0,rv v10gy dose,6.666666666666666,0.05191740021109581
0,cardiac toxicity,6.388888888888889,0.3775479719042778
0,cardiac dosimetry,6.388888888888889,0.4814695715904236
0,stage nsclc,5.666666666666666,0.05508729815483093
0,os using,5.5,0.006993578746914864
0,cardiac substructures,5.388888888888889,0.37395475804805756
0,undergone sabr,5.333333333333334,0.11024421453475952
0,nsclc ).,5.166666666666666,0
0,ann analysis,5.166666666666666,0.06903650611639023
0,radiation dose,4.916666666666666,0.12889187037944794
0,cardiac follow,4.888888888888889,0.3526470884680748
0,mean dose,4.666666666666666,0.06809468939900398
0,maximum dose,4.666666666666666,0.018855048343539238
0,present analysis,4.5,0.08948754519224167
0,153 patients,4.5,0.4592966139316559
0,112 patients,4.5,0.4592966139316559
0,test accuracy,4.0,0.06708875112235546
0,single institution,4.0,0.06403937749564648
0,rv v10gy,4.0,0.04535781592130661
0,risk might,4.0,0.09812851250171661
0,rights reserved,4.0,0.030988029204308987
0,right ventricle,4.0,0.08423669962212443
0,predictive power,4.0,0.10997296869754791
0,meier method,4.0,0.02466774173080921
0,less well,4.0,0.07417707145214081
0,important predictor,4.0,0.09338973462581635
0,dosimetric variables,4.0,0.16231437306851149
0,decreased os,4.0,0.050335654988884926
0,data support,4.0,0.060604334343224764
0,7 %.,4.0,0.005520308390259743
0,whole heart,3.5,0.1958015188574791
0,overall survival,3.5,0.08623267896473408
0,negatively predicted,3.5,0.03199911257252097
0,ann,2.6666666666666665,0.034718528389930725
0,patients,2.5,0.4592966139316559
0,analysis,2.5,0.10335448384284973
0,sabr,2.3333333333333335,0.09470625221729279
0,radiation,2.25,0.19930675625801086
0,v10gy,2.0,0
0,rv,2.0,0.04535781592130661
0,os,2.0,0.05572452023625374
0,4,2.0,-8.371472358703613e-05
0,survival,1.5,0.13855862617492676
0,predicted,1.5,0.05830582231283188
0,heart,1.5,0.30470412969589233
0,warranted,1.0,0.049046266824007034
0,v50gy,1.0,0
0,v25gy,1.0,0
0,total,1.0,0.003683900460600853
0,subvolumes,1.0,0
0,small,1.0,0.03130773827433586
0,results,1.0,0.0652550756931305
0,received,1.0,0.012420294806361198
0,prioritizing,1.0,0.07201765477657318
0,predict,1.0,0.029006652534008026
0,performed,1.0,0.1553603708744049
0,organ,1.0,0.20346218347549438
0,objective,1.0,0.01818794757127762
0,minimizing,1.0,0.0323416143655777
0,methods,1.0,0.024640876799821854
0,materials,1.0,0.04768626391887665
0,kaplan,1.0,0
0,introduction,1.0,0.021546807140111923
0,included,1.0,0.029688812792301178
0,importance,1.0,0.08358374238014221
0,however,1.0,-0.011453256011009216
0,early,1.0,0.03449202701449394
0,considered,1.0,0.11262063682079315
0,conclusion,1.0,0.03420025110244751
0,characterized,1.0,0.05963318794965744
0,associations,1.0,0.07526065409183502
0,association,1.0,0.10596190392971039
0,associated,1.0,0.10097402334213257
0,assess,1.0,0.061772990971803665
0,analyzed,1.0,0.13667140901088715
0,additionally,1.0,0.012068133801221848
0,64,1.0,0
0,5,1.0,0.010449972003698349
0,2014,1.0,0
0,2009,1.0,0
0,2,1.0,0.03300613537430763
0,induced injury models representing ckd,18.583333333333332,0.06428309204056859
0,reperfusion injury model showed increase,18.166666666666664,0.08531399518251419
0,implicates aryl hydrocarbon receptor,16.0,0.07877596653997898
0,blood urea nitrogen levels,15.0,0.07484954409301281
0,transgenic mouse line expressing,14.5,0.044462861493229866
0,translationally relevant animal models,14.25,0.10451737605035305
0,serum indoxyl sulfate levels,12.5,0.057381595174471535
0,acute kidney injury,10.333333333333332,0.22788383439183235
0,serum indoxyl sulfate,9.5,0.06374773010611534
0,reporter gene mouse,9.5,0.052178144454956055
0,persisted despite reduction,9.0,0.05686705435315768
0,kidney diseases using,9.0,0.14261628687381744
0,indoxyl sulfate levels,9.0,0.07446230575442314
0,following validation using,9.0,0.03875246147314707
0,fed mice showed,9.0,0.046836684147516884
0,"dioxin derivative ),",9.0,0.02039101254194975
0,chronic kidney disease,9.0,0.20107183357079825
0,galactosidase increase coincided,8.583333333333334,0.0375749704738458
0,galactosidase reporter gene,8.25,0.06700308124224345
0,distal renal tubules,8.0,0.2618601322174072
0,canonical ahr ligand,8.0,0.04182950034737587
0,"aki ), respectively",8.0,0.07446910440921783
0,animal models,6.25,0.10543617233633995
0,indoxyl sulfate,6.0,0.10427528619766235
0,significant increase,5.333333333333334,0.06752268224954605
0,discrete models,5.25,0.07559778541326523
0,specific model,5.166666666666667,0.07189378701150417
0,transgenic mice,5.0,0.11334550380706787
0,renal tubules,5.0,0.3186631500720978
0,galactosidase expression,4.25,0.019622274674475193
0,various tissues,4.0,0.08639504015445709
0,uremic toxicity,4.0,0.18517572432756424
0,study demonstrates,4.0,0.13596440106630325
0,results demonstrate,4.0,0.04682372510433197
0,provide hypothesis,4.0,0.0792127326130867
0,promoter tethered,4.0,0.02839609421789646
0,generating insights,4.0,0.11741924285888672
0,emerging evidence,4.0,0.09086420573294163
0,elsevier inc,4.0,0.007824641652405262
0,drinking water,4.0,0.06393536180257797
0,dependent activation,4.0,0.05984760448336601
0,comprehensive analysis,4.0,0.0983453206717968
0,cerebral cortex,4.0,0.16239580512046814
0,cardiac myocytes,4.0,0.404574990272522
0,artificially increased,4.0,0.047837682999670506
0,ahr responsive,4.0,0.023736486211419106
0,ahr induction,4.0,0.05226786620914936
0,ahr activation,4.0,0.04509698413312435
0,specific manifestations,3.666666666666667,0.06636909395456314
0,probe tissue,3.5,0.1443043164908886
0,reperfusion,3.0,0.21687349677085876
0,levels,3.0,0.04464932531118393
0,induced,3.0,-0.006984012201428413
0,ckd,3.0,0
0,galactosidase,2.25,0.038687899708747864
0,mice,2.0,0.08878521621227264
0,aki,2.0,0.0643581748008728
0,ahr,2.0,0.006809871643781662
0,specific,1.6666666666666667,0.08915150165557861
0,tissue,1.5,0.17500048875808716
0,β,1.0,0.06373848021030426
0,warrant,1.0,0.09318732470273972
0,use,1.0,0.0033735278993844986
0,urine,1.0,0.049266472458839417
0,uremia,1.0,0.19908669590950012
0,time,1.0,0.05442593991756439
0,thus,1.0,-0.023273250088095665
0,subjected,1.0,-0.031078075990080833
0,signaling,1.0,0.05109945684671402
0,response,1.0,0.05596902221441269
0,relationship,1.0,0.0036004912108182907
0,recapitulated,1.0,0.09843818843364716
0,published,1.0,0.10513044893741608
0,proximal,1.0,0.17394670844078064
0,pattern,1.0,0.04877403751015663
0,microvasculature,1.0,0.27667921781539917
0,mediator,1.0,0.0685284212231636
0,mechanism,1.0,0.045044392347335815
0,machine,1.0,0.04470905661582947
0,learning,1.0,0.027504589408636093
0,ischemia,1.0,0.27857813239097595
0,investigation,1.0,0.0926906168460846
0,inhibiting,1.0,0.01660192385315895
0,humans,1.0,0.06040411442518234
0,however,1.0,-0.011453256011009216
0,hepatocytes,1.0,0.09208139777183533
0,excretion,1.0,0.04911281168460846
0,distinct,1.0,0.00011970847845077515
0,details,1.0,0.005935193970799446
0,conducted,1.0,0.055469855666160583
0,changes,1.0,-0.006772637367248535
0,adenine,1.0,0.005901865661144257
0,previously published machine learning algorithm,25.0,0.05311735942959785
0,copyright © 2019 elsevier inc,25.0,0.014825990734001001
0,participants ≥ 40 years old,24.0,0.07889330573379993
0,sleep heart health study,14.4,0.2562171183526516
0,years per standard,10.0,0.05278274230659008
0,adjusted hazard ratio,9.0,0.0643040935198466
0,"21 ], p",9.0,0.11820723116397858
0,overnight sleep electroencephalogram,8.4,0.13963889641066393
0,"age norms ),",8.333333333333334,0.09089286625385284
0,reduced life expectancy,8.333333333333332,0.07977507884303729
0,life expectancy decreased,8.333333333333332,0.08221983412901561
0,excess brain age,8.0,0.09863210531572501
0,comparing eeg features,8.0,0.06427210755646229
0,brain age index,8.0,0.12767832477887472
0,81 [- 1,8.0,-0.001867588609457016
0,life expectancy,5.333333333333333,0.10085635632276535
0,brain age,5.0,0.13737871497869492
0,sleep microstructure,4.4,0.11192703992128372
0,sleep eeg,4.4,0.16289515793323517
0,chronological age,4.333333333333334,0.10039451345801353
0,rights reserved,4.0,0.030988029204308987
0,quantified using,4.0,-0.0027791615575551987
0,patterns normal,4.0,0.07037824019789696
0,independent predictor,4.0,0.06677553988993168
0,findings show,4.0,0.1106913685798645
0,based biomarker,4.0,0.19838448241353035
0,4877 ).,4.0,0
0,002 ).,4.0,0
0,deviation increase,3.5,0.07744038105010986
0,ca );,3.5,0.030504325404763222
0,sleep,2.4,0.16289515793323517
0,age,2.3333333333333335,0.10348664224147797
0,eeg,2.0,0
0,1,2.0,-0.001867588609457016
0,deviation,1.5,0.0922837108373642
0,ca,1.5,0.030504325404763222
0,underwent,1.0,0.19980251789093018
0,part,1.0,0.037912048399448395
0,n,1.0,-0.021267158910632133
0,measures,1.0,0.031176652759313583
0,individual,1.0,0.01554524153470993
0,estimated,1.0,0.0099962018430233
0,difference,1.0,0.05812316760420799
0,cohort,1.0,0.15340903401374817
0,bai,1.0,0.06427306681871414
0,ba,1.0,0.02534140646457672
0,associated,1.0,0.10097402334213257
0,apparent,1.0,0.05247381702065468
0,44,1.0,0
0,24,1.0,0
0,12,1.0,0
0,03,1.0,0
0,0,1.0,0.04786166548728943
0,novel hf screening framework based,20.083333333333332,0.09322609603405
0,conveys relevant information related,16.0,0.07303400139790028
0,hf screening without de,14.75,0.07420177292078733
0,reduced ejection fraction automatically,14.0,0.015764055773615837
0,preserved ejection fraction,10.0,-0.0003367569297552109
0,based hidden semi,9.333333333333334,0.031127265344063442
0,hf early screening,9.25,0.09833873187502225
0,gated recurrent unit,9.0,0.15254432956377664
0,crafted feature extraction,9.0,0.0278667410214742
0,cardiovascular disease caused,9.0,0.2552662380039692
0,abnormal cardiac structure,9.0,0.28137923156221706
0,good performance demonstrates,8.0,0.04549215485652288
0,gru model gives,7.533333333333333,0.027140002232044935
0,segment hs frames,7.5,0.010015912664433321
0,proposed gru model,6.533333333333334,0.054264677688479424
0,early screening,6.0,0.09201321564614773
0,therefore based,5.333333333333334,0.054697250947356224
0,automatically learn,5.0,0.03765938617289066
0,normalized frames,4.5,0.020375743974000216
0,proposed model,4.2,0.054264677688479424
0,markov model,4.2,0.05463607236742973
0,timely manner,4.0,0.01326160691678524
0,satisfactory performance,4.0,0.053107086569070816
0,logistic regression,4.0,0.08010278269648552
0,learn features,4.0,0.03278607875108719
0,important implication,4.0,0.06380340456962585
0,identify subjects,4.0,0.09229006804525852
0,hs signals,4.0,-0.003248268738389015
0,hs directly,4.0,0.012654533609747887
0,heart sound,4.0,0.16543865762650967
0,heart failure,4.0,0.2074820026755333
0,expert knowledge,4.0,0.1035585068166256
0,efficient tool,4.0,0.03821410611271858
0,deep features,4.0,0.04473218321800232
0,average accuracy,4.0,0.0271481997333467
0,"82 %,",4.0,0
0,three methods,3.5,0.0509991105645895
0,results show,3.5,0.037321701645851135
0,hs analysis,3.5,0.048361023887991905
0,comparison models,3.5,0.11063048616051674
0,hf,3.25,0.1109897643327713
0,gru,2.3333333333333335,0
0,model,2.2,0.05463607236742973
0,proposed,2.0,0.053893283009529114
0,performance,2.0,0.034930430352687836
0,hs,2.0,-0.006632436066865921
0,results,1.5,0.0652550756931305
0,methods,1.5,0.024640876799821854
0,comparison,1.5,0.11286726593971252
0,analysis,1.5,0.10335448384284973
0,used,1.0,0.010911919176578522
0,type,1.0,0.038444433361291885
0,treatment,1.0,0.27399298548698425
0,taken,1.0,0.015877021476626396
0,study,1.0,0.2376001477241516
0,objective,1.0,0.01818794757127762
0,nosing,1.0,-0.027487633749842644
0,normal,1.0,0.08618243783712387
0,means,1.0,-0.011965315788984299
0,input,1.0,-0.02608153410255909
0,independent,1.0,0.018626149743795395
0,hand,1.0,-0.03252475708723068
0,function,1.0,0.11069313436746597
0,evaluate,1.0,0.08850531280040741
0,effectiveness,1.0,0.07677281647920609
0,develop,1.0,0.10439212620258331
0,conclusion,1.0,0.03420025110244751
0,complete,1.0,-0.01845567114651203
0,better,1.0,0.06907322257757187
0,background,1.0,0.03833860531449318
0,adopted,1.0,0.036430153995752335
0,addition,1.0,0.1140233725309372
0,98,1.0,0
0,improve coronary heart disease,16.0,0.2537367455661297
0,even advanced multivariate subgrouping,14.75,0.08917408064007759
0,comprehensive lipoprotein subclass data,12.333333333333332,0.11742260865867138
0,advance chd risk assessment,11.833333333333334,0.11066222563385963
0,copyright © 2019,9.0,0.01832666527479887
0,artificial intelligence methodology,9.0,0.1003768468896548
0,also striking dose,9.0,0.02974361926317215
0,driven metabolic subgrouping,8.75,0.15189987793564796
0,distinct lipoprotein profiles,8.666666666666666,0.0863042523463567
0,detailed lipoprotein profiles,8.666666666666666,0.102725800126791
0,containing lipoprotein particles,8.666666666666666,0.07924254486958186
0,scale population cohorts,8.0,0.06907390306393306
0,identified four som,8.0,0.040186176697413124
0,mediated chd risk,7.833333333333334,0.13930997997522354
0,apolipoprotein b quartiles,7.833333333333334,0.11799608170986176
0,define subgroups based,7.5,0.06915139313787222
0,comprehensive data,5.666666666666666,0.09975692257285118
0,risk assessment,5.333333333333334,0.1390596479177475
0,chd risk,4.833333333333334,0.19420234858989716
0,apolipoprotein b,4.833333333333334,0.11756717413663864
0,univariate subgrouping,4.75,0.17608550190925598
0,population subgrouping,4.75,0.1400190144777298
0,unsupervised data,4.666666666666666,0.062471356242895126
0,lipoprotein metabolism,4.666666666666666,0.2194259911775589
0,based subgroups,4.5,0.10964987054467201
0,lowest risk,4.333333333333334,0.10560203809291124
0,elsevier b,4.333333333333334,0.033724576234817505
0,would work,4.0,0.049196621403098106
0,trained som,4.0,0.0373152419924736
0,rights reserved,4.0,0.030988029204308987
0,response behaviour,4.0,0.05596902221441269
0,organizing map,4.0,0.04522853624075651
0,lowest concentrations,4.0,0.05109940189868212
0,independent cohort,4.0,0.08601759187877178
0,hdl measures,4.0,0.04244064353406429
0,based cohort,4.0,0.1192891038954258
0,7607 ).,4.0,0
0,results suggest,3.5,0.05601985938847065
0,highest concentrations,3.5,0.059084730222821236
0,based subgroup,3.5,0.08692967146635056
0,lipoprotein,2.6666666666666665,0.24346190690994263
0,chd,2.5,0
0,risk,2.3333333333333335,0.19420234858989716
0,som,2.0,-0.0491781085729599
0,population,2.0,0.1400190144777298
0,based,2.0,0.08516917377710342
0,subgroup,1.5,0.08869016915559769
0,results,1.5,0.0652550756931305
0,highest,1.5,0.03297238424420357
0,v,1.0,0.019843820482492447
0,utilised,1.0,0
0,therefore,1.0,0.024225328117609024
0,suggested,1.0,0.05237164720892906
0,self,1.0,0.05501733347773552
0,published,1.0,0.10513044893741608
0,non,1.0,0.06398928165435791
0,n,1.0,-0.021267158910632133
0,methods,1.0,0.024640876799821854
0,means,1.0,-0.011965315788984299
0,may,1.0,-0.009713593870401382
0,majority,1.0,0.026061898097395897
0,large,1.0,0.07130777090787888
0,individuals,1.0,0.054066821932792664
0,however,1.0,-0.011453256011009216
0,explored,1.0,0.10362917929887772
0,explained,1.0,0.09177323430776596
0,conclusions,1.0,0.07628431916236877
0,compared,1.0,0.10162706673145294
0,background,1.0,0.03833860531449318
0,authors,1.0,0.21598771214485168
0,applied,1.0,0.006987035274505615
0,aims,1.0,0.04269438236951828
0,5789,1.0,0
0,angptl4 show instead lower tg,20.5,0.06504038535058498
0,targets also partially reduces ldl,20.166666666666668,0.03516053128987551
0,"c ), ascvd risk",13.333333333333334,0.11769891902804375
0,new therapeutic targets,9.5,0.14279050131638846
0,"ascvd ), genetic",9.333333333333334,0.14568692445755005
0,metabolic abnormalities characterized,9.0,0.18973019470771155
0,like proteins 3,9.0,0.06095490542550882
0,copyright © 2020,9.0,0.01832666527479887
0,better pharmacological target,9.0,0.1205684741338094
0,atherosclerotic cardiovascular disease,9.0,0.32278160750865936
0,angptl4 induces activation,9.0,0.047091588377952576
0,3 clinical trials,9.0,0.21364745932320753
0,major side effects,8.5,0.045416937520106636
0,"lpl ), antagonizing",8.333333333333334,0.0913989245891571
0,density lipoprotein cholesterol,7.833333333333334,0.20296098291873932
0,antisense oligonucleotide angptl3,7.5,0.1572440043091774
0,also dependent,5.5,0.03940634988248348
0,density lipoprotein,4.833333333333334,0.18309740722179413
0,ldl receptor,4.666666666666666,0.09437026083469391
0,tg ).,4.5,0.11089863628149033
0,plasma tg,4.5,0.1409715972840786
0,new angptl3,4.5,0.10631739348173141
0,major role,4.5,0.057752544060349464
0,antisense oligonucleotides,4.5,0.1439826749265194
0,lipoprotein lipase,4.333333333333334,0.1796080730855465
0,still needed,4.0,0.02503137569874525
0,similar evidence,4.0,0.07097295485436916
0,significant increase,4.0,0.06752268224954605
0,provided data,4.0,0.04858158901333809
0,prandial levels,4.0,0.07011855766177177
0,plasma levels,4.0,0.1078469417989254
0,phase 2,4.0,0.022693641483783722
0,murine models,4.0,0.11007319390773773
0,monoclonal antibodies,4.0,0.12355393916368484
0,marked reduction,4.0,0.05334847792983055
0,including non,4.0,0.06365767121315002
0,human primates,4.0,0.09901634976267815
0,genetic studies,4.0,0.19772488623857498
0,function mutations,4.0,0.10775118693709373
0,experimental evidence,4.0,0.11312074400484562
0,elsevier ltd,4.0,0.036545224487781525
0,elevated fasting,4.0,0.11189347133040428
0,efficacy profile,4.0,0.13016825541853905
0,conclusive data,4.0,0.09317950531840324
0,atherogenic dyslipidemias,4.0,0.2651878297328949
0,apparently without,4.0,-0.03499055653810501
0,animal models,4.0,0.10543617233633995
0,term treatment,3.5,0.16576884500682354
0,head comparison,3.5,0.09867046773433685
0,hdl ).,3.5,0.053704634308815
0,beyond low,3.5,0.03432120382785797
0,4 antagonists,3.5,0.05366957187652588
0,rich lipoproteins,3.0,0.08345704339444637
0,angptl4,3.0,0
0,ldl,2.6666666666666665,0
0,tg,2.5,0.11089863628149033
0,c,2.5,0.04119548946619034
0,lpl,2.0,0
0,angptl3,2.0,0
0,treatment,1.5,0.27399298548698425
0,studies,1.5,0.24976284801959991
0,rich,1.5,0.03535805270075798
0,low,1.5,0.06519334763288498
0,lipoproteins,1.5,0.13155603408813477
0,head,1.5,0.08447366952896118
0,hdl,1.5,0.053704634308815
0,4,1.5,-8.371472358703613e-05
0,way,1.0,-0.018800776451826096
0,vldl,1.0,0
0,triglycerides,1.0,0.22974732518196106
0,short,1.0,0.011583387851715088
0,safety,1.0,0.19278490543365479
0,remnants,1.0,-0.07162114977836609
0,relevance,1.0,0.032082222402095795
0,regulating,1.0,0.07387600094079971
0,published,1.0,0.10513044893741608
0,proven,1.0,0.05978071689605713
0,post,1.0,0.10225207358598709
0,paved,1.0,0.008062216453254223
0,order,1.0,-0.015195201151072979
0,observed,1.0,0.08740169554948807
0,modest,1.0,0.026598036289215088
0,lrx,1.0,0
0,loss,1.0,0.0528750903904438
0,inhibition,1.0,0.03232728689908981
0,independent,1.0,0.018626149743795395
0,indeed,1.0,0.02782384306192398
0,hypertriglyceridemia,1.0,0.2080441117286682
0,hydrolysis,1.0,-0.02199055254459381
0,humans,1.0,0.06040411442518234
0,high,1.0,0.06070782244205475
0,found,1.0,0.03727259859442711
0,former,1.0,0.023285511881113052
0,development,1.0,0.1793753206729889
0,determinants,1.0,0.14320151507854462
0,demonstrated,1.0,0.0564635805785656
0,define,1.0,-0.011845561675727367
0,cluster,1.0,0.13339947164058685
0,carriers,1.0,0.0009299982339143753
0,associated,1.0,0.10097402334213257
0,angiopoietin,1.0,0.098587267100811
0,among,1.0,0.09849628061056137
0,activity,1.0,0.01650470495223999
0,approved drug targeting ikkε,15.0,0.11822428057591121
0,combined genetic mouse model,14.5,0.06208374258130789
0,human breast cancer tissues,13.95,0.17000863142311573
0,breast cancer oncogene ikkε,13.45,0.20383465538422266
0,human healthy donors,9.5,0.10483638445536296
0,breast cancer associated,9.45,0.19615726669629416
0,breast tissue leading,9.2,0.15831726292769113
0,vivo tumour formation,9.0,0.11437010392546654
0,serine biosynthesis pathway,9.0,0.03813344364364942
0,potential therapeutic strategy,9.0,0.14621483782927194
0,factor considered responsible,9.0,0.052743569016456604
0,pathway connecting obesity,8.0,0.11911950632929802
0,grade chronic inflammation,8.0,0.09798703094323476
0,breast cancer,6.45,0.24374888837337494
0,© 2020,4.0,0.024751247838139534
0,pharmacological tools,4.0,0.11925086658447981
0,medium conditioned,4.0,-0.005938710644841194
0,macrophages infiltrate,4.0,0.09092675149440765
0,macrophages derived,4.0,0.047424687538295984
0,induced obesity,4.0,0.12821147497743368
0,homologue tbk1,4.0,0.03471856564283371
0,formally demonstrate,4.0,0.028481854125857353
0,fat diet,4.0,0.09509199112653732
0,driven inflammation,4.0,0.10050170496106148
0,downstream target,4.0,0.03712199069559574
0,cellular metabolism,4.0,0.1656900942325592
0,0 license,4.0,0.04783251881599426
0,higher risk,3.5,0.15365959703922272
0,ikkε,3.0,0
0,genetic,2.5,0.14568692445755005
0,obesity,2.0,0.2634069621562958
0,inflammation,2.0,0.16907447576522827
0,risk,1.5,0.19420234858989716
0,validated,1.0,0.08453492820262909
0,terms,1.0,0.08489501476287842
0,reduce,1.0,0.08915511518716812
0,published,1.0,0.10513044893741608
0,mediated,1.0,0.08441761136054993
0,low,1.0,0.06519334763288498
0,link,1.0,0.0573977567255497
0,identified,1.0,0.10330121219158173
0,high,1.0,0.06070782244205475
0,furthermore,1.0,-0.04380498453974724
0,finally,1.0,-0.036436013877391815
0,fda,1.0,0.12308475375175476
0,exposed,1.0,0.025203905999660492
0,effects,1.0,0.04013404995203018
0,demonstrated,1.0,0.0564635805785656
0,delayed,1.0,0.022720033302903175
0,cc,1.0,0.1696670651435852
0,authors,1.0,0.21598771214485168
0,amlexanox,1.0,0
0,altogether,1.0,0.0018933191895484924
0,alteration,1.0,0.0038754730485379696
0,4,1.0,-8.371472358703613e-05
0,technologies mostly target older adults,20.2,0.08236526995897293
0,included three external variables,16.0,0.05303584737703204
0,using wearable healthcare technologies,14.25,0.16370974108576775
0,"e ., technology anxiety",13.666666666666666,0.10642477869987488
0,perceived ubiquity construct affects,13.5,0.017020114697515965
0,sensor technologies represent,9.75,0.16466748714447021
0,including older adults,9.45,0.08684574936827023
0,using new technology,9.166666666666666,0.09094270318746567
0,wearing smart clothes,9.0,0.04992654174566269
0,hypothesized model showed,9.0,0.06986963128050168
0,everyday health conditions,9.0,0.12047616268197696
0,continuously recording people,9.0,0.046656198178728424
0,"81 participants ),",9.0,0.06751469522714615
0,among older adults,8.95,0.09856915598114331
0,mobile wireless technologies,8.75,0.16541812320550284
0,technology acceptance model,8.666666666666666,0.1127035307387511
0,technology acceptance behavior,8.666666666666666,0.10546111563841502
0,determining older users,8.2,0.0700897965580225
0,older adults,6.45,0.09860559366643429
0,technology anxiety,5.666666666666666,0.13840679824352264
0,perceived ubiquity,5.5,-0.002799723297357559
0,wearable devices,5.0,0.17093516886234283
0,relationships among,4.5,0.05285274423658848
0,perceived usefulness,4.5,0.04540914669632912
0,perceived ease,4.5,0.03608732670545578
0,user groups,4.0,0.04403817653656006
0,traditional components,4.0,0.0581503976136446
0,original constructs,4.0,-0.018015174195170403
0,negative effect,4.0,0.01399598247371614
0,may enhance,4.0,0.04312879033386707
0,indirect effect,4.0,-0.011605968931689858
0,cardiovascular disease,4.0,0.3688889145851135
0,biomedical signals,4.0,0.2268461138010025
0,behavioral intention,4.0,0.07342912163585424
0,affect users,4.0,0.05771458335220814
0,31 outpatients,4.0,0.4107869267463684
0,tam ).,3.666666666666667,0.010671783238649368
0,extended tam,3.666666666666667,-0.0042148251086473465
0,risk patients,3.5,0.3267494812607765
0,technology,2.6666666666666665,0.2082480788230896
0,wireless,2.0,0.16406379640102386
0,users,2.0,0.05023464933037758
0,tam,1.6666666666666667,0.010671783238649368
0,patients,1.5,0.4592966139316559
0,validity,1.0,0.028293684124946594
0,validated,1.0,0.08453492820262909
0,use,1.0,0.0033735278993844986
0,understanding,1.0,0.037985511124134064
0,treatment,1.0,0.27399298548698425
0,study,1.0,0.2376001477241516
0,shown,1.0,0.044945128262043
0,results,1.0,0.0652550756931305
0,resistance,1.0,-0.012645460665225983
0,perception,1.0,0.037292104214429855
0,obtain,1.0,0.024071499705314636
0,method,1.0,0.016362402588129044
0,interestingly,1.0,0.01742842048406601
0,given,1.0,0.014340896159410477
0,general,1.0,0.14236244559288025
0,found,1.0,0.03727259859442711
0,examine,1.0,0.12551988661289215
0,diagnosis,1.0,0.24688632786273956
0,considered,1.0,0.11262063682079315
0,confirm,1.0,0.02169613540172577
0,characteristic,1.0,0.01731044426560402
0,change,1.0,-0.0021246224641799927
0,attitude,1.0,0.02193225920200348
0,advances,1.0,0.1283981204032898
0,addition,1.0,0.1140233725309372
0,four thousand three hundred thirty,24.0,0.027090127021074294
0,population reporting positive dietary behaviours,17.533333333333335,0.07728529302403331
0,46 nationally representative surveys,16.0,0.03532430777947108
0,males reported positive sub,13.166666666666668,0.05812704190611839
0,related cvd risk factors,12.5,0.11482787256439526
0,"sub ), meeting fruit",11.5,0.09417998418211937
0,positive salt use behaviour,11.333333333333334,-0.0023972907414038977
0,three dietary behaviours,10.2,0.11732501164078712
0,dietary behaviours related,9.7,0.14038702845573425
0,positive behaviours increases,9.533333333333333,0.0335276834666729
0,generalized linear models,9.0,0.053460544596115746
0,dietary behaviour measurements,9.0,0.15240547806024551
0,cvd risk factors,9.0,0.1105011198669672
0,"7 %, varying",9.0,-0.008712119422852993
0,"8 %, p",8.6,0.05388450529426336
0,"6 %, p",8.6,0.06631398946046829
0,"5 %, p",8.6,0.06432860158383846
0,middle income countries,8.333333333333334,0.04233554440240065
0,vegetable oil rather,8.0,0.05858286718527476
0,understand whether associations,8.0,0.03418383623162905
0,sex would change,8.0,0.019359012444814045
0,"9 %, p",7.6,0.051567317917943
0,dietary behaviours,6.2,0.1572926789522171
0,dietary behaviour,6.0,0.1572926789522171
0,cvd risk,5.5,0.19420234858989716
0,positive subs,5.333333333333334,0.03651653602719307
0,positive manner,5.333333333333334,0.011260611936450005
0,poor sub,5.333333333333334,0.11069182306528091
0,understand whether,5.0,0.01364542730152607
0,meeting f,4.666666666666667,0.04576711729168892
0,"04 ),",4.666666666666666,0
0,"01 ),",4.666666666666666,0
0,seven countries,4.333333333333334,0.055816229432821274
0,waist circumference,4.0,0.10453496873378754
0,urgently needed,4.0,0.07509406842291355
0,urgent action,4.0,0.04816771298646927
0,two participants,4.0,0.07082313299179077
0,st vincent,4.0,0.014862632378935814
0,small proportion,4.0,0.049277735874056816
0,sex differences,4.0,0.08822785504162312
0,nutrition transition,4.0,0.12113450840115547
0,notably different,4.0,0.062111616134643555
0,lmic ).,4.0,0
0,leading causes,4.0,0.07052885740995407
0,interaction terms,4.0,0.05844408646225929
0,included countries,4.0,0.050362151116132736
0,diets high,4.0,0.08853452652692795
0,diagnosed hypertension,4.0,0.2424214482307434
0,cardiovascular diseases,4.0,0.40692125260829926
0,animal fats,4.0,0.11840036511421204
0,aid identification,4.0,0.060509104281663895
0,2017 ).,4.0,0
0,05 ).,4.0,0
0,02 ).,4.0,0
0,vs 22,3.75,0.08122316002845764
0,3 vs,3.75,0.05048286076635122
0,v intake,3.666666666666667,0.0829950887709856
0,undiagnosed hypertension,3.666666666666667,0.2591855525970459
0,increasing prevalence,3.666666666666667,0.10552124865353107
0,increase f,3.666666666666667,0.03340049088001251
0,included data,3.666666666666667,0.06793325021862984
0,higher prevalence,3.666666666666667,0.13447841256856918
0,high wc,3.5,0.05496258661150932
0,effective interventions,3.5,0.07961596548557281
0,2 vs,3.25,0.05711464770138264
0,v recommendations,3.166666666666667,0.06333994679152966
0,undiagnosed diabetes,3.166666666666667,0.23389938473701477
0,reporting,3.0,0.002092784270644188
0,p,2.6,0.11820723116397858
0,use,2.5,0.0033735278993844986
0,salt,2.5,-0.020302094519138336
0,males,2.5,0.06523969769477844
0,fruit,2.5,0.03746720775961876
0,cvd,2.5,0
0,vegetable,2.0,0.10064415633678436
0,sex,2.0,0.025031838566064835
0,9,2.0,-0.015072595328092575
0,vs,1.75,0.08122316002845764
0,v,1.6666666666666667,0.019843820482492447
0,undiagnosed,1.6666666666666667,0.15374761819839478
0,prevalence,1.6666666666666667,0.1558399796485901
0,included,1.6666666666666667,0.029688812792301178
0,f,1.6666666666666667,0.004203930497169495
0,wc,1.5,0.0492173507809639
0,recommendations,1.5,0.10683607310056686
0,interventions,1.5,0.13485746085643768
0,diabetes,1.5,0.31405115127563477
0,2,1.5,0.03300613537430763
0,women,1.0,0.14002981781959534
0,vegetables,1.0,0.11610875278711319
0,value,1.0,0.012530318461358547
0,used,1.0,0.010911919176578522
0,twenty,1.0,0.025144485756754875
0,trend,1.0,0.07326872646808624
0,test,1.0,0.08394099026918411
0,sugar,1.0,0.04370478540658951
0,sexes,1.0,0.05338051915168762
0,reverse,1.0,-0.026650352403521538
0,results,1.0,0.0652550756931305
0,research,1.0,0.27731871604919434
0,required,1.0,-0.0036199837923049927
0,recorded,1.0,0.01999819651246071
0,parallel,1.0,0.08594085276126862
0,nepal,1.0,-0.010250802151858807
0,need,1.0,0.09471543878316879
0,methods,1.0,0.024640876799821854
0,men,1.0,0.09247083961963654
0,low,1.0,0.06519334763288498
0,lmics,1.0,0
0,limited,1.0,0.009723823517560959
0,kenya,1.0,-0.02073751948773861
0,investigated,1.0,0.0572904571890831
0,investigate,1.0,0.04426265507936478
0,interactions,1.0,0.01733073592185974
0,identifies,1.0,0.0749189555644989
0,however,1.0,-0.011453256011009216
0,guyana,1.0,0
0,grenadines,1.0,0
0,georgia,1.0,0.0072740111500024796
0,findings,1.0,0.21199440956115723
0,females,1.0,0.09382091462612152
0,fat,1.0,0.07365494966506958
0,eswatini,1.0,0
0,diet,1.0,0.11652903258800507
0,death,1.0,0.12083880603313446
0,dataset,1.0,0.1345919519662857
0,crucial,1.0,0.045712754130363464
0,country,1.0,0.03611394017934799
0,cooking,1.0,0.09309457987546921
0,conclusion,1.0,0.03420025110244751
0,bhutan,1.0,0
0,background,1.0,0.03833860531449318
0,association,1.0,0.10596190392971039
0,associated,1.0,0.10097402334213257
0,adults,1.0,0.051906388252973557
0,added,1.0,0.07914778590202332
0,4,1.0,-8.371472358703613e-05
0,31,1.0,0
0,27,1.0,0
0,24,1.0,0
0,2013,1.0,0
0,14,1.0,0
0,13,1.0,0
0,1,1.0,-0.001867588609457016
0,0,1.0,0.04786166548728943
0,continuous combined oestrogen plus progestogen,24.0,0.07330138981342316
0,three groups taking daily 2,23.0,0.029457681253552435
0,© 2020 john wiley,16.0,0.01283923846979936
0,suggesting decreased cholesterol loading,15.0,0.08325034100562334
0,apolipoprotein ai (- 29,14.25,0.14053908362984657
0,tibolone reduces serum hdl,12.666666666666666,0.09641320072114468
0,principal hdl protein component,12.666666666666666,0.05905203428119421
0,neta reduces ldl cholesterol,12.166666666666666,0.11936797201633453
0,continuous oral oestradiol,10.0,0.10616718977689743
0,reduced (- 27,9.25,0.03761252388358116
0,similarly diminished relative,9.0,0.026002008467912674
0,main outcome measures,9.0,0.054799883315960564
0,fasting serum lipid,9.0,0.1366153433918953
0,cvd risk needs,8.5,0.13244888186454773
0,blind study patients,8.5,0.2387076516946157
0,apolipoprotein concentrations measured,8.5,0.12023848791917165
0,neta reduced hdl,8.333333333333332,0.05344395712018013
0,c (- 22,8.25,0.04119548946619034
0,tibolone (- 12,7.75,0.2623269259929657
0,density lipoprotein cholesterol,7.0,0.20296098291873932
0,protein component,6.0,0.04374817572534084
0,hdl concentrations,5.166666666666666,0.06945085525512695
0,apolipoprotein b,5.0,0.11756717413663864
0,hdl apolipoproteins,4.666666666666666,0.15053748339414597
0,study design,4.5,0.18439188599586487
0,plasma lipid,4.5,0.2079559564590454
0,cardiovascular risk,4.5,0.38447242230176926
0,5mg tibolone,4.5,0.1683463752269745
0,sons ltd,4.0,0.05613034591078758
0,respectively ).,4.0,0.08458003401756287
0,menopausal women,4.0,0.13960367441177368
0,lipoprotein markers,4.0,0.14080185070633888
0,lesser extent,4.0,0.030761336907744408
0,healthy post,4.0,0.10234558582305908
0,greatest reduction,4.0,0.0704815499484539
0,changes may,4.0,-0.008243115618824959
0,also apparent,4.0,0.04748770222067833
0,24 months,4.0,0.04044569283723831
0,101 post,4.0,0.10225207358598709
0,008 ).,4.0,0
0,001 ).,4.0,0
0,"001 ),",4.0,0
0,significant effect,3.666666666666667,0.03837192221544683
0,greatest effect,3.666666666666667,0.013444689800962806
0,cholesterol,3.0,0.2426881343126297
0,2,3.0,0.03300613537430763
0,neta,2.6666666666666665,0.06901471316814423
0,hdl,2.6666666666666665,0.053704634308815
0,tibolone,2.5,0.2623269259929657
0,ldl,2.5,0
0,lipoprotein,2.0,0.24346190690994263
0,density,2.0,0.12273290753364563
0,c,2.0,0.04119548946619034
0,12,2.0,0
0,effect,1.6666666666666667,0.004295531194657087
0,vldl,1.0,0
0,treatment,1.0,0.27399298548698425
0,single,1.0,0.015469912439584732
0,results,1.0,0.0652550756931305
0,randomised,1.0,0
0,placebo,1.0,0.1521017700433731
0,p,1.0,0.11820723116397858
0,one,1.0,0.060579702258110046
0,objective,1.0,0.01818794757127762
0,low,1.0,0.06519334763288498
0,investigation,1.0,0.0926906168460846
0,impact,1.0,0.029600899666547775
0,however,1.0,-0.011453256011009216
0,high,1.0,0.06070782244205475
0,effects,1.0,0.04013404995203018
0,e2,1.0,0.026212796568870544
0,double,1.0,0.06585106253623962
0,controlled,1.0,0.01649477332830429
0,contrast,1.0,0.11486168205738068
0,conclusion,1.0,0.03420025110244751
0,compare,1.0,0.09237030148506165
0,centre,1.0,0
0,baseline,1.0,0.05839666724205017
0,6,1.0,0.014420747756958008
0,3,1.0,0.019742561504244804
0,1,1.0,-0.001867588609457016
0,0,1.0,0.04786166548728943
0,randomized controlled trials exist,16.0,0.1081011202186346
0,aha )/ american college,15.5,0.05913352329904834
0,ef ≥ 50 %).,15.0,0.11043588072061539
0,ef ≤ 40 %),15.0,0.06511054560542107
0,unique phenotype altogether,9.0,0.04243475695451101
0,remains poorly understood,9.0,0.017611078917980194
0,mortality rates among,9.0,0.15200363844633102
0,include overlap suggest,9.0,0.06843713546792667
0,heterogeneous clinical characteristics,9.0,0.22591565921902657
0,american heart association,9.0,0.13888628330702582
0,mineralocorticoid receptor antagonists,8.666666666666666,0.12379894157250722
0,reduced ejection fraction,8.5,0.003271050751209259
0,preserved ejection fraction,8.5,-0.0003367569297552109
0,times resembles hfref,8.0,0.010520853102207184
0,angiotensin receptor blockers,7.666666666666666,0.1153479553759098
0,range ejection fraction,7.5,0.017157687495152157
0,hfmref patients represent,7.0,0.28996559977531433
0,ejection fraction,5.5,-0.013899685814976692
0,angiotensin receptor,5.166666666666666,0.15015103667974472
0,heart failure,4.5,0.2074820026755333
0,beta blockers,4.5,0.04017282463610172
0,ultimately came,4.0,0.009806003421545029
0,though hfref,4.0,0.000676378607749939
0,recent findings,4.0,0.12625432386994362
0,potential benefit,4.0,0.06485588848590851
0,others still,4.0,0.022606109268963337
0,neprilysin inhibitors,4.0,0.11038336157798767
0,hfmref population,4.0,0.1400190144777298
0,hfmref ).,4.0,0
0,gray zone,4.0,0.0446006297133863
0,future research,4.0,0.19114605337381363
0,complex disorder,4.0,0.08638937026262283
0,classification created,4.0,0.0072456467896699905
0,better elucidate,4.0,0.06758690997958183
0,others hfpef,3.666666666666667,0.04656439274549484
0,hfpef studies,3.666666666666667,0.24976284801959991
0,ef,3.0,0.0846770852804184
0,range,2.0,0.07927243411540985
0,patients,2.0,0.4592966139316559
0,hfref,2.0,0
0,hfmref,2.0,0
0,hfpef,1.6666666666666667,0
0,similar,1.0,0.08377962559461594
0,significant,1.0,0.07244831323623657
0,review,1.0,0.06275224685668945
0,purpose,1.0,-0.006926483474671841
0,prognosis,1.0,0.23093095421791077
0,pathophysiology,1.0,0.3145177364349365
0,needed,1.0,0.05141492560505867
0,mid,1.0,0.01741810142993927
0,management,1.0,0.23943668603897095
0,known,1.0,0.03723067417740822
0,group,1.0,0.05019131675362587
0,epidemiology,1.0,0.5018433332443237
0,efs,1.0,0
0,describe,1.0,-0.011884354054927826
0,condition,1.0,0.1885339617729187
0,cardiology,1.0,1.0
0,borderline,1.0,0.04753698781132698
0,assigned,1.0,0.027462657541036606
0,acc,1.0,0.031766559928655624
0,49,1.0,0
0,41,1.0,0
0,2013,1.0,0
0,simple adequate diagnosis approach enabling,23.0,0.05546252690255642
0,obtain efficient algorithm classification models,23.0,0.06569989249110222
0,femoral pulse wave velocity,16.0,0.09601000463590026
0,"artificial neural networks ,""",15.0,0.0984438161055247
0,renal circulations models,9.0,0.21952311942974725
0,measured using carotid,9.0,0.10692945122718811
0,mean blood pressure,9.0,0.1193637525041898
0,pwv index determinations,8.6,0.040988555178046227
0,individual pwv index,8.6,0.06191139295697212
0,usual clinical practice,8.5,0.23101734121640524
0,high cardiovascular risk,8.5,0.27655088901519775
0,large arteries prediction,8.25,0.1356812839706739
0,angiographic chd decisions,8.25,0.18281084764748812
0,"pwv ), particularly",8.1,0.09882432222366333
0,present review focuses,8.0,0.06809098273515701
0,index involving age,8.0,0.0970173900326093
0,coronary heart disease,8.0,0.30995577573776245
0,pwv index may,7.6,0.049281975254416466
0,defined chd prediction,7.5,0.04327132040634751
0,artificial intelligence,5.0,0.1279079094529152
0,coronary prediction,4.75,0.26980457454919815
0,particularly relevant,4.5,0.09507549554109573
0,high levels,4.5,0.05267857387661934
0,heart rate,4.5,0.20280320569872856
0,clinical characteristics,4.5,0.2635910790413618
0,chd ).,4.25,0
0,vulnerable plaques,4.0,0.100182194262743
0,substantial marker,4.0,0.053410956636071205
0,recent works,4.0,0.06085926666855812
0,recent findings,4.0,0.12625432386994362
0,major predictor,4.0,0.0943070687353611
0,decision tree,4.0,0.01597189251333475
0,aortic stiffness,4.0,0.2073110193014145
0,also used,4.0,0.02670675329864025
0,widely associated,3.5,0.07393751665949821
0,models,3.0,0.10839370638132095
0,enabling,3.0,0.018889283761382103
0,pwv,2.6,0
0,prediction,2.25,0.07748128473758698
0,chd,2.25,0
0,review,2.0,0.06275224685668945
0,may,2.0,-0.009713593870401382
0,involving,2.0,0.07928798347711563
0,associated,1.5,0.10097402334213257
0,variability,1.0,0.1899898201227188
0,use,1.0,0.0033735278993844986
0,together,1.0,0.0037281587719917297
0,symptoms,1.0,0.1447140872478485
0,results,1.0,0.0652550756931305
0,relation,1.0,0.07857805490493774
0,purpose,1.0,-0.006926483474671841
0,presence,1.0,0.03234631195664406
0,possible,1.0,0.014038797467947006
0,patients,1.0,0.4592966139316559
0,parameter,1.0,0.057895369827747345
0,measurement,1.0,0.1633169949054718
0,interest,1.0,0.08689615875482559
0,improve,1.0,0.08507965505123138
0,imperfections,1.0,-0.05309125781059265
0,hypertension,1.0,0.364623486995697
0,gender,1.0,0.08549608290195465
0,due,1.0,-0.005625979043543339
0,damage,1.0,0.03876449540257454
0,constitute,1.0,0.08978849649429321
0,considered,1.0,0.11262063682079315
0,consider,1.0,0.0554787740111351
0,cerebrovascular,1.0,0.42472130060195923
0,calculation,1.0,0.006885142996907234
0,addition,1.0,0.1140233725309372
0,accuracy,1.0,0.05023651197552681
0,cell subsets compared across tissues,20.0,0.10764573961496353
0,provide effective recall responses,15.0,0.018439022824168205
0,lung draining lymph node,14.666666666666666,0.11497419560328126
0,abundance throughout tissues,10.0,0.055957432836294174
0,cell receptor analysis,9.25,0.1004092867175738
0,recognize distinct antigens,9.0,0.0217315877477328
0,including higher expression,9.0,0.058999851966897644
0,different precursor pools,9.0,0.04467801873882612
0,paired human lung,8.666666666666666,0.1341235116124153
0,innate immune receptors,8.5,0.04317892932643493
0,identified substantial differences,8.0,0.10255308200915654
0,clonal overlap observed,8.0,0.11239932229121526
0,cell subsets within,8.0,0.11093318214019139
0,cell subsets,6.0,0.1341228224337101
0,immune responses,5.5,0.0350717157125473
0,clonal overlap,5.0,0.12489813566207886
0,transcriptional landscape,4.0,0.08073817985132337
0,study focused,4.0,0.14896457269787788
0,separate roles,4.0,0.06673466600477695
0,results suggest,4.0,0.05601985938847065
0,flow cytometry,4.0,0.14311635494232178
0,specific memory,3.8,0.08743619918823242
0,many memory,3.8,0.06628750264644623
0,cd8 memory,3.8,0.08572089672088623
0,cells persist,3.666666666666667,0.05757993459701538
0,cells originate,3.666666666666667,0.04161769896745682
0,ldln memory,3.3,0.08572089672088623
0,subsets,2.75,0.16474252939224243
0,lung,2.6666666666666665,0.2565838694572449
0,within,2.0,0.06455390155315399
0,identified,2.0,0.10330121219158173
0,memory,1.8,0.08572089672088623
0,cells,1.6666666666666667,0.06259886920452118
0,ldln,1.5,0
0,years,1.0,0.05066175013780594
0,validated,1.0,0.08453492820262909
0,using,1.0,-0.04173736274242401
0,samples,1.0,0.053145233541727066
0,pathogen,1.0,0.08378986269235611
0,likely,1.0,0.06529493629932404
0,greater,1.0,0.09047040343284607
0,exposure,1.0,0.00614194106310606
0,differ,1.0,0.033852480351924896
0,determined,1.0,-0.03170712664723396
0,cd4,1.0,0
0,array,1.0,0.0669817253947258
0,antigen,1.0,0.06479129940271378
0,human induced pluripotent stem cell,25.0,0.07952122204005718
0,free organoids expressing characteristic markers,23.333333333333336,0.034582868218421936
0,cdx2 expression throughout directed differentiation,23.0,0.04985477635636926
0,directed differentiation protocol,11.0,0.11331250766913097
0,free defined conditions,9.333333333333334,0.025532946301003296
0,therapeutic screening applications,9.0,0.17459005862474442
0,derived ipsc lines,9.0,0.0009401352144777775
0,cdx2egfp ipsc knock,9.0,0.01082112267613411
0,inflammatory bowel disease,8.5,0.153837059934934
0,proximal intestinal lineages,8.333333333333334,0.1378726065158844
0,employ hios generated,8.0,0.033244432881474495
0,free hios,5.333333333333334,0.026203567162156105
0,disease modeling,4.5,0.12076562270522118
0,small intestinal,4.333333333333334,0.08687162213027477
0,intestinal progenitors,4.333333333333334,0.115701824426651
0,would facilitate,4.0,0.05612398497760296
0,vitro models,4.0,0.16052529588341713
0,reporter line,4.0,0.00481969490647316
0,primed towards,4.0,0.04214552044868469
0,hindgut progenitors,4.0,0.07798996567726135
0,gastrointestinal tract,4.0,0.19168946519494057
0,future potential,4.0,0.0865546204149723
0,cystic fibrosis,4.0,0.19149300456047058
0,cftr mutation,4.0,0.07678423076868057
0,robust generation,3.666666666666667,0.053357912227511406
0,efficient generation,3.666666666666667,0.08278057351708412
0,colonic epithelium,3.5,0.1331745684146881
0,hios,2.0,0.032261669635772705
0,generation,1.6666666666666667,0.062373146414756775
0,colonic,1.5,0.14906805753707886
0,way,1.0,-0.018800776451826096
0,variety,1.0,0.07650606334209442
0,using,1.0,-0.04173736274242401
0,track,1.0,0.04564104974269867
0,serum,1.0,0.02322017401456833
0,report,1.0,0.05636989697813988
0,purification,1.0,0.13488033413887024
0,mesenchyme,1.0,0.14130011200904846
0,kinetics,1.0,0.09281712025403976
0,follow,1.0,0.08601848781108856
0,enabling,1.0,0.018889283761382103
0,emergence,1.0,0.041484735906124115
0,diseases,1.0,0.23910000920295715
0,development,1.0,0.1793753206729889
0,demonstrating,1.0,0.04213862493634224
0,correction,1.0,0.11102229356765747
0,affect,1.0,0.0651945173740387
0,"one unknown metabolite ), demonstrating",23.333333333333332,0.025808981619775295
0,potentially clinically useful diagnostic panel,22.0,0.20840480476617812
0,left ventricular ejection fraction,15.0,0.06285456009209156
0,reduced ejection fraction,10.0,0.003271050751209259
0,novel diagnostic panel,10.0,0.22091330587863922
0,diagnostic value seems,9.166666666666666,0.16479080636054277
0,forest models fitted,9.0,0.09681257357199986
0,fasting serum samples,9.0,0.07270796969532967
0,39 controls without,9.0,0.018867237493395805
0,3 ± 5,9.0,0.061469657346606255
0,"learning methods ),",8.833333333333334,0.026072733104228973
0,two innovative tools,8.5,0.050241141890486084
0,selected metabolites correlated,8.333333333333334,0.06965835516651471
0,confirm clinical utility,8.0,0.2127372274796168
0,85 vs 0,8.0,0.06454241275787354
0,feature selection based,7.5,0.06597682336966197
0,metabolites panel,5.666666666666667,0.09040232002735138
0,"82 ),",5.333333333333334,0
0,two isomers,4.5,0.07948259636759758
0,predictive value,4.5,0.09369275299832225
0,model based,4.5,0.06990262307226658
0,eight metabolites,4.333333333333334,0.07447085157036781
0,uric acid,4.0,-0.01845341920852661
0,test set,4.0,0.04346809536218643
0,resampled data,4.0,0.06245528906583786
0,proposed markers,4.0,0.046017538756132126
0,metabolic derangement,4.0,0.16070407256484032
0,mass spectrometry,4.0,0.11169328168034554
0,machine learning,4.0,0.03610682301223278
0,lvef 24,4.0,0
0,lpc 20,4.0,0
0,lpc 18,4.0,0
0,liquid chromatography,4.0,0.059112719260156155
0,linear modelling,4.0,-0.02034170553088188
0,large scale,4.0,0.03372824937105179
0,heart failure,4.0,0.2074820026755333
0,functional parameters,4.0,0.1085384339094162
0,enables identification,4.0,0.020660273730754852
0,docosahexaenoic acid,4.0,-0.007209718227386475
0,deoxycholic acid,4.0,-0.1316230595111847
0,current knowledge,4.0,0.034344976767897606
0,combined approach,4.0,0.041969139128923416
0,check feasibility,4.0,0.06530202552676201
0,9 %),4.0,-0.015072595328092575
0,untargeted metabolomics,3.5,0.1833551749587059
0,hfref ).,3.5,0
0,selection,2.0,0.05145580321550369
0,clinical,2.0,0.49838685989379883
0,0,2.0,0.04786166548728943
0,metabolomics,1.5,0.2973555326461792
0,machine,1.5,0.04470905661582947
0,hfref,1.5,0
0,verified,1.0,0.020177435129880905
0,unrestrained,1.0,-0.03551895171403885
0,study,1.0,0.2376001477241516
0,simple,1.0,-0.0471973717212677
0,resulted,1.0,-0.0046446360647678375
0,random,1.0,-0.09545474499464035
0,multi,1.0,0.048057474195957184
0,gaps,1.0,0.1010507345199585
0,followed,1.0,0.06544908136129379
0,fingerprinted,1.0,0.08695214986801147
0,echocardiographic,1.0,0.39793336391448975
0,disease,1.0,0.1630353331565857
0,crucial,1.0,0.045712754130363464
0,create,1.0,0.025220831856131554
0,comparable,1.0,0.07046344876289368
0,common,1.0,0.08981665968894958
0,combination,1.0,-0.03356827795505524
0,bnp,1.0,0.07405637949705124
0,aim,1.0,0.040013544261455536
0,accuracy,1.0,0.05023651197552681
0,2,1.0,0.03300613537430763
0,1,1.0,-0.001867588609457016
0,copyright © 2019 world federation,25.0,0.019841113593429327
0,learning methods represents nowadays,15.0,0.04544960428029299
0,provide functional quantitative maps,12.5,0.09108909219503403
0,multiple quantitative maps,9.5,0.09117300808429718
0,underlying physiological processes,9.0,0.09540027628342311
0,specific vascular receptors,9.0,0.22801082084576288
0,reflecting complementary variables,9.0,0.06849972407023112
0,red blood cells,9.0,0.08733377108971278
0,probabilistic framework based,9.0,0.06603620449701945
0,extracted complementary information,9.0,0.09788103277484576
0,different pathological conditions,9.0,0.09420795987049739
0,new kinetic models,8.5,0.08923088262478511
0,indicator dilution principles,8.5,0.06337719162305196
0,immense diagnostic possibilities,8.5,0.20748108377059302
0,molecular imaging modality,8.2,0.31370048721631366
0,ultrasound contrast agents,7.5,0.17141840606927872
0,uca intravascular kinetics,7.5,0.2210892103612423
0,us imaging based,7.2,0.20267962167660394
0,functional imaging,5.2,0.3125504329800606
0,uca kinetics,5.0,0.09281712025403976
0,intravascular indicator,5.0,0.21760058403015137
0,available methods,5.0,0.03195909224450588
0,ucas provide,4.666666666666667,0.01998533308506012
0,quantitative dce,4.666666666666667,0.09732342511415482
0,several models,4.5,0.0992397628724575
0,dynamic contrast,4.5,0.08945749700069427
0,diagnostic accuracy,4.5,0.26929054595530033
0,us imaging,4.2,0.2614348456263542
0,ultimate approach,4.0,-0.020622991025447845
0,spatiotemporal analysis,4.0,0.10792147368192673
0,rights reserved,4.0,0.030988029204308987
0,rheology comparable,4.0,0.08506524562835693
0,recent introduction,4.0,0.031030522659420967
0,optimal combination,4.0,0.022879071533679962
0,microbubbles encapsulated,4.0,0.08751724287867546
0,integrative approach,4.0,0.1669810451567173
0,increased complexity,4.0,0.03582800552248955
0,future perspective,4.0,0.06049598008394241
0,enhanced ultrasound,4.0,0.23202553391456604
0,emerging machine,4.0,0.08413559198379517
0,elsevier inc,4.0,0.007824641652405262
0,current value,4.0,0.02352467691525817
0,critically discussed,4.0,0.09196114167571068
0,comprehensive review,4.0,0.07804420217871666
0,combined use,4.0,0.028586206026375294
0,biocompatible shell,4.0,0.05245092511177063
0,aiding diagnosis,4.0,0.12259403243660927
0,novel ucas,3.666666666666667,0.09435988962650299
0,advanced dce,3.666666666666667,0.08296222984790802
0,imaging,2.2,0.4709222614765167
0,us,2.0,0.05194742977619171
0,ultrasound,2.0,0.39892449975013733
0,ucas,1.6666666666666667,0
0,dce,1.6666666666666667,0.054687947034835815
0,vasculature,1.0,0.242548406124115
0,temporal,1.0,0.09402984380722046
0,targeted,1.0,0.06072039157152176
0,spatial,1.0,0.08762417733669281
0,requires,1.0,-0.041584912687540054
0,published,1.0,0.10513044893741608
0,proposed,1.0,0.053893283009529114
0,parallel,1.0,0.08594085276126862
0,opened,1.0,0.050522319972515106
0,micro,1.0,0.06720928847789764
0,medicine,1.0,0.497326135635376
0,interpretation,1.0,0.059899576008319855
0,improving,1.0,0.09750453382730484
0,extraction,1.0,0.06110062450170517
0,developed,1.0,0.1218160092830658
0,biology,1.0,0.32473820447921753
0,article,1.0,0.0808369517326355
0,advances,1.0,0.1283981204032898
0,important factor affecting patient prognosis,25.0,0.15825233310461045
0,several circulating long noncoding rnas,23.0,0.06038216594606638
0,multivariate regression analysis indicated,16.0,0.09539835806936026
0,left ventricular ejection fraction,15.0,0.06285456009209156
0,"e ., 24 h",14.0,0.035510603338479996
0,stage ami remain unclear,13.714285714285715,0.04258148279041052
0,90 controls without ami,13.214285714285715,0.046877504636844
0,chast levels obviously decreased,12.166666666666666,0.05551470071077347
0,ami cardiac remodeling remains,11.647619047619049,0.2195061882957816
0,left ventricular short,10.0,0.09693366661667824
0,different time points,9.0,0.061143690099318825
0,copyright © 2018,9.0,0.01832666527479887
0,chronic pathological process,9.0,0.11591181593636672
0,acute myocardial infarction,9.0,0.3220969835917155
0,axis shortening rate,8.5,0.056283374316990376
0,cardiac contractile function,8.1,0.3139617418249448
0,24 h,6.0,0.028560467064380646
0,stage ami,5.714285714285714,0.07899266853928566
0,circulating levels,5.666666666666666,0.02894296869635582
0,cardiac function,5.1,0.3649844117462635
0,substantially decreased,5.0,0.0594140961766243
0,cardiac remodeling,4.933333333333334,0.39070071280002594
0,ami population,4.714285714285714,0.12145852670073509
0,expression levels,4.666666666666666,0.022602987475693226
0,cardiac hypertrophy,4.6,0.4386647641658783
0,mortality rate,4.5,0.18758423253893852
0,circulating lncrnas,4.5,0.01323661208152771
0,ami patients,4.380952380952381,0.28109732642769814
0,standardized β,4.0,0.057075146585702896
0,significantly increased,4.0,0.08945312350988388
0,reportedly involved,4.0,0.027414369396865368
0,quartile values,4.0,0.06170115154236555
0,potential roles,4.0,0.07343285530805588
0,positively associated,4.0,0.05594427511096001
0,may serve,4.0,0.01723203808069229
0,independent predictor,4.0,0.06677553988993168
0,grouped according,4.0,0.05860742926597595
0,expression level,4.0,0.029294763691723347
0,elsevier b,4.0,0.033724576234817505
0,consecutively enrolled,4.0,0.10446788836270571
0,clinical parameters,4.0,0.2806425616145134
0,cardiovascular diseases,4.0,0.40692125260829926
0,candidate biomarker,4.0,0.22020019590854645
0,blood samples,4.0,0.10585649497807026
0,associated transcript,4.0,0.06365201808512211
0,3 days,4.0,0.026123247109353542
0,050 ).,4.0,0
0,034 ).,4.0,0
0,three patients,3.666666666666667,0.2683269791305065
0,highest quartiles,3.5,0.07591314055025578
0,ami,2.7142857142857144,0.10289803892374039
0,controls,2.5,0.05869656428694725
0,chast,2.5,0
0,remodeling,2.3333333333333335,0.16212573647499084
0,patients,1.6666666666666667,0.4592966139316559
0,quartiles,1.5,0.11885389685630798
0,lncrnas,1.5,0
0,v,1.0,0.019843820482492447
0,study,1.0,0.2376001477241516
0,results,1.0,0.0652550756931305
0,published,1.0,0.10513044893741608
0,post,1.0,0.10225207358598709
0,phase,1.0,0.012381147593259811
0,p,1.0,0.11820723116397858
0,methods,1.0,0.024640876799821854
0,measured,1.0,0.07410861551761627
0,however,1.0,-0.011453256011009216
0,fifty,1.0,0.0258838701993227
0,early,1.0,0.03449202701449394
0,conclusion,1.0,0.03420025110244751
0,compared,1.0,0.10162706673145294
0,collected,1.0,-0.03091895952820778
0,biomarkers,1.0,0.28697043657302856
0,background,1.0,0.03833860531449318
0,319,1.0,0
0,0,1.0,0.04786166548728943
0,goes beyond standard clinical biomarkers,22.166666666666668,0.178989914059639
0,essential step towards personalized,15.5,0.035362593829631805
0,poor metabolic health outcome,15.166666666666666,0.1793831493705511
0,comprehensive multimodal health assessments,14.833333333333332,0.14907078724354506
0,collected 1385 data features,14.666666666666666,0.03958506137132645
0,unsupervised machine learning methods,14.5,0.028904886916279793
0,preventative health risk assessment,14.166666666666666,0.20199226960539818
0,biomarkers identified distinct subsets,13.916666666666666,0.13878347165882587
0,diabetes signature included 1,13.833333333333334,0.08660480193793774
0,identify multimodal biomarker signatures,13.466666666666665,0.12330984883010387
0,identified potential early signatures,11.883333333333333,0.04955928213894367
0,established clinical biomarkers,10.166666666666666,0.2824543279906114
0,1 -( 1,9.666666666666668,-0.001867588609457016
0,rapidly moving towards,9.5,0.029875487710038822
0,multimodal data integration,9.333333333333332,0.11867383619149525
0,similar health statuses,9.166666666666666,0.15692517161369324
0,longitudinal validation cohort,9.0,0.13385053475697836
0,lean mass percentage,9.0,0.04488169401884079
0,body mass index,9.0,0.05078936616579691
0,uncovering novel biomarkers,8.916666666666666,0.14477243771155676
0,found novel associations,8.75,0.06896438077092171
0,novel biomarker signatures,8.55,0.1327559066315492
0,gut microbiome health,8.5,0.1406711538632711
0,microbiome genera intestinimonas,8.333333333333334,0.11025713384151459
0,palmitoyl )- 2,8.0,0.030119876377284527
0,driven paradigm based,8.0,0.077513853708903
0,novel biomarkers,5.916666666666666,0.19066516309976578
0,potential biomarker,5.333333333333334,0.18986782059073448
0,cardiometabolic biomarkers,5.166666666666666,0.3330060839653015
0,disease risk,5.0,0.17861884087324142
0,disease signatures,4.8,0.07767168618738651
0,method identified,4.75,0.059831807389855385
0,individuals based,4.25,0.06961799785494804
0,uremic toxin,4.0,0.106047541834414
0,unclassified genus,4.0,0.06559236347675323
0,subset membership,4.0,0.09650228172540665
0,modern medicine,4.0,0.28829772770404816
0,integrated analysis,4.0,0.10105378925800323
0,insulin resistance,4.0,0.07306778058409691
0,including metabolome,4.0,0.13026027381420135
0,erysipelotrichaceae family,4.0,0.11515630781650543
0,driven stratification,4.0,0.07956575229763985
0,diverse modalities,4.0,0.16604063287377357
0,disease subtypes,4.0,0.15105699747800827
0,different modalities,4.0,0.1434122994542122
0,cresol sulfate,4.0,0.11512698978185654
0,better predictor,4.0,0.09199907630681992
0,another metabolite,4.0,0.04009090177714825
0,advanced imaging,4.0,0.2910793870687485
0,1253 individuals,3.75,0.054066821932792664
0,1083 individuals,3.75,0.054066821932792664
0,results demonstrate,3.5,0.04682372510433197
0,health,3.1666666666666665,0.31966903805732727
0,signatures,2.8,-0.007691960781812668
0,identified,2.75,0.10330121219158173
0,data,2.6666666666666665,0.1061776876449585
0,methods,2.5,0.024640876799821854
0,diabetes,2.5,0.31405115127563477
0,potential,2.3333333333333335,0.06813585013151169
0,microbiome,2.3333333333333335,0.1713476926088333
0,2,2.0,0.03300613537430763
0,individuals,1.75,0.054066821932792664
0,stratification,1.5,0.127202570438385
0,results,1.5,0.0652550756931305
0,utilized,1.0,0.03543274104595184
0,stearoyl,1.0,0
0,stages,1.0,0.01961425319314003
0,set,1.0,0.0029952004551887512
0,p,1.0,0.11820723116397858
0,oleoyl,1.0,0
0,methodology,1.0,0.045314721763134
0,linolenoyl,1.0,0
0,identification,1.0,0.04679466038942337
0,hypertension,1.0,0.364623486995697
0,gpc,1.0,0
0,glucose,1.0,0.18350757658481598
0,genetics,1.0,0.35186567902565
0,enyl,1.0,0
0,dihomo,1.0,0
0,conclusions,1.0,0.07628431916236877
0,combination,1.0,-0.03356827795505524
0,cinnamoylglycine,1.0,0
0,background,1.0,0.03833860531449318
0,additionally,1.0,0.012068133801221848
0,abundance,1.0,0.031378280371427536
0,symptoms experienced following allergen exposure,24.5,0.0666883459314704
0,allergen immunotherapy may modulate,16.166666666666664,0.09228260908275843
0,study selections authors assessment,16.0,0.14127464313060045
0,supervised oral food challenge,14.375,0.09149938123300672
0,may impact upon risk,14.333333333333332,0.04491367004811764
0,specific reaction phenotypes exist,12.1,0.06609362829476595
0,unpublished literature relating,9.0,0.12284465009967487
0,copyright © 2020,9.0,0.01832666527479887
0,clinically useful predictors,9.0,0.18619909137487411
0,applying unbiased machine,9.0,0.025486625575770933
0,facilitating risk stratification,8.666666666666666,0.12443741286794345
0,food anaphylaxis may,8.375,0.07499146834015846
0,different reaction phenotypes,8.1,0.0635421338180701
0,major research theme,8.0,0.11968768884738286
0,food allergy encompasses,7.875,0.11814224471648534
0,different clinical phenotypes,7.433333333333334,0.23598669469356537
0,reaction phenotypes,5.6,0.06163828261196613
0,food allergy,4.875,0.1314816176891327
0,different pathophysiology,4.5,0.19093378633260727
0,different cohorts,4.5,0.06920190155506134
0,severe food,4.375,0.08559423685073853
0,many food,4.375,0.06290549039840698
0,food hypersensitivities,4.375,0.10860107094049454
0,severe anaphylaxis,4.333333333333334,0.12398136407136917
0,clinical practice,4.333333333333334,0.3287031501531601
0,clinical experience,4.333333333333334,0.2710565775632858
0,anaphylaxis caused,4.333333333333334,0.09187600575387478
0,prescribe eai,4.0,0.18838778138160706
0,predict patients,4.0,0.24415163323283195
0,nonfood triggers,4.0,0.08045602403581142
0,integrating datasets,4.0,0.10757995769381523
0,important area,4.0,0.10090585425496101
0,endotype discovery,4.0,0.10541436076164246
0,elsevier inc,4.0,0.007824641652405262
0,current inability,4.0,0.006383638828992844
0,allergic reactions,4.0,0.047186478972435
0,allergic individuals,4.0,0.054546818137168884
0,patient management,3.666666666666667,0.32721012830734253
0,one patient,3.666666666666667,0.23778163641691208
0,data sources,3.666666666666667,0.06687838211655617
0,available data,3.666666666666667,0.0727274976670742
0,similar way,3.5,0.03248942457139492
0,emerging evidence,3.5,0.09086420573294163
0,risk,2.6666666666666665,0.19420234858989716
0,phenotypes,2.6,0.14222338795661926
0,exist,2.5,0.05194644629955292
0,food,2.375,0.07895687222480774
0,research,2.0,0.27731871604919434
0,patient,1.6666666666666667,0.4149835705757141
0,data,1.6666666666666667,0.1061776876449585
0,way,1.5,-0.018800776451826096
0,emerging,1.5,0.12356212735176086
0,whether,1.0,0.031672295182943344
0,varies,1.0,0.011406470090150833
0,severity,1.0,0.06077773869037628
0,robust,1.0,0.04434267804026604
0,results,1.0,0.0652550756931305
0,remains,1.0,-0.006274711340665817
0,relevance,1.0,0.032082222402095795
0,range,1.0,0.07927243411540985
0,published,1.0,0.10513044893741608
0,perhaps,1.0,0.026446938514709473
0,objective,1.0,0.01818794757127762
0,number,1.0,0.03055502660572529
0,much,1.0,0.04524269700050354
0,manner,1.0,0.012784529477357864
0,likely,1.0,0.06529493629932404
0,improvements,1.0,0.08724521100521088
0,impacting,1.0,0.0265291016548872
0,given,1.0,0.014340896159410477
0,g,1.0,0.02275453880429268
0,future,1.0,0.10497339069843292
0,e,1.0,0.042460739612579346
0,discuss,1.0,0.09245206415653229
0,devices,1.0,0.20759570598602295
0,determined,1.0,-0.03170712664723396
0,decision,1.0,0.016830462962388992
0,currently,1.0,0.0543237179517746
0,confirm,1.0,0.02169613540172577
0,conclusion,1.0,0.03420025110244751
0,community,1.0,0.1393434703350067
0,clearly,1.0,0.01570729911327362
0,asthma,1.0,0.2230728715658188
0,another,1.0,0.01875428482890129
0,patients undergoing cardiac resynchronization therapy,23.266666666666666,0.3535023838281631
0,1510 patients undergoing crt implantation,20.43333333333333,0.22174531407654285
0,receiver operating characteristic curves,16.0,0.06894586770795286
0,patients undergoing crt implantation,15.433333333333334,0.22174531407654285
0,exhibited good discriminative capabilities,15.0,0.08117436245083809
0,seattle heart failure model,14.666666666666666,0.12998606357723475
0,already existing risk scores,12.666666666666666,0.09332914417609572
0,random forest demonstrated,9.0,0.02035261814792951
0,oxford university press,9.0,0.14006692667802176
0,53 %) deaths,9.0,0.13547095656394958
0,51 %) deaths,9.0,0.13547095656394958
0,implant clinical features,8.5,0.269252626846234
0,best performing model,8.166666666666666,0.06637180348237355
0,"001 ), respectively",8.166666666666666,0.08458003401756287
0,multiple ml models,8.0,0.08587437868118286
0,"001 ), 0",7.166666666666666,0.04786166548728943
0,crt patients,6.266666666666667,0.24587681517004967
0,existing scores,5.666666666666666,0.08625730872154236
0,158 patients,5.6,0.4592966139316559
0,"001 ),",5.166666666666666,0
0,estimated risk,5.0,0.10209927521646023
0,discriminative ability,5.0,0.028918486088514328
0,evaluated scores,4.666666666666666,0.06443625688552856
0,crt score,4.666666666666666,0.03668207302689552
0,crt ).,4.666666666666666,0.03245701640844345
0,"score ),",4.5,0.040907129645347595
0,implant parameters,4.5,0.16438641399145126
0,best performance,4.5,0.04327479936182499
0,training cohort,4.0,0.14062443375587463
0,test cohort,4.0,0.11867501214146614
0,retrospective database,4.0,0.1024093497544527
0,predict 1,4.0,0.013569531962275505
0,personalized assessment,4.0,0.07178138755261898
0,machine learning,4.0,0.03610682301223278
0,linear association,4.0,0.04281009919941425
0,independent cohort,4.0,0.08601759187877178
0,european society,4.0,0.084633007645607
0,cause death,4.0,0.10442091524600983
0,year follow,3.666666666666667,0.05729828216135502
0,cause mortality,3.666666666666667,0.18113460391759872
0,trained classifiers,3.5,0.07140291482210159
0,three pre,3.5,0.05716896057128906
0,year mortality,3.3333333333333335,0.15142212994396687
0,model,2.6666666666666665,0.05463607236742973
0,crt,2.6666666666666665,0.03245701640844345
0,models,2.0,0.10839370638132095
0,0,2.0,0.04786166548728943
0,year,1.6666666666666667,0.028578076511621475
0,mortality,1.6666666666666667,0.27426618337631226
0,trained,1.5,0.1238085925579071
0,pre,1.5,0.03698057681322098
0,©,1.0,0.024751247838139534
0,valid,1.0,-0.002878095954656601
0,utilization,1.0,0.17883524298667908
0,train,1.0,0.012325972318649292
0,thirty,1.0,0.005658911541104317
0,tested,1.0,0.06802673637866974
0,superior,1.0,0.026375602930784225
0,semmelweiscrtscore,1.0,0
0,semmelweis,1.0,0
0,selected,1.0,0.03362758085131645
0,screen,1.0,0.02763313800096512
0,results,1.0,0.0652550756931305
0,published,1.0,0.10513044893741608
0,prognostication,1.0,0.09497688710689545
0,predictors,1.0,0.16273410618305206
0,prediction,1.0,0.07748128473758698
0,period,1.0,0.022214137017726898
0,p,1.0,0.11820723116397858
0,outperformed,1.0,0.10277935117483139
0,non,1.0,0.06398928165435791
0,methods,1.0,0.024640876799821854
0,eaarn,1.0,0
0,develop,1.0,0.10439212620258331
0,conclusion,1.0,0.03420025110244751
0,com,1.0,-0.008797436952590942
0,ci,1.0,0.06607142090797424
0,cardiology,1.0,1.0
0,capturing,1.0,0.02603818289935589
0,behalf,1.0,0.003146544098854065
0,available,1.0,0.03927730768918991
0,author,1.0,0.1725224107503891
0,areas,1.0,0.15646809339523315
0,among,1.0,0.09849628061056137
0,aims,1.0,0.04269438236951828
0,aim,1.0,0.040013544261455536
0,95,1.0,0
0,872,1.0,0
0,867,1.0,0
0,861,1.0,0
0,859,1.0,0
0,849,1.0,0
0,805,1.0,0
0,803,1.0,0
0,80,1.0,0
0,793,1.0,0
0,785,1.0,0
0,776,1.0,0
0,768,1.0,0
0,733,1.0,0
0,718,1.0,0
0,711,1.0,0
0,703,1.0,0
0,674,1.0,0
0,5,1.0,0.010449972003698349
0,2020,1.0,0
0,considering three different signals,16.0,0.04214341100305319
0,apply convolutional neural networks,16.0,0.06441126608600219
0,classical machine learning approaches,15.5,0.0630470272153616
0,ventricular tachycardia arrhythmia ).,15.0,0.27448873221874237
0,false alarm reduction task,13.25,0.045533626805990934
0,true alarms using single,13.0,0.017549444921314716
0,method efficiently using,9.5,0.015509519726037979
0,deep learning model,9.5,0.04270285740494728
0,term memory units,9.0,0.0845995085934798
0,temporal information presented,9.0,0.09301357716321945
0,requiring prior knowledge,9.0,0.01503097964450717
0,intensive care units,9.0,0.1665316546956698
0,evaluation results demonstrate,9.0,0.07833343744277954
0,cardiology challenge 2015,9.0,0.5142910564318299
0,automatically extract time,9.0,0.03529825806617737
0,segmented input signal,8.5,0.03833579458296299
0,proposed method achieves,8.5,0.01928752971192201
0,step training algorithm,8.0,0.07104579359292984
0,"e ., pre",7.5,0.03972065821290016
0,false alarms,6.0,0.05193839594721794
0,arrhythmia analysis,5.0,0.22753757238388062
0,signal segments,4.5,0.06406820937991142
0,proposed network,4.5,0.053635960444808006
0,"g .,",4.5,0.02275453880429268
0,alarm type,4.25,0.04680870659649372
0,alarm classification,4.25,0.0374180655926466
0,without ignoring,4.0,-0.011837407015264034
0,study proposes,4.0,0.15312867611646652
0,physionet computing,4.0,0.19677644968032837
0,modal biosignals,4.0,0.04848790913820267
0,long short,4.0,0.017329098656773567
0,lead ecg,4.0,0.20019515231251717
0,invariant features,4.0,0.0539687555283308
0,important regions,4.0,0.08360010758042336
0,existing algorithms,4.0,0.12376144900918007
0,engineered features,4.0,0.04996407404541969
0,either rule,4.0,0.0011742804199457169
0,effectively suppresses,4.0,0.006785145029425621
0,dataset provided,4.0,0.0627887211740017
0,build rules,4.0,0.020580900833010674
0,based methods,4.0,0.05490502528846264
0,attention mechanism,4.0,0.03812773339450359
0,"71 %,",4.0,0
0,"30 %,",4.0,0
0,current work,3.5,0.048871228471398354
0,single,2.5,0.015469912439584732
0,alarm,2.25,0.05517297983169556
0,training,2.0,0.1278398334980011
0,e,2.0,0.042460739612579346
0,work,1.5,0.06322342157363892
0,two,1.0,0.0741315707564354
0,tuning,1.0,0.018936164677143097
0,trained,1.0,0.1238085925579071
0,specificity,1.0,0.09074191749095917
0,sensitivity,1.0,0.0724399983882904
0,put,1.0,0.021826867014169693
0,multi,1.0,0.048057474195957184
0,literature,1.0,0.2259182184934616
0,likely,1.0,0.06529493629932404
0,icus,1.0,0
0,hand,1.0,-0.03252475708723068
0,fine,1.0,0.0010942183434963226
0,experiments,1.0,0.11820036172866821
0,emphasis,1.0,0.04609560966491699
0,depending,1.0,-0.02532743103802204
0,contribute,1.0,0.06670629978179932
0,consider,1.0,0.0554787740111351
0,capture,1.0,0.040161751210689545
0,auc,1.0,-0.016484811902046204
0,addition,1.0,0.1140233725309372
0,93,1.0,0
0,92,1.0,0
0,90,1.0,0
0,89,1.0,0
0,88,1.0,0
0,51,1.0,0
0,05,1.0,0
0,back propagation artificial neural network,23.5,0.07500344589352607
0,three common machine learning algorithms,20.65,0.06566276177763938
0,"rf ], support vector machine",19.9,0.050761915976181626
0,2787 consecutive participants recruited,16.0,0.05952285975217819
0,controlled blood glucose rate,14.916666666666666,0.11486809700727463
0,atherosclerotic cardiovascular disease history,14.666666666666666,0.2553268736228347
0,type 2 diabetes mellitus,14.5,0.1302253995090723
0,predict blood glucose status,14.416666666666666,0.09925034129992127
0,machine learning algorithms,10.65,0.0537132682899634
0,machine learning models,9.65,0.06020245080192884
0,blood glucose control,9.416666666666666,0.13266404469807944
0,predict glycemic control,9.0,0.09051298846801122
0,multivariable analysis found,9.0,0.10243288551767667
0,multicenter study aimed,9.0,0.21390139559904733
0,collected via questionnaire,9.0,0.004461426287889481
0,building predictive models,9.0,0.11881967137257259
0,address variable collinearity,9.0,0.07939760759472847
0,traditional logistic model,8.5,0.06221557408571243
0,poor glycemic control,8.5,0.10205783943335216
0,stepwise logistic regression,8.166666666666666,0.09225025773048401
0,logistic regression models,8.166666666666666,0.08953309059143066
0,developing diabetic complications,8.0,0.23149593671162924
0,elastic network,5.5,0.0007574055343866348
0,learning algorithm,5.25,0.050343846902251244
0,blood pressure,5.25,0.14018943160772324
0,"svm ],",5.0,0
0,family history,4.666666666666666,0.08405948989093304
0,hypertension history,4.166666666666666,0.20879307948052883
0,en regression,4.166666666666666,0.07748933881521225
0,total cholesterol,4.0,0.12318601738661528
0,six cities,4.0,0.06386727653443813
0,risk factors,4.0,0.1105011198669672
0,related data,4.0,0.11482953280210495
0,random forest,4.0,0.0022971369326114655
0,protective factors,4.0,0.046882765367627144
0,north china,4.0,0.07139208167791367
0,january 2016,4.0,0.008016379550099373
0,higher risk,4.0,0.15365959703922272
0,glycosylated hemoglobin,4.0,0.11331010982394218
0,figures increased,4.0,0.03390362113714218
0,dimensional reduction,4.0,0.09996243193745613
0,december 2017,4.0,-0.008337358944118023
0,closely related,4.0,0.08334605768322945
0,central adiposity,4.0,0.15343288332223892
0,biochemical indices,4.0,0.1657055839896202
0,basic information,4.0,0.052439759485423565
0,application value,4.0,0.018131728749722242
0,alternative choices,4.0,0.02596322726458311
0,27 centers,4.0,0.22233490645885468
0,treated t2dm,3.75,0.1644953340291977
0,t2dm duration,3.75,0.043179526925086975
0,respectively ).,3.5,0.08458003401756287
0,insulin dose,3.5,0.1086290031671524
0,higher sensitivity,3.5,0.09277842193841934
0,elevated hba1c,3.5,0.08202844113111496
0,ann ]),3.5,0.034718528389930725
0,machine,3.4,0.04470905661582947
0,t2dm patients,3.25,0.4592966139316559
0,rf,3.0,0.04890134930610657
0,logistic,2.5,0.07028506696224213
0,diabetes,2.5,0.31405115127563477
0,control,2.5,0.05591680109500885
0,complications,2.0,0.2546522915363312
0,t2dm,1.75,0
0,svm,1.5,0
0,sensitivity,1.5,0.0724399983882904
0,respectively,1.5,0.08458003401756287
0,patients,1.5,0.4592966139316559
0,insulin,1.5,0.1587810218334198
0,hypertension,1.5,0.364623486995697
0,hba1c,1.5,0
0,en,1.5,0.06505817919969559
0,ann,1.5,0.034718528389930725
0,well,1.0,0.09099400043487549
0,used,1.0,0.010911919176578522
0,simulate,1.0,-0.004721604287624359
0,results,1.0,0.0652550756931305
0,prognosis,1.0,0.23093095421791077
0,performed,1.0,0.1553603708744049
0,moreover,1.0,0.01877431571483612
0,methods,1.0,0.024640876799821854
0,half,1.0,0.06323976814746857
0,explore,1.0,0.06985367834568024
0,exercise,1.0,0.1012873649597168
0,curve,1.0,-0.04778170958161354
0,conclusions,1.0,0.07628431916236877
0,compare,1.0,0.09237030148506165
0,combining,1.0,0.01566525548696518
0,bp,1.0,0.052511051297187805
0,background,1.0,0.03833860531449318
0,areas,1.0,0.15646809339523315
0,additionally,1.0,0.012068133801221848
0,addition,1.0,0.1140233725309372
0,accuracy,1.0,0.05023651197552681
0,84,1.0,0
0,82,1.0,0
0,79,1.0,0
0,78,1.0,0
0,75,1.0,0
0,73,1.0,0
0,72,1.0,0
0,70,1.0,0
0,61,1.0,0
0,56,1.0,0
0,52,1.0,0
0,45,1.0,0
0,0,1.0,0.04786166548728943
0,2 health care provider networks,19.5,0.15556418672204017
0,machine learning methods offered,16.0,0.0371210677549243
0,deploy targeted interventions aimed,16.0,0.07570216758176684
0,compare machine learning approaches,16.0,0.051947323605418205
0,emr )- derived information,15.0,0.03160948911681771
0,conducted including 9502 medicare,15.0,0.1184983601172765
0,home days loss greater,14.866666666666667,0.051847354508936405
0,efficient modeling approach based,14.583333333333334,0.07424812018871307
0,boosted modeling consistently provided,14.333333333333334,0.041061907075345516
0,home time loss outcomes,13.27142857142857,0.0930250370875001
0,home days loss claims,13.200000000000001,0.041661021299660206
0,modeled using logistic regression,12.833333333333334,0.04285163152962923
0,"423 ), hf hospitalization",12.75,0.18449676781892776
0,predicting key hf outcomes,12.154761904761905,0.11348996218293905
0,health care professionals,11.0,0.2550073266029358
0,home days loss,10.866666666666667,0.038973004867633186
0,home time loss,10.7,0.04628034060200056
0,predicting key outcomes,9.404761904761905,0.11432336146632831
0,logistic regression based,9.083333333333334,0.08179157972335815
0,various threshold probabilities,9.0,0.045091199999054275
0,"massachusetts ("" providers",9.0,0.04796740598976612
0,least absolute shrinkage,9.0,0.044560267279545464
0,electronic medical record,9.0,0.20672879181802273
0,accurate risk stratification,9.0,0.11140455802281697
0,traditional logistic regression,8.833333333333334,0.07397704944014549
0,selection operation regression,8.833333333333334,0.08157629768053691
0,based predictive models,8.583333333333334,0.12280602256457011
0,based models appeared,8.583333333333334,0.06333546464641888
0,lowest brier scores,8.5,-0.014212530727187792
0,575 vs 0,8.433333333333334,0.06454241275787354
0,484 vs 0,8.433333333333334,0.06454241275787354
0,413 vs 0,8.433333333333334,0.06454241275787354
0,249 vs 0,8.433333333333334,0.06454241275787354
0,emr vs claims,8.166666666666668,0.06547411531209946
0,trained using data,8.0,0.06274963915348053
0,top cost decile,8.0,0.04955455412467321
0,net benefit estimates,8.0,0.030171713481346767
0,good calibration across,8.0,0.11524555087089539
0,generally similar performance,8.0,0.04026287173231443
0,testing set ).,7.7,0.04342283681035042
0,gbms predicting mortality,7.333333333333334,0.15880807302892208
0,boosted modeling,6.333333333333334,0.07809735462069511
0,logistic regression,5.833333333333334,0.08010278269648552
0,hf hospitalization,5.75,0.18449676781892776
0,networks ).,5.7,0.04708750545978546
0,2 outcomes,5.571428571428571,0.13313263095915318
0,using claims,5.333333333333334,0.00399385392665863
0,vs claims,5.166666666666667,0.06547411531209946
0,network 2,5.0,0.043192386627197266
0,net benefit,5.0,0.045609232038259506
0,"403 ),",5.0,0
0,regression trees,4.833333333333334,0.04729419481009245
0,9502 patients,4.75,0.4592966139316559
0,emr predictors,4.666666666666667,0.16273410618305206
0,main outcomes,4.571428571428571,0.15206529572606087
0,4 outcomes,4.571428571428571,0.11658770591020584
0,training set,4.5,0.06541751697659492
0,brier score,4.5,-0.016325034201145172
0,augmenting claims,4.333333333333334,0.08499852195382118
0,807 ).,4.2,0
0,252 ).,4.2,0
0,year follow,4.0,0.05729828216135502
0,recall curves,4.0,-0.00414190674200654
0,random forests,4.0,-0.009110379964113235
0,limited improvement,4.0,0.06959893368184566
0,includes physicians,4.0,0.3086783364415169
0,improve prediction,4.0,0.08128046989440918
0,high cost,4.0,0.047133004292845726
0,heart failure,4.0,0.2074820026755333
0,decision curves,4.0,0.01502574561163783
0,december 31,4.0,-0.008337358944118023
0,cause mortality,4.0,0.18113460391759872
0,c statistics,4.0,0.04330148361623287
0,added value,4.0,0.04583905218169093
0,improving patients,3.75,0.27840057387948036
0,enrolled patients,3.75,0.3189901113510132
0,gbm ).,3.7,0
0,network 1,3.666666666666667,0.02575552463531494
0,january 1,3.666666666666667,0.0030743954703211784
0,additional predictors,3.666666666666667,0.11644388735294342
0,prognostic study,3.5,0.27590933442115784
0,highest discrimination,3.5,0.017607683315873146
0,higher auprcs,3.0,0.11311684548854828
0,hf,2.75,0.1109897643327713
0,0,2.6,0.04786166548728943
0,outcomes,2.5714285714285716,0.23325912654399872
0,models,2.3333333333333335,0.10839370638132095
0,claims,2.3333333333333335,0.04972507059574127
0,similar,2.0,0.08377962559461594
0,mortality,2.0,0.27426618337631226
0,gbms,2.0,0
0,data,2.0,0.1061776876449585
0,cost,2.0,0.033558186143636703
0,calibration,2.0,0.21323038637638092
0,patients,1.75,0.4592966139316559
0,predictors,1.6666666666666667,0.16273410618305206
0,1,1.6666666666666667,-0.001867588609457016
0,study,1.5,0.2376001477241516
0,higher,1.5,0.11311684548854828
0,gbm,1.5,0
0,discrimination,1.5,0.0022429823875427246
0,auprcs,1.5,0
0,years,1.0,0.05066175013780594
0,total,1.0,0.003683900460600853
0,tested,1.0,0.06802673637866974
0,setting,1.0,0.04959516599774361
0,selecting,1.0,0.034643977880477905
0,sd,1.0,0.08195707201957703
0,results,1.0,0.0652550756931305
0,relevance,1.0,0.032082222402095795
0,quality,1.0,0.11005230993032455
0,precision,1.0,0.05533473938703537
0,period,1.0,0.022214137017726898
0,performed,1.0,0.1553603708744049
0,participants,1.0,0.06751469522714615
0,obtained,1.0,-0.0006794054061174393
0,objectives,1.0,0.043118979781866074
0,measures,1.0,0.031176652759313583
0,mean,1.0,0.07771239429712296
0,life,1.0,0.07387976348400116
0,institutions,1.0,0.12473896145820618
0,inclusion,1.0,0.01680990308523178
0,included,1.0,0.029688812792301178
0,importance,1.0,0.08358374238014221
0,however,1.0,-0.011453256011009216
0,gradient,1.0,0.07820996642112732
0,focus,1.0,0.08422843366861343
0,evaluate,1.0,0.08850531280040741
0,emrs,1.0,0
0,differences,1.0,0.1514238715171814
0,design,1.0,0.13118362426757812
0,critical,1.0,0.12879085540771484
0,conclusions,1.0,0.07628431916236877
0,comprise,1.0,0.08721785247325897
0,clinicians,1.0,0.43662092089653015
0,classification,1.0,0.01966315135359764
0,ci,1.0,0.06607142090797424
0,calculated,1.0,-0.0013035684823989868
0,boston,1.0,0.05194654315710068
0,area,1.0,0.1299571692943573
0,analyzed,1.0,0.13667140901088715
0,age,1.0,0.10348664224147797
0,95,1.0,0
0,8,1.0,-0.010438220575451851
0,798,1.0,0
0,790,1.0,0
0,781,1.0,0
0,78,1.0,0
0,773,1.0,0
0,772,1.0,0
0,764,1.0,0
0,763,1.0,0
0,747,1.0,0
0,745,1.0,0
0,744,1.0,0
0,737,1.0,0
0,734,1.0,0
0,733,1.0,0
0,727,1.0,0
0,724,1.0,0
0,718,1.0,0
0,708,1.0,0
0,707,1.0,0
0,705,1.0,0
0,703,1.0,0
0,676,1.0,0
0,6113,1.0,0
0,521,1.0,0
0,3389,1.0,0
0,25,1.0,0
0,2018,1.0,0
0,2014,1.0,0
0,2007,1.0,0
0,analyzed using unsupervised machine learning,20.666666666666664,0.03718254342675209
0,cognitive impairment may help predict,20.0,0.03531698957085609
0,unsupervised machine learning framework,17.5,0.029263979755342007
0,identified using feature selection,15.666666666666666,0.04358128644526005
0,ad within 5 years,14.5,0.03959752153605223
0,may help distinguish,11.0,0.0008510984480381012
0,subtle cognitive alterations,10.0,0.041224939127763115
0,screening early evidence,9.0,0.08073090513547261
0,model yielded 83,9.0,0.039245073683559895
0,framingham heart study,9.0,0.271152138710022
0,"93 %, 86",9.0,0
0,74 ± 1,9.0,0.0761744249612093
0,"71 %, 88",9.0,0
0,57 ± 1,9.0,0.0761744249612093
0,41 ± 1,9.0,0.0761744249612093
0,07 ± 3,9.0,0.08697950001806021
0,early ad screening,8.5,0.0722502979139487
0,boston naming tests,8.5,0.06674937903881073
0,precede clinical evidence,8.333333333333334,0.20928849404056868
0,63 ± 4,8.0,0.07706636190414429
0,52 ± 3,8.0,0.08697950001806021
0,analyzed using,7.166666666666666,0.04746702313423157
0,ad ).,4.5,0.03272446244955063
0,clinical trials,4.333333333333334,0.3105999082326889
0,clinical practice,4.333333333333334,0.3287031501531601
0,np tests,4.166666666666667,0.061667101457715034
0,© 2019,4.0,0.024751247838139534
0,visual reproduction,4.0,0.05073693813756108
0,viable option,4.0,0.042450493201613426
0,trails b,4.0,0.05535547435283661
0,logical memory,4.0,0.06757079623639584
0,including age,4.0,0.08340635150671005
0,demographic data,4.0,0.11111131310462952
0,delayed recall,4.0,0.0006075957790017128
0,coordinating center,4.0,0.11021558381617069
0,attractive modality,4.0,0.18748723343014717
0,approach could,4.0,0.017238449305295944
0,longitudinal np,3.666666666666667,0.08868619240820408
0,subsequent development,3.5,0.08682634122669697
0,risk individuals,3.5,0.12413458526134491
0,results suggest,3.5,0.05601985938847065
0,national alzheimer,3.5,0.16505338996648788
0,predict,3.0,0.029006652534008026
0,nacc respectively,3.0,0.08458003401756287
0,ad,2.5,0.03272446244955063
0,63,2.0,0
0,52,2.0,0
0,np,1.6666666666666667,0.021217424422502518
0,risk,1.5,0.19420234858989716
0,results,1.5,0.0652550756931305
0,respectively,1.5,0.08458003401756287
0,nacc,1.5,0
0,development,1.5,0.1793753206729889
0,alzheimer,1.5,0.24842241406440735
0,testing,1.0,0.08385047316551208
0,subset,1.0,0.12691286206245422
0,specificity,1.0,0.09074191749095917
0,sensitivity,1.0,0.0724399983882904
0,progression,1.0,0.08447402715682983
0,processed,1.0,0.03618676960468292
0,neuropsychological,1.0,0.16074728965759277
0,n,1.0,-0.021267158910632133
0,methods,1.0,0.024640876799821854
0,low,1.0,0.06519334763288498
0,introduction,1.0,0.021546807140111923
0,immediate,1.0,0.05999145656824112
0,high,1.0,0.06070782244205475
0,fhs,1.0,0
0,features,1.0,0.04349645599722862
0,disease,1.0,0.1630353331565857
0,discussion,1.0,0.10436347126960754
0,context,1.0,0.04743277281522751
0,authors,1.0,0.21598771214485168
0,accuracy,1.0,0.05023651197552681
0,87,1.0,0
0,85,1.0,0
0,80,1.0,0
0,689,1.0,0
0,38,1.0,0
0,19,1.0,0
0,1696,1.0,0
0,© 2019 rafiq et al,25.0,0.06660202704370022
0,wilcoxon signed ranked sum tests,25.0,0.04060510639101267
0,ongoing randomized trial carehnd,16.0,0.12674412628014883
0,charlson comorbidity index scores,16.0,0.13498600323994955
0,professional collaboration within patient,15.0,0.16412832774221897
0,compare care utilization frequencies,13.261904761904763,0.14457008428871632
0,often insufficiently coordinated,9.0,0.0387130423138539
0,multiple chronic conditions,9.0,0.11347085485855739
0,total care utilization,8.261904761904763,0.1499533373862505
0,care utilization patterns,8.261904761904763,0.1669167180856069
0,care utilization data,8.261904761904763,0.18411793311436972
0,innovative methods beyond,8.0,0.04160820320248604
0,including diagnostic data,8.0,0.21928277611732483
0,hnd patient care,7.628571428571428,0.34116221964359283
0,integrated care interventions,7.428571428571429,0.16698380808035532
0,hnd patients recruited,7.2,0.30508099496364594
0,care utilization,5.261904761904762,0.22308805584907532
0,utilization indicators,4.833333333333334,0.14900752156972885
0,patient characteristics,4.5,0.22188943438231945
0,traditional care,4.428571428571429,0.1645332258194685
0,centered care,4.428571428571429,0.19406159222126007
0,care received,4.428571428571429,0.13988058175891638
0,care providers,4.428571428571429,0.19536062702536583
0,care outcomes,4.428571428571429,0.25029999762773514
0,hnd patients,4.2,0.4592966139316559
0,hnd center,4.2,0.1649731695652008
0,two groups,4.0,0.04741007462143898
0,two arms,4.0,0.12033706530928612
0,statistically significant,4.0,0.08100135251879692
0,several diagnoses,4.0,0.18671197444200516
0,regional database,4.0,0.09448611177504063
0,previous research,4.0,0.15220990404486656
0,positive effect,4.0,0.007016112795099616
0,patients included,4.0,0.24449271336197853
0,nct03362983 ).,4.0,0
0,machine learning,4.0,0.03610682301223278
0,kidney diseases,4.0,0.23479311168193817
0,key components,4.0,0.06046810373663902
0,initial effects,4.0,0.024121366441249847
0,high utilizers,4.0,0.1618865504860878
0,high level,4.0,0.05937035009264946
0,hereafter referred,4.0,0.0487165953963995
0,different specialties,4.0,0.1953858658671379
0,diagnoses profiles,4.0,0.1493346355855465
0,descriptive statistics,4.0,0.02271125465631485
0,control group,4.0,0.05305405892431736
0,health care,3.9285714285714284,0.2935049533843994
0,study aims,3.5,0.14014726504683495
0,mcc patients,3.5,0.22936759982258081
0,care,2.4285714285714284,0.26734086871147156
0,hnd,2.2,0
0,patients,2.0,0.4592966139316559
0,methods,2.0,0.024640876799821854
0,integrated,2.0,0.09875309467315674
0,diagnostic,2.0,0.48834457993507385
0,study,1.5,0.2376001477241516
0,mcc,1.5,-0.0005614142864942551
0,health,1.5,0.31966903805732727
0,characteristics,1.5,0.02879529818892479
0,variation,1.0,0.0704495757818222
0,sub,1.0,0.157742440700531
0,similar,1.0,0.08377962559461594
0,sicker,1.0,0.2706219553947449
0,shown,1.0,0.044945128262043
0,results,1.0,0.0652550756931305
0,rct,1.0,0
0,purpose,1.0,-0.006926483474671841
0,person,1.0,0.019730402156710625
0,performed,1.0,0.1553603708744049
0,perform,1.0,0.09922076761722565
0,multidisciplinary,1.0,0.31782692670822144
0,intervention,1.0,0.06027820706367493
0,inter,1.0,0.08877119421958923
0,intensive,1.0,0.12172117084264755
0,informed,1.0,-0.004203645512461662
0,indication,1.0,0.06315438449382782
0,impact,1.0,0.029600899666547775
0,however,1.0,-0.011453256011009216
0,heart,1.0,0.30470412969589233
0,explored,1.0,0.10362917929887772
0,explore,1.0,0.06985367834568024
0,experienced,1.0,0.08525562286376953
0,expected,1.0,0.06577444076538086
0,evaluate,1.0,0.08850531280040741
0,diabetes,1.0,0.31405115127563477
0,describe,1.0,-0.011884354054927826
0,counterparts,1.0,0.054215896874666214
0,conducted,1.0,0.055469855666160583
0,conclusion,1.0,0.03420025110244751
0,comparison,1.0,0.11286726593971252
0,collected,1.0,-0.03091895952820778
0,cardiovascular,1.0,0.5747424960136414
0,beginning,1.0,-0.018236802890896797
0,extended model especially performed better,23.333333333333336,0.0714992918074131
0,model improves lqts diagnosis,13.433333333333334,0.12250732257962227
0,improve lqts diagnosis,9.1,0.16598299145698547
0,retrospective cohort consisting,9.0,0.12853251894315085
0,remains challenging due,9.0,-0.0035153599455952644
0,negative family members,9.0,0.05879921838641167
0,first 2 hermite,9.0,0.02615824155509472
0,external cohort consisting,9.0,0.11375816911458969
0,copyright © 2020,9.0,0.01832666527479887
0,combining new polynomial,9.0,0.06328615049521129
0,84 %) followed,9.0,0.06544908136129379
0,clinical qtc cut,8.5,0.250034530647099
0,best overall accuracy,8.5,0.04525413736701012
0,baseline qtc cut,8.5,0.03003943432122469
0,wave morphology parameters,8.35,0.068363801886638
0,wave morphology characterizations,8.35,0.05947886034846306
0,first 2 hg,8.0,-0.010433906068404516
0,333 lqts patients,7.933333333333334,0.4592966139316559
0,wave morphology features,7.85,0.06189653277397156
0,"qtc ), age",7.5,0.10348664224147797
0,wave morphology,5.35,0.07109657116234303
0,wave morphologies,4.6,0.07032989151775837
0,diagnosing lqts,4.6,0.2861221432685852
0,different features,4.5,0.05542314611375332
0,best fit,4.5,0.0624514352530241
0,72 patients,4.333333333333334,0.4592966139316559
0,3 patients,4.333333333333334,0.23951958771795034
0,weight coefficients,4.0,0.04868531413376331
0,three support,4.0,0.04619416268542409
0,precordial leads,4.0,0.08328859508037567
0,low sensitivity,4.0,0.06881667301058769
0,linear combination,4.0,-0.02695499174296856
0,limb leads,4.0,0.07060671225190163
0,elsevier inc,4.0,0.007824641652405262
0,diagnosing long,4.0,0.15459847636520863
0,considerable overlap,4.0,0.06889205425977707
0,average complex,4.0,0.04190417705103755
0,79 %).,4.0,0
0,69 %).,4.0,0
0,345 genotype,4.0,0.12612563371658325
0,qt syndrome,3.666666666666667,-0.005484644323587418
0,corrected qt,3.666666666666667,0.019606608897447586
0,models fed,3.5,0.055948127061128616
0,healthy subjects,3.5,0.1198251061141491
0,finally used,3.5,-0.012762047350406647
0,45 controls,3.5,0.05869656428694725
0,model,3.3333333333333335,0.05463607236742973
0,lqts,2.6,0
0,qtc,2.5,0
0,hg,2.0,-0.08361820131540298
0,age,2.0,0.10348664224147797
0,qt,1.6666666666666667,-0.026990704238414764
0,used,1.5,0.010911919176578522
0,subjects,1.5,0.13721111416816711
0,models,1.5,0.10839370638132095
0,controls,1.5,0.05869656428694725
0,well,1.0,0.09099400043487549
0,vector,1.0,0.09440627694129944
0,svm,1.0,0
0,study,1.0,0.2376001477241516
0,stt,1.0,0
0,specific,1.0,0.08915150165557861
0,sex,1.0,0.025031838566064835
0,segments,1.0,0.08423002809286118
0,robustness,1.0,0.028073906898498535
0,results,1.0,0.0652550756931305
0,published,1.0,0.10513044893741608
0,polynomials,1.0,0.057253893464803696
0,patient,1.0,0.4149835705757141
0,offs,1.0,-0.06257563829421997
0,objective,1.0,0.01818794757127762
0,methods,1.0,0.024640876799821854
0,machine,1.0,0.04470905661582947
0,lqt,1.0,0
0,interval,1.0,0.14205302298069
0,ii,1.0,0.06888964027166367
0,gender,1.0,0.08549608290195465
0,gauss,1.0,0.17139707505702972
0,fitting,1.0,0.04899413511157036
0,fitted,1.0,0.08199499547481537
0,error,1.0,-0.03215598687529564
0,conclusion,1.0,0.03420025110244751
0,classified,1.0,0.05302777886390686
0,check,1.0,0.018208332359790802
0,characterizing,1.0,0.0694388896226883
0,characterized,1.0,0.05963318794965744
0,characterize,1.0,0.05313561111688614
0,based,1.0,0.08516917377710342
0,background,1.0,0.03833860531449318
0,adding,1.0,0.09709080308675766
0,"8 %), mineralocorticoid receptor antagonists",18.333333333333336,0.09023965103551745
0,"9 %), angiotensin receptor blockers",16.333333333333336,0.08274281769990921
0,previously published registries similar,15.0,0.09421996399760246
0,4 %) remained similar,14.5,0.03753080343206724
0,esc heart failure published,13.0,0.14705964177846909
0,patients reached target doses,12.666666666666666,0.1622823541983962
0,esc hf guidelines despite,12.5,0.06819290015846491
0,mineralocorticoid receptor antagonists,12.0,0.12379894157250722
0,esc hf guidelines recommendations,11.5,0.1031226646155119
0,angiotensin receptor blockers,10.0,0.1153479553759098
0,"4 %), angiotensin",9.833333333333334,0.10292404890060425
0,reduced ejection fraction,9.0,0.003271050751209259
0,converting enzyme inhibitors,9.0,0.06566230580210686
0,converting enzyme inhibitor,9.0,0.05182438219587008
0,"9 %, respectively",9.0,0.034753719344735146
0,30 april 2017,9.0,0.02560396119952202
0,enrolled 1056 patients,8.666666666666666,0.3189901113510132
0,results also suggest,8.0,0.05151376873254776
0,outpatient cardiology clinics,8.0,0.6046819388866425
0,14 catalan hospitals,8.0,0.29836682230234146
0,linx registry shows,7.5,0.06111572993298372
0,"7 %), sacubitril",7.333333333333334,0.005520308390259743
0,target doses,6.0,0.08042247965931892
0,heart failure,6.0,0.2074820026755333
0,esc guidelines,5.75,0.0973324105143547
0,"7 %),",5.333333333333334,0.005520308390259743
0,previous registries,5.0,0.10000563785433769
0,pharmacological recommendations,5.0,0.18274031206965446
0,7 %),5.0,0.005520308390259743
0,"1 %),",5.0,-0.001867588609457016
0,hf drugs,4.75,0.13704586774110794
0,linx registry,4.5,0.08399210590869188
0,© 2020,4.0,0.024751247838139534
0,sons ltd,4.0,0.05613034591078758
0,new version,4.0,0.044691598042845726
0,monotherapy decreased,4.0,0.11667018383741379
0,may 2016,4.0,-0.009713593870401382
0,low proportion,4.0,0.06622054055333138
0,john wiley,4.0,0.0068832337856292725
0,hospitals according,4.0,0.24770694226026535
0,european society,4.0,0.084633007645607
0,appropriate adherence,4.0,0.06785585917532444
0,almost one,4.0,0.03667417913675308
0,1 february,3.666666666666667,-0.008940475061535835
0,sectional study,3.5,0.2051400989294052
0,higher level,3.5,0.08557486161589622
0,esc,3.0,0.06814411282539368
0,blockers,3.0,0.045741792768239975
0,angiotensin,3.0,0.20593181252479553
0,9,3.0,-0.015072595328092575
0,8,3.0,-0.010438220575451851
0,hf,2.75,0.1109897643327713
0,guidelines,2.75,0.12652070820331573
0,patients,2.6666666666666665,0.4592966139316559
0,sacubitril,2.0,0
0,results,2.0,0.0652550756931305
0,registry,2.0,0.13723981380462646
0,hospitals,2.0,0.4598262906074524
0,cardiology,2.0,1.0
0,7,2.0,0.005520308390259743
0,1,1.6666666666666667,-0.001867588609457016
0,study,1.5,0.2376001477241516
0,level,1.5,0.05803287774324417
0,valsartan,1.0,0.3132857382297516
0,use,1.0,0.0033735278993844986
0,treatment,1.0,0.27399298548698425
0,titration,1.0,0.1384366899728775
0,released,1.0,-0.011258095502853394
0,quarter,1.0,0.02147839590907097
0,publication,1.0,0.05962849035859108
0,prescription,1.0,0.16285577416419983
0,prescribed,1.0,0.13220295310020447
0,population,1.0,0.1400190144777298
0,observational,1.0,0.1594090461730957
0,multicentre,1.0,0.267255961894989
0,months,1.0,0.04044569283723831
0,methods,1.0,0.024640876799821854
0,management,1.0,0.23943668603897095
0,ivabradine,1.0,0.3274857997894287
0,greater,1.0,0.09047040343284607
0,describe,1.0,-0.011884354054927826
0,cross,1.0,0.1382628083229065
0,consequence,1.0,0.00507243350148201
0,conclusions,1.0,0.07628431916236877
0,complexity,1.0,-0.0006290450692176819
0,compared,1.0,0.10162706673145294
0,class,1.0,0.02183631807565689
0,beta,1.0,0.03460385650396347
0,behalf,1.0,0.003146544098854065
0,authors,1.0,0.21598771214485168
0,aims,1.0,0.04269438236951828
0,aim,1.0,0.040013544261455536
0,accomplished,1.0,0.017712406814098358
0,91,1.0,0
0,72,1.0,0
0,48,1.0,0
0,25,1.0,0
0,24,1.0,0
0,23,1.0,0
0,21,1.0,0
0,19,1.0,0
0,16,1.0,0
0,new dihydropyridine calcium channel blockers,22.0,0.09904947075992823
0,mmol creatinine (> 300 mg,18.333333333333332,0.1505225201447805
0,diabetic hypertensive patients treated,13.75,0.30211174115538597
0,calcium channel blockers,12.0,0.06105601694434881
0,diabetic hypertensive patients,9.75,0.3479838768641154
0,validated digital device,9.0,0.12929092844327292
0,significant difference among,9.0,0.07635592048366864
0,mean age 60,9.0,0.09059951826930046
0,clinitek device analyzer,9.0,0.16878881305456161
0,angiotensin aldosterone system,9.0,0.16395087788502374
0,9 mg albumin,8.833333333333334,0.05081244930624962
0,668 unselected patients,8.75,0.3539966642856598
0,"males 38 %),",8.666666666666666,0.06523969769477844
0,different drug combinations,8.5,0.07228653381268184
0,"9 %, p",8.0,0.051567317917943
0,"8 %, lercanidipine",8.0,0.12984164711087942
0,4 ± 10,8.0,0.07706636190414429
0,"8 %), macroalbuminuria",7.666666666666666,0.1287631904706359
0,"6 %, amlodipine",7.0,0.10188530385494232
0,300 mg,6.833333333333334,0.09104277193546295
0,mmol creatinine,6.5,0.18026239424943924
0,creatinine ratio,5.0,0.1493717022240162
0,"2 %),",4.666666666666666,0.03300613537430763
0,urinary albumin,4.5,0.13936226069927216
0,several combinations,4.5,0.03447212651371956
0,similar effect,4.0,0.04403757839463651
0,renal outcomes,4.0,0.34220316261053085
0,raas inhibitors,4.0,0.1365484818816185
0,pait survey,4.0,0.02947916090488434
0,low number,4.0,0.047874187119305134
0,kidney disease,4.0,0.19676077365875244
0,early marker,4.0,0.04418988898396492
0,decreased occurrence,4.0,0.04510323889553547
0,blood pressure,4.0,0.14018943160772324
0,6 months,4.0,0.02743322029709816
0,4 %),4.0,-8.371472358703613e-05
0,2 years,4.0,0.041833942756056786
0,2 %.,4.0,0.03300613537430763
0,without albuminuria,3.8,0.09529329836368561
0,control albuminuria,3.8,0.13373274356126785
0,albuminuria translates,3.8,0.12359282746911049
0,significantly lowered,3.666666666666667,0.05978113226592541
0,significantly higher,3.666666666666667,0.10986901819705963
0,treatments decrease,3.5,0.18158124387264252
0,previous treatment,3.5,0.15054703876376152
0,g ).,3.5,0.02275453880429268
0,enalapril compared,3.5,0.19556830078363419
0,analysed data,3.5,0.1061776876449585
0,amlodipine perindopril,3.5,0.23532819747924805
0,310 subjects,3.5,0.13721111416816711
0,3 %).,3.5,0.019742561504244804
0,ramipril albuminuria,3.3,0.20104482769966125
0,patients,2.75,0.4592966139316559
0,p,2.0,0.11820723116397858
0,macroalbuminuria,2.0,0.26796460151672363
0,lercanidipine,2.0,0.2701215147972107
0,amlodipine,2.0,0.18934985995292664
0,6,2.0,0.014420747756958008
0,4,2.0,-8.371472358703613e-05
0,albuminuria,1.8,0.21154868602752686
0,significantly,1.6666666666666667,0.10662119090557098
0,treatments,1.5,0.2853734493255615
0,treatment,1.5,0.27399298548698425
0,subjects,1.5,0.13721111416816711
0,ramipril,1.5,0.19054096937179565
0,perindopril,1.5,0.28130653500556946
0,g,1.5,0.02275453880429268
0,enalapril,1.5,0.28950953483581543
0,data,1.5,0.1061776876449585
0,3,1.5,0.019742561504244804
0,verapamil,1.0,0.2621586322784424
0,valsartan,1.0,0.3132857382297516
0,using,1.0,-0.04173736274242401
0,use,1.0,0.0033735278993844986
0,trandolapril,1.0,0.23690202832221985
0,showing,1.0,0.002325989305973053
0,results,1.0,0.0652550756931305
0,renin,1.0,0.18859215080738068
0,reduction,1.0,0.11836925148963928
0,reduced,1.0,0.03761252388358116
0,prevalence,1.0,0.1558399796485901
0,present,1.0,0.0756206065416336
0,normoalbuminuria,1.0,0
0,nitrendipine,1.0,0
0,multistic,1.0,0
0,microalbuminuria,1.0,0.2237807959318161
0,methods,1.0,0.024640876799821854
0,measured,1.0,0.07410861551761627
0,maintained,1.0,0.03229638934135437
0,loss,1.0,0.0528750903904438
0,introduction,1.0,0.021546807140111923
0,frequency,1.0,0.059476010501384735
0,felodipine,1.0,0.19666710495948792
0,favoring,1.0,0.08206921815872192
0,evaluate,1.0,0.08850531280040741
0,due,1.0,-0.005625979043543339
0,defined,1.0,0.009061356075108051
0,conclusions,1.0,0.07628431916236877
0,combined,1.0,0.05379888415336609
0,changes,1.0,-0.006772637367248535
0,cardiovascular,1.0,0.5747424960136414
0,baseline,1.0,0.05839666724205017
0,assessed,1.0,0.06162751466035843
0,analyzed,1.0,0.13667140901088715
0,aims,1.0,0.04269438236951828
0,84,1.0,0
0,53,1.0,0
0,5,1.0,0.010449972003698349
0,46,1.0,0
0,41,1.0,0
0,358,1.0,0
0,33,1.0,0
0,30,1.0,0
0,263,1.0,0
0,23,1.0,0
0,21,1.0,0
0,19,1.0,0
0,15,1.0,0
0,11,1.0,0
0,01,1.0,0
0,0,1.0,0.04786166548728943
0,constructed showed comparable predicting accuracy,23.0,0.0490543469786644
0,constructed using computational approaches,16.5,0.06322937924414873
0,receiver operating characteristic curve,16.0,0.053695183247327805
0,e )- stained whole,16.0,0.050068978841106095
0,term survival groups according,14.333333333333334,0.06309487577527761
0,1733 quantitative image features,12.166666666666666,0.09093482171495755
0,west china hospital,9.0,0.18584545205036798
0,tnm staging systems,9.0,0.09466038830578327
0,fully automated pipeline,9.0,0.06894889970620473
0,external validation sets,9.0,0.062281412382920585
0,distinguish hepatocellular carcinoma,9.0,0.1279252270857493
0,different time points,9.0,0.061143690099318825
0,develop quantitative feature,9.0,0.10188550750414531
0,cancer genome atlas,9.0,0.1906172583500544
0,assigned risk scores,9.0,0.07852762813369434
0,adjacent normal tissues,9.0,0.09039139499266942
0,adjacent normal tissue,9.0,0.11436919122934341
0,diagnostic classifier based,8.5,0.22222079584995905
0,classify tissue slides,8.5,0.08022588863968849
0,tissue microarray images,8.333333333333334,0.1775288830200831
0,significantly stratify patients,8.25,0.2640812247991562
0,successfully distinguish hcc,8.0,0.01990586146712303
0,learning models derived,7.833333333333334,0.04134630194554726
0,predicting patients,5.75,0.2513232883065939
0,quantitative features,5.166666666666666,0.09172767959535122
0,image features,5.166666666666666,0.06642278097569942
0,based models,4.833333333333334,0.09678144007921219
0,histopathological slides,4.5,0.1503736600279808
0,survival outcomes,4.333333333333334,0.18590887635946274
0,statistical models,4.333333333333334,0.11060013622045517
0,slide images,4.333333333333334,0.03692284971475601
0,histopathological images,4.333333333333334,0.1540200039744377
0,hcc patients,4.25,0.4592966139316559
0,31 features,4.166666666666666,0.04349645599722862
0,surgical resection,4.0,0.38057055324316025
0,prognostic model,4.0,0.1844272967427969
0,learning methods,4.0,0.026072733104228973
0,histopathological slide,4.0,0.12079568207263947
0,hcc diagnosis,4.0,0.24688632786273956
0,findings suggest,4.0,0.12938952632248402
0,assist clinicians,4.0,0.21805593371391296
0,886 ).,4.0,0
0,predict patients,3.75,0.24415163323283195
0,extracted features,3.6666666666666665,0.027844730764627457
0,prognosis prediction,3.5,0.15420611947774887
0,auc 0,3.0,0.015688426792621613
0,survival,2.3333333333333335,0.13855862617492676
0,features,2.1666666666666665,0.04349645599722862
0,hcc,2.0,0
0,prognosis,1.5,0.23093095421791077
0,predict,1.5,0.029006652534008026
0,methods,1.5,0.024640876799821854
0,extracted,1.5,0.012193005532026291
0,auc,1.5,-0.016484811902046204
0,0,1.5,0.04786166548728943
0,used,1.0,0.010911919176578522
0,train,1.0,0.012325972318649292
0,total,1.0,0.003683900460600853
0,test,1.0,0.08394099026918411
0,surgery,1.0,0.3447723090648651
0,study,1.0,0.2376001477241516
0,shorter,1.0,0.08764592558145523
0,set,1.0,0.0029952004551887512
0,results,1.0,0.0652550756931305
0,random,1.0,-0.09545474499464035
0,objective,1.0,0.01818794757127762
0,moreover,1.0,0.01877431571483612
0,machine,1.0,0.04470905661582947
0,longer,1.0,0.0349513441324234
0,hepatectomy,1.0,0.32705748081207275
0,hematoxylin,1.0,0.20370984077453613
0,h,1.0,0.028560467064380646
0,eosin,1.0,0.23330606520175934
0,conclusions,1.0,0.07628431916236877
0,area,1.0,0.1299571692943573
0,analyze,1.0,0.0579666830599308
0,aim,1.0,0.040013544261455536
0,able,1.0,-0.006554350256919861
0,988,1.0,0
0,among people prescribed loop diuretics,18.0,0.10049626827239991
0,less common among individuals,16.333333333333332,0.07493497617542744
0,dimensional dementia assessment scale,16.0,0.08744572475552559
0,performed including 2494 people,15.5,0.10580221315224965
0,drug classes among people,15.5,0.11046043783426285
0,collected concerning drug use,14.166666666666666,0.04832139750942588
0,angiotensin ii receptor blockers,12.5,0.10373337659984827
0,people prescribed asa,10.5,0.07720055306951205
0,mineralocorticoid receptor antagonists,9.5,0.12379894157250722
0,two questionnaire surveys,9.0,0.0713474452495575
0,especially regarding adherence,9.0,0.07497867941856384
0,converting enzyme inhibitors,9.0,0.06566230580210686
0,associated factors within,9.0,0.06410927201310794
0,elderly people living,8.833333333333334,0.12953860312700272
0,cardiovascular drug treatment,8.833333333333332,0.3397956043481827
0,severe cognitive impairment,8.166666666666666,0.07753808796405792
0,increasing cognitive impairment,8.166666666666666,0.06519506002465884
0,"6 %, β",8.0,0.039079613983631134
0,cardiovascular agents used,7.666666666666666,0.19537448386351267
0,four different levels,7.5,0.0594781960050265
0,loop diuretics,6.166666666666666,0.08653094992041588
0,1654 people,5.5,0.09872020781040192
0,cognitive impairment,5.166666666666666,0.07019133120775223
0,four levels,5.0,0.05554237589240074
0,cardiovascular drugs,4.666666666666666,0.36892223358154297
0,treatment patterns,4.5,0.16428351402282715
0,different drugs,4.5,0.1152259036898613
0,cognitive function,4.5,0.11822796240448952
0,daily living,4.333333333333334,0.06507956236600876
0,significantly lower,4.0,0.10325782373547554
0,nursing homes,4.0,0.18970278091728687
0,northern sweden,4.0,0.07957284152507782
0,mddas ).,4.0,0
0,heart failure,4.0,0.2074820026755333
0,describe changes,4.0,-0.00932849571108818
0,atrial fibrillation,4.0,0.26550570130348206
0,2013 living,4.0,0.1055341437458992
0,results indicate,3.5,0.043764496222138405
0,4 %.,3.5,-8.371472358703613e-05
0,2013 compared,3.166666666666667,0.10162706673145294
0,diuretics,2.6666666666666665,0.21879620850086212
0,use,2.5,0.0033735278993844986
0,blockers,2.5,0.045741792768239975
0,angiotensin,2.5,0.20593181252479553
0,β,2.0,0.06373848021030426
0,used,2.0,0.010911919176578522
0,2013,1.6666666666666667,0
0,results,1.5,0.0652550756931305
0,compared,1.5,0.10162706673145294
0,4,1.5,-8.371472358703613e-05
0,warfarin,1.0,0.32206350564956665
0,using,1.0,-0.04173736274242401
0,study,1.0,0.2376001477241516
0,room,1.0,0.1170908510684967
0,relation,1.0,0.07857805490493774
0,purpose,1.0,-0.006926483474671841
0,proxy,1.0,0.006921097636222839
0,proportion,1.0,0.06724773347377777
0,prescription,1.0,0.16285577416419983
0,population,1.0,0.1400190144777298
0,pattern,1.0,0.04877403751015663
0,multi,1.0,0.048057474195957184
0,mras,1.0,0
0,methods,1.0,0.024640876799821854
0,increased,1.0,0.07228505611419678
0,improvement,1.0,0.12947404384613037
0,improved,1.0,0.0877273678779602
0,guidelines,1.0,0.12652070820331573
0,functioning,1.0,0.0729140043258667
0,effect,1.0,0.004295531194657087
0,data,1.0,0.1061776876449585
0,conclusion,1.0,0.03420025110244751
0,cognition,1.0,0.18422648310661316
0,arbs,1.0,0.026489917188882828
0,analyse,1.0,0
0,aim,1.0,0.040013544261455536
0,adl,1.0,0.0771344006061554
0,activities,1.0,0.02935326099395752
0,acei,1.0,0
0,8,1.0,-0.010438220575451851
0,45,1.0,0
0,41,1.0,0
0,37,1.0,0
0,36,1.0,0
0,2007,1.0,0
0,11,1.0,0
0,0,1.0,0.04786166548728943
0,highly controlled ubiquitous posttranslational modification,25.0,0.03599901720881462
0,clinically applied risk prediction scores,19.75,0.12173875272274018
0,based type 2 diabetes score,19.333333333333332,0.10231560468673706
0,glycans improve type 2 diabetes,19.0,0.12429139763116837
0,prospective european prospective investigation,16.0,0.07116947881877422
0,precisely targeted primary prevention,16.0,0.0851284060627222
0,"e ., myocardial infarction",16.0,0.19994248946507773
0,epic )- potsdam cohort,14.666666666666666,0.07331506907939911
0,finland cardiovascular risk study,14.25,0.2549746581353247
0,weighted c indices men,14.166666666666666,0.05404847953468561
0,glycan profiling may thus,14.083333333333334,0.036230096127837896
0,weighted c index 0,14.0,0.0424300255253911
0,glycan profiling integrates information,12.583333333333334,0.07811998389661312
0,weighted prediction scores,11.666666666666666,0.021261521925528843
0,type 2 diabetes,11.333333333333332,0.1285005733370781
0,american diabetes association,9.6,0.14200195716693997
0,verified incident cases,9.0,0.048442874724666275
0,nonlinear model building,9.0,0.04953139275312424
0,enzymatic protein glycosylation,9.0,0.1012729008992513
0,internal validation cohort,8.666666666666666,0.13578038911024728
0,baseline plasma samples,8.666666666666666,0.0941954863568147
0,validated machine learning,8.5,0.05224952474236488
0,2 years ).,8.233333333333334,0.041833942756056786
0,plasma protein n,7.833333333333332,0.07531461678445339
0,selected predictive n,7.0,0.062405203158656754
0,diabetes risk,6.85,0.25412674993276596
0,applied separately,5.5,0.02309310995042324
0,chromatographic profiling,5.333333333333334,0.08542603254318237
0,risk stratification,5.25,0.16070245951414108
0,cardiovascular diseases,5.0,0.40692125260829926
0,plasma n,4.833333333333333,0.07488869968801737
0,glycan groups,4.75,0.07744613289833069
0,selected n,4.666666666666666,0.006180210970342159
0,glycans improved,4.666666666666666,0.11930149048566818
0,externally validated,4.5,0.07196013256907463
0,5 years,4.5,0.030555861070752144
0,strongly predictive,4.333333333333334,0.09019435569643974
0,stroke ).,4.333333333333334,0.2592560052871704
0,moderately predictive,4.333333333333334,0.12656795978546143
0,ci 0,4.333333333333334,0.056966543197631836
0,73 ).,4.333333333333334,0
0,39 n,4.166666666666666,-0.021267158910632133
0,© 2020,4.0,0.024751247838139534
0,time 8,4.0,0.02199385967105627
0,time 6,4.0,0.0344233438372612
0,research design,4.0,0.20425117015838623
0,relative abundance,4.0,0.03959193639457226
0,random subsample,4.0,-0.03890769463032484
0,predict incidence,4.0,0.10471471771597862
0,median follow,4.0,0.11098180711269379
0,constructed case,4.0,0.062248438596725464
0,cohorts including,4.0,0.0671900138258934
0,cardiometabolic diseases,4.0,0.3090708702802658
0,"88 ),",4.0,0
0,"548 ),",4.0,0
0,500 participants,4.0,0.06751469522714615
0,cvd separately,3.666666666666667,0.039199184626340866
0,cvd incidence,3.666666666666667,0.18042278289794922
0,2,3.4,0.03300613537430763
0,based,3.0,0.08516917377710342
0,glycan,2.75,0.1342036873102188
0,glycans,2.6666666666666665,0.15087561309337616
0,cohort,2.6666666666666665,0.15340903401374817
0,men,2.5,0.09247083961963654
0,information,2.5,0.07507836818695068
0,0,2.3333333333333335,0.04786166548728943
0,n,2.1666666666666665,-0.021267158910632133
0,cvd,1.6666666666666667,0
0,workflow,1.0,0.19669874012470245
0,women,1.0,0.14002981781959534
0,useful,1.0,0.07975795120000839
0,results,1.0,0.0652550756931305
0,physician,1.0,0.5361219048500061
0,objective,1.0,0.01818794757127762
0,methods,1.0,0.024640876799821854
0,investigate,1.0,0.04426265507936478
0,glycome,1.0,0
0,generated,1.0,0.05094560980796814
0,finrisk,1.0,0
0,finding,1.0,0.017409224063158035
0,established,1.0,0.06200568750500679
0,cvds,1.0,0
0,cross,1.0,0.1382628083229065
0,context,1.0,0.04743277281522751
0,construction,1.0,0.09718848764896393
0,conclusions,1.0,0.07628431916236877
0,cancer,1.0,0.23309507966041565
0,accuracy,1.0,0.05023651197552681
0,ability,1.0,-0.022223003208637238
0,95,1.0,0
0,83,1.0,0
0,820,1.0,0
0,78,1.0,0
0,72,1.0,0
0,66,1.0,0
0,64,1.0,0
0,60,1.0,0
0,55,1.0,0
0,508,1.0,0
0,27,1.0,0
0,found increased igf1 protein levels,20.625,0.057593357749283314
0,systemic versus localized signaling,15.0,0.07976250723004341
0,like growth factor 1,15.0,0.06482672225683928
0,cas9 gene activation approach,14.5,0.08306808024644852
0,class 2 mrna variants,14.333333333333332,0.03818295026818911
0,igf1 mrna transcript variants,14.208333333333332,0.04301820509135723
0,treating skeletal muscle atrophy,13.166666666666666,0.14565661270171404
0,igf1 mrna variants,10.208333333333332,0.059706397354602814
0,© 2019 federation,9.0,0.02798494976013899
0,key positive regulator,9.0,0.06445485105117162
0,cell culture media,9.0,0.07892321298519771
0,enhancing igf1 signaling,8.875,0.08659395948052406
0,sgrna target location,8.5,0.0427208561450243
0,increasing gene expression,8.5,0.06381330577035745
0,diverse biology seen,8.5,0.16452294091383615
0,multiple igf1 isoforms,8.375,0.08628405630588531
0,increased cellular phosphorylation,8.25,0.0943344384431839
0,potential therapeutic applications,8.0,0.1474572072426478
0,class 1,6.0,0.009984364733099937
0,igf1 signaling,5.875,0.05109945684671402
0,multiple igf1,5.375,0.08332659304141998
0,muscle atrophy,5.166666666666666,0.09330413676798344
0,novel approach,5.0,0.06224964186549187
0,selectively increased,4.75,0.06518071703612804
0,induced atrophy,4.666666666666666,0.06069842632859945
0,sgrna ).,4.5,0
0,muscle wasting,4.5,0.042959196493029594
0,muscle mass,4.5,0.043688489124178886
0,experimental biology,4.5,0.2464067041873932
0,cellular proliferation,4.5,0.14812444150447845
0,tissue expression,4.0,0.08777856919914484
0,prevented dexamethasone,4.0,0.046328664757311344
0,novel strategy,4.0,0.09888306632637978
0,main effector,4.0,0.05729024298489094
0,guide rna,4.0,0.008003558963537216
0,genome engineering,4.0,0.23896826803684235
0,findings suggest,4.0,0.12938952632248402
0,complicates treatment,4.0,0.1590868327766657
0,american societies,4.0,0.06495580892078578
0,also showed,3.5,0.04536193795502186
0,igf1,2.875,0
0,increased,2.75,0.07228505611419678
0,potential,2.0,0.06813585013151169
0,expression,2.0,0.0005566496402025223
0,showed,1.5,0.048222288489341736
0,well,1.0,0.09099400043487549
0,vitro,1.0,0.2126568853855133
0,using,1.0,-0.04173736274242401
0,single,1.0,0.015469912439584732
0,recapitulate,1.0,0.032004695385694504
0,quality,1.0,0.11005230993032455
0,potency,1.0,-0.0018293820321559906
0,particularly,1.0,0.09882432222366333
0,overexpression,1.0,0.07107347995042801
0,occur,1.0,0.06010684743523598
0,myotubes,1.0,0
0,life,1.0,0.07387976348400116
0,insulin,1.0,0.1587810218334198
0,injury,1.0,0.04424106702208519
0,human,1.0,0.08946964889764786
0,function,1.0,0.11069313436746597
0,disease,1.0,0.1630353331565857
0,differentiation,1.0,0.09310577064752579
0,differ,1.0,0.033852480351924896
0,crispr,1.0,0
0,changing,1.0,-0.028789706528186798
0,akt1,1.0,0
0,age,1.0,0.10348664224147797
0,affects,1.0,0.04985688626766205
0,tidal carbon dioxide partial pressure,24.2,0.07858753018081188
0,时刻i qa 、 ai及chop mrna和蛋白表达水平均显著高于t,23.666666666666664,0.012214049696922302
0,arterial oxygen partial pressure difference,22.866666666666667,0.12222025319933891
0,peak )） 的情况 。 比较两组t,21.75,0.02320476621389389
0,2 )）、 单侧肺通气后1 h （,21.675824175824175,0.03078330121934414
0,1 )）、 单侧肺通 气即刻 （,21.07142857142857,-0.001867588609457016
0,2 )） 和气道压力峰值 （ p,20.79010989010989,0.0756066832691431
0,2 )]、 呼气末二氧化碳分压 （ p,20.79010989010989,0.0756066832691431
0,"2 )), oxygen partial pressure",20.453205128205127,0.06869272980839014
0,lung cancer undergoing thoracoscopic lobectomy,20.25,0.259964182972908
0,2 )）、 氧分压 （ pao,19.675824175824175,0.06844891794025898
0,underwent elective thoracoscopic lobectomy,17.0,0.28585878759622574
0,pulmonary protective mechanism could,14.833333333333334,0.15206588432192802
0,3 )）、 双肺通气即刻 （,14.714285714285714,0.019742561504244804
0,0 )）、 气管插管后即刻 （,14.714285714285714,0.04786166548728943
0,4 )）、 手术结束时 （,14.547619047619047,-8.371472358703613e-05
0,binding protein homologous protein,14.0,0.05706182587891817
0,"hr ), oxygen saturation",13.966666666666667,0.05794923876722654
0,"2 )), 1 hour",13.44368131868132,0.030836739887793858
0,"map ), heart rate",13.3,0.1573411524295807
0,"iqa ), apoptotic index",13.3,0.09493203461170197
0,mean arterial pressure,11.2,0.1702456052104632
0,2 )）、 肺泡,10.747252747252748,0.03300613537430763
0,时刻 。 c组患者t,10.0,0
0,airway pressure peak,9.95,0.10684075206518173
0,水平均显著高于d组 （ 均p,9.928571428571429,0
0,水平均显著低于c组 （ 均p,9.928571428571429,0
0,时刻 （ 均p,9.928571428571429,0
0,10和sod水平均显著高于c组 （ 均p,9.928571428571429,0
0,时刻map 、 hr水平显著低于t,9.666666666666666,0
0,均显著高于c组 ， p,9.4,0.11820723116397858
0,unilateral pulmonary ventilation,9.333333333333334,0.24165771653254828
0,bilateral pulmonary ventilation,9.333333333333334,0.27257020274798077
0,6 （ il,9.195238095238095,0.03850977122783661
0,"2 )), alveolar",9.086538461538462,0.09956246800720692
0,目的 ： 探讨右美托咪啶对胸腔镜肺叶切除术老年肺癌患者肺损伤及ccaat,9.0,0
0,tumor necrosis factor,9.0,0.12045644720395406
0,super oxide dismutase,9.0,0.06645799179871877
0,second affiliated hospital,9.0,0.182779831190904
0,improving oxidative stress,9.0,0.07301891160507996
0,"1 )), immediately",8.982142857142858,0.0034143193624913692
0,6 、 il,8.933333333333334,0.03850977122783661
0,0 )( p,8.9,0.083034448325634
0,05 ）； 两组患者t,8.8,0
0,05 ）， 且d组t,8.8,0
0,05 ）。 两组患者t,8.8,0
0,05 ）。 d组患者t,8.8,0
0,8和mda水平均显著低于c组 ， il,8.666666666666666,0.06259879469871521
0,"3 )), immediately",8.625,0.01421939441934228
0,"0 )), immediately",8.625,0.02827894641086459
0,α ）、 白细胞介素,8.5,0.06381849944591522
0,dexmedetomidine could attenuate,8.5,0.11212912574410439
0,"2 )], end",8.461538461538462,0.023402906954288483
0,α （ tnf,8.428571428571429,0.06381849944591522
0,"α ), interleukin",8.3,0.09299088642001152
0,6 ）、 il,8.266666666666666,0.03850977122783661
0,"6 ), il",8.066666666666666,0.03850977122783661
0,120 elderly patients,8.0,0.32182903587818146
0,spontaneous breathing recovery,7.5,0.08097539842128754
0,"2 )),",6.586538461538462,0.03300613537430763
0,"2 ),",6.2615384615384615,0.03300613537430763
0,lung cancer,6.25,0.24483947455883026
0,"1 ),",5.657142857142857,-0.001867588609457016
0,2 )、,5.461538461538462,0.03300613537430763
0,"4 )),",5.458333333333334,-8.371472358703613e-05
0,"3 ),",5.3,0.019742561504244804
0,"0 ),",5.3,0.04786166548728943
0,spontaneous breathing,5.0,0.08018719404935837
0,elderly patients,5.0,0.32182903587818146
0,1 )、,4.857142857142858,-0.001867588609457016
0,1 )~,4.857142857142858,-0.001867588609457016
0,1 )-,4.857142857142858,-0.001867588609457016
0,05 ).,4.8,0
0,peak )),4.75,0.02320476621389389
0,lung tissue,4.75,0.21579217910766602
0,lung injury,4.75,0.15041246823966503
0,alveolar damage,4.5,0.10244164802134037
0,3 )、,4.5,0.019742561504244804
0,3 )~,4.5,0.019742561504244804
0,3 )-,4.5,0.019742561504244804
0,0 )、,4.5,0.04786166548728943
0,"ai ),",4.3,0.07966839522123337
0,recovery time,4.166666666666667,0.06848887354135513
0,动脉 氧分压的差值,4.0,0
0,zhengzhou university,4.0,0.23365965485572815
0,two groups,4.0,0.04741007462143898
0,tracheal intubation,4.0,0.26566949486732483
0,significantly shorter,4.0,0.09713355824351311
0,significantly lower,4.0,0.10325782373547554
0,significantly higher,4.0,0.10986901819705963
0,random phenotype,4.0,0.008278440684080124
0,postoperative awake,4.0,0.19153598695993423
0,october 2018,4.0,-0.007237447425723076
0,mediated apoptosis,4.0,0.11204681545495987
0,march 2019,4.0,-0.027591872960329056
0,inflammatory factors,4.0,0.09863114543259144
0,anesthetic induction,4.0,0.1603073962032795
0,agitation occurrence,4.0,0.059697529301047325
0,009 pmid,4.0,0
0,group c,3.75,0.045693403109908104
0,dexmedetomidine group,3.75,0.17142814584076405
0,control group,3.75,0.05305405892431736
0,reducing chop,3.666666666666667,0.013314586132764816
0,elapsed time,3.666666666666667,0.017667675390839577
0,chop mrna,3.666666666666667,-0.06419391185045242
0,60 ).,3.5,0
0,5 )).,3.5,0.010449972003698349
0,2,3.4615384615384617,0.03300613537430763
0,p,3.4,0.11820723116397858
0,protein,3.0,0.07616645097732544
0,pao,3.0,0.10389170050621033
0,peak,2.75,0.02320476621389389
0,il,2.6666666666666665,0.06259879469871521
0,6,2.6,0.014420747756958008
0,α,2.5,0.06381849944591522
0,map,2.5,0.06641704589128494
0,iqa,2.5,0
0,hr,2.5,0.037340112030506134
0,0,2.5,0.04786166548728943
0,4,2.3333333333333335,-8.371472358703613e-05
0,tnf,2.0,0
0,end,2.0,0.013799678534269333
0,dexmedetomidine,2.0,0.2926649749279022
0,group,1.75,0.05019131675362587
0,time,1.6666666666666667,0.05442593991756439
0,chop,1.6666666666666667,-0.06419391185045242
0,ai,1.5,0.07966839522123337
0,60,1.5,0
0,5,1.5,0.010449972003698349
0,时刻肿瘤坏死因子,1.0,0
0,时刻pao,1.0,0
0,时刻p,1.0,0
0,时il,1.0,0
0,和t,1.0,0
0,values,1.0,0.023721983656287193
0,total,1.0,0.003683900460600853
0,surgery,1.0,0.3447723090648651
0,spo,1.0,-0.02494291216135025
0,sod,1.0,-0.00016865134239196777
0,selected,1.0,0.03362758085131645
0,results,1.0,0.0652550756931305
0,related,1.0,0.1234813779592514
0,recorded,1.0,0.01999819651246071
0,ratios,1.0,0.09756212681531906
0,publisher,1.0,0.08886848390102386
0,objective,1.0,0.01818794757127762
0,n,1.0,-0.021267158910632133
0,methods,1.0,0.024640876799821854
0,medline,1.0,0
0,mda,1.0,0.07220671325922012
0,malondialdehyde,1.0,0.12827050685882568
0,levels,1.0,0.04464932531118393
0,j,1.0,0.010428212583065033
0,issn,1.0,0
0,inhibition,1.0,0.03232728689908981
0,indexed,1.0,0.00026863813400268555
0,extent,1.0,0.017291061580181122
0,expression,1.0,0.0005566496402025223
0,evaluate,1.0,0.08850531280040741
0,et,1.0,0.06867760419845581
0,enhancer,1.0,-0.00576905719935894
0,effect,1.0,0.004295531194657087
0,doi,1.0,0.055976808071136475
0,divided,1.0,0.11364559084177017
0,detected,1.0,0.10373490303754807
0,conscious,1.0,0.098431795835495
0,conclusions,1.0,0.07628431916236877
0,compared,1.0,0.10162706673145294
0,co,1.0,0.08638649433851242
0,cma,1.0,-0.022496625781059265
0,ccaat,1.0,0
0,8和il,1.0,0
0,8,1.0,-0.010438220575451851
0,3760,1.0,0
0,31914556,1.0,0
0,2491,1.0,0
0,2020,1.0,0
0,10,1.0,0
0,0376,1.0,0
0,01,1.0,0
0,ai mimetic peptides treatment led,17.133333333333333,0.10157105103135108
0,data provides compelling proof,16.0,0.03244350757449865
0,l5f mimetic peptide administered,14.833333333333334,0.07244823624690373
0,high density lipoprotein particles,14.5,0.109603775665164
0,also showed altered expression,14.0,0.022893853951245546
0,improved blood glucose clearance,13.933333333333334,0.12997659109532833
0,fold auc decrease compared,13.0,0.06455062702298164
0,reduced hepatic macrophage infiltration,12.666666666666666,0.09317235928028822
0,ai mimetic peptide,9.833333333333334,0.0801036184032758
0,fold decrease compared,9.5,0.09156243999799092
0,fold auc compared,9.5,0.06013782322406769
0,mimetic peptides could,9.133333333333333,0.033981618781884514
0,ai mimetic peptides,9.133333333333333,0.059091915686925255
0,new therapeutic option,9.0,0.1437749428053697
0,intraperitoneal injection bi,9.0,0.09728226438164711
0,hepatic mrna expression,9.0,0.07605277094990015
0,ai injected directly,9.0,0.047990646213293076
0,improved insulin tolerance,8.966666666666667,0.09339556718866031
0,improved glucose homeostasis,8.933333333333334,0.1250926380356153
0,improve insulin sensitivity,8.833333333333334,0.10543355842431386
0,insulin tolerance tests,8.633333333333333,0.09819203739364941
0,insulin tolerance test,8.633333333333333,0.09213344131906827
0,key markers involved,8.5,0.045241216818491616
0,glucose tolerance test,8.4,0.10037562623620033
0,induced insulin resistance,8.333333333333334,0.04638384965558847
0,reduce hepatic inflammation,8.25,0.1365928277373314
0,decreased hepatic inflammation,8.25,0.12185671925544739
0,test whether apo,8.0,0.07399833823243777
0,metabolic test results,8.0,0.14035562922557196
0,major apolipoprotein found,8.0,0.10412385935584705
0,mimetic peptides,6.133333333333333,0.048803675919771194
0,fold compared,6.0,0.09844914078712463
0,reduced infiltration,5.666666666666666,0.04464881680905819
0,reduced expression,5.666666666666666,0.019084586761891842
0,glucose tolerance,5.4,0.10859294421970844
0,insulin resistance,5.333333333333334,0.07306778058409691
0,hepatic inflammation,5.25,0.16031168401241302
0,5f showed,4.666666666666667,0.0498478002846241
0,inflammatory markers,4.5,0.10430209711194038
0,time pcr,4.0,0.05442593991756439
0,respective pathways,4.0,0.09091972559690475
0,previously demonstrated,4.0,0.03576158918440342
0,male c57bl,4.0,0.05418261140584946
0,lipid synthesis,4.0,0.17085880041122437
0,length apo,4.0,0.07803621515631676
0,hdls ).,4.0,0
0,gluconeogenic enzymes,4.0,0.08565188944339752
0,five weeks,4.0,0.05049150250852108
0,findings suggest,4.0,0.12938952632248402
0,fat diet,4.0,0.09509199112653732
0,clinically feasible,4.0,0.1972884088754654
0,6 mice,4.0,0.051602981984615326
0,1β ifn,4.0,0
0,16 weeks,4.0,0.04700612649321556
0,genes associated,3.666666666666667,0.10460993647575378
0,associated genes,3.666666666666667,0.10460993647575378
0,overall suppression,3.5,0.0514624435454607
0,5f 1,3.3333333333333335,0.024802861735224724
0,4f 1,3.166666666666667,0.02642112597823143
0,treatment,3.0,0.27399298548698425
0,ai,3.0,0.07966839522123337
0,peptides,2.8,0.05771190673112869
0,glucose,2.6,0.18350757658481598
0,high,2.5,0.06070782244205475
0,inflammation,2.25,0.16907447576522827
0,results,2.0,0.0652550756931305
0,apolipoprotein,2.0,0.20140977203845978
0,apo,2.0,0.10638172924518585
0,associated,1.6666666666666667,0.10097402334213257
0,5f,1.6666666666666667,0.051473312079906464
0,1,1.6666666666666667,-0.001867588609457016
0,suppression,1.5,0.06901815533638
0,4f,1.5,0.054709840565919876
0,γ,1.0,0.0845392495393753
0,weekly,1.0,0.045745816081762314
0,total,1.0,0.003683900460600853
0,tnfα,1.0,0
0,suppressed,1.0,0.036808378994464874
0,suggesting,1.0,0.051274579018354416
0,study,1.0,0.2376001477241516
0,srebp1c,1.0,0
0,saa1,1.0,0
0,real,1.0,0.02762891724705696
0,pepck,1.0,0
0,p,1.0,0.11820723116397858
0,overnutrition,1.0,0.2756476402282715
0,ns,1.0,0.09590061008930206
0,mimetics,1.0,0.22551001608371735
0,methods,1.0,0.024640876799821854
0,macrophages,1.0,0.10670876502990723
0,liver,1.0,0.23269252479076385
0,lipogenic,1.0,0
0,l,1.0,0.02060166746377945
0,iv,1.0,0.05570073053240776
0,il,1.0,0.06259879469871521
0,iii,1.0,0.040875934064388275
0,ii,1.0,0.06888964027166367
0,hfd,1.0,0
0,gluconeogenesis,1.0,0.1624269038438797
0,g6pase,1.0,0
0,full,1.0,0.008461154997348785
0,fed,1.0,0.0035025477409362793
0,f4,1.0,0.021830834448337555
0,emulate,1.0,0.05798235535621643
0,effects,1.0,0.04013404995203018
0,effect,1.0,0.004295531194657087
0,development,1.0,0.1793753206729889
0,contributes,1.0,0.05899214372038841
0,conducted,1.0,0.055469855666160583
0,conclusion,1.0,0.03420025110244751
0,concept,1.0,0.01763022691011429
0,chrebp,1.0,0
0,cd68,1.0,0
0,background,1.0,0.03833860531449318
0,assessed,1.0,0.06162751466035843
0,assess,1.0,0.061772990971803665
0,apoa,1.0,0
0,aim,1.0,0.040013544261455536
0,97,1.0,0
0,80,1.0,0
0,77,1.0,0
0,66,1.0,0
0,63,1.0,0
0,61,1.0,0
0,5,1.0,0.010449972003698349
0,40,1.0,0
0,39,1.0,0
0,31,1.0,0
0,3,1.0,0.019742561504244804
0,2,1.0,0.03300613537430763
0,17,1.0,0
0,15,1.0,0
0,05,1.0,0
0,01,1.0,0
0,001,1.0,0
0,0,1.0,0.04786166548728943
0,70 matthews correlation coefficient,16.0,0.021809862305720646
0,various bioinformatics tools focused,14.5,0.11963242618367076
0,potassium channel ligand peptides,12.6,0.05837068543769419
0,bioinformatics software written,9.5,0.17731094484527907
0,python programming language,9.0,0.031231781467795372
0,primary structure information,9.0,0.05981886759400368
0,predict peptide ligands,9.0,0.07374909768501918
0,experimentally verified activity,9.0,0.03764022265871366
0,electrical impulse formation,9.0,0.06452376674860716
0,considered promising alternatives,9.0,0.09439623604218166
0,artificial neural network,9.0,0.10054086024562518
0,predict ligand peptides,8.6,0.04301730543375015
0,support vector machine,8.5,0.051382104866206646
0,potassium channels play,8.5,0.06818718152741592
0,high predictive capacity,8.5,0.08935829624533653
0,novel ligand peptides,8.1,0.06480171779791515
0,random forest algorithm,8.0,0.02592579275369644
0,biological data used,8.0,0.08192053188880284
0,tool called pplk,7.333333333333334,-0.0033244574442505836
0,ligand peptides,5.6,0.050022631883621216
0,potassium channels,5.5,0.06790807750076056
0,random forest,5.0,0.0022971369326114655
0,current tools,5.0,0.007188108749687672
0,novel tool,4.833333333333334,0.03380005061626434
0,high reliability,4.5,0.08591756969690323
0,four machine,4.5,0.05557224154472351
0,first tool,4.333333333333334,-0.0037247203290462494
0,validating models,4.0,0.088039331138134
0,plasma membrane,4.0,0.14300056546926498
0,nearest neighbors,4.0,0.05300748534500599
0,molecules used,4.0,0.04682210832834244
0,model generated,4.0,0.052790841087698936
0,many diseases,4.0,0.1429770588874817
0,learning algorithms,4.0,0.05821537412703037
0,key role,4.0,0.05408843792974949
0,hormone secretion,4.0,0.07382428739219904
0,friendly interface,4.0,0.025791128166019917
0,different activities,4.0,0.04835154861211777
0,cardiovascular diseases,4.0,0.40692125260829926
0,applied research,4.0,0.14215287566184998
0,94 specificity,4.0,0.09074191749095917
0,91 accuracy,4.0,0.05023651197552681
0,77 sensitivity,4.0,0.0724399983882904
0,peptides,2.6,0.05771190673112869
0,used,2.0,0.010911919176578522
0,pplk,2.0,0
0,work,1.0,0.06322342157363892
0,using,1.0,-0.04173736274242401
0,treatment,1.0,0.27399298548698425
0,training,1.0,0.1278398334980011
0,study,1.0,0.2376001477241516
0,showed,1.0,0.048222288489341736
0,regulating,1.0,0.07387600094079971
0,prediction,1.0,0.07748128473758698
0,obtained,1.0,-0.0006794054061174393
0,none,1.0,0.034597981721162796
0,ions,1.0,0.010986916720867157
0,however,1.0,-0.011453256011009216
0,flow,1.0,0.06411638855934143
0,discovery,1.0,0.10541436076164246
0,developed,1.0,0.1218160092830658
0,currently,1.0,0.0543237179517746
0,cancer,1.0,0.23309507966041565
0,c,1.0,0.04119548946619034
0,basic,1.0,0.029801150783896446
0,0,1.0,0.04786166548728943
0,none declared,4.0,0.0609555933624506
0,interest statement,4.0,0.09834937378764153
0,competing interests,4.0,0.07788273692131042
0,31911505 conflict,4.0,0.10667978227138519
0,316030 pmid,4.0,0
0,heartjnl,1.0,0
0,doi,1.0,0.055976808071136475
0,2019,1.0,0
0,1136,1.0,0
0,10,1.0,0
0,echocardiogram data using machine learning,20.5,0.09839973673224449
0,chronic obstructive pulmonary disease,15.0,0.23184162378311157
0,86 plasma proteins differed,15.0,0.10223243509729703
0,"05 ), including biomarkers",14.25,0.17514824867248535
0,"100 days ), mid",13.25,0.024961017072200775
0,identified distinct hfpef phenogroups,13.0,0.05171046033501625
0,using machine learning,12.0,0.01015876109401385
0,identified six phenogroups,9.25,0.08770859241485596
0,rennes cohort study,9.0,0.1955045908689499
0,preserved ejection fraction,9.0,-0.0003367569297552109
0,median 78 years,9.0,0.09330343827605247
0,laboratory variables collected,9.0,0.0909705962985754
0,false discovery rate,9.0,0.07485300054152806
0,concomitant atrial fibrillation,9.0,0.20986218998829523
0,composite end point,9.0,0.027480129152536392
0,"85 %), hypertension",9.0,0.364623486995697
0,derive hfpef phenotype,8.75,0.06330310646444559
0,320 hfpef outpatients,8.75,0.4107869267463684
0,right ventricular function,8.5,0.11878196864078443
0,1000 days ).,8.5,0.03250393271446228
0,"af ), anaemia",8.25,0.058493904769420624
0,versus phenogroups 1,7.75,0.04306546784937382
0,compare clinical characteristics,7.5,0.20651748652259508
0,8 ); 2,7.25,0.01128395739942789
0,6 ); 2,7.25,0.02371344156563282
0,9 ); 5,7.0,-0.002311311662197113
0,100 days,6.0,0.03250393271446228
0,32 echocardiogram,5.5,0.3553447127342224
0,05 ).,5.5,0
0,"001 ),",5.25,0
0,kidney disease,5.0,0.19676077365875244
0,cardiovascular proteins,5.0,0.3253435641527176
0,kidney function,4.5,0.17058967426419258
0,differential characteristics,4.5,0.028938804753124714
0,phenogroup 2,4.25,0.03300613537430763
0,© author,4.0,0.09863682929426432
0,third experienced,4.0,0.06213100254535675
0,stable condition,4.0,0.1300930380821228
0,significantly different,4.0,0.0869855135679245
0,significant differences,4.0,0.11193609237670898
0,see rights,4.0,0.03032690193504095
0,secondary analyses,4.0,0.12579138576984406
0,risk factors,4.0,0.1105011198669672
0,primary outcome,4.0,0.06885062530636787
0,poorer diastolic,4.0,0.19171904027462006
0,higher burden,4.0,0.0941302590072155
0,heterogeneous syndrome,4.0,0.083293117582798
0,heart failure,4.0,0.2074820026755333
0,differential levels,4.0,0.036865818314254284
0,cause mortality,4.0,0.18113460391759872
0,based clustering,4.0,0.11250630393624306
0,applied model,4.0,0.030811553820967674
0,9 )).,4.0,-0.015072595328092575
0,83 )).,4.0,0
0,83 %),4.0,0
0,30 %).,4.0,0
0,18 months,4.0,0.04044569283723831
0,11 clinical,4.0,0.49838685989379883
0,)) 2020,4.0,0
0,term follow,3.5,0.0717815961688757
0,rank p,3.5,0.06202162988483906
0,outcomes across,3.5,0.14927400648593903
0,baseline proteomics,3.5,0.18783657252788544
0,phenogroups,2.75,0
0,hfpef,2.75,0
0,2,2.25,0.03300613537430763
0,clinical,2.0,0.49838685989379883
0,af,2.0,0.058493904769420624
0,9,2.0,-0.015072595328092575
0,8,2.0,-0.010438220575451851
0,6,2.0,0.014420747756958008
0,5,2.0,0.010449972003698349
0,1,2.0,-0.001867588609457016
0,term,1.5,0.05754470452666283
0,proteomics,1.5,0.3172764778137207
0,p,1.5,0.11820723116397858
0,outcomes,1.5,0.23325912654399872
0,well,1.0,0.09099400043487549
0,used,1.0,0.010911919176578522
0,use,1.0,0.0033735278993844986
0,two,1.0,0.0741315707564354
0,thirds,1.0,-0.0059935562312603
0,short,1.0,0.011583387851715088
0,results,1.0,0.0652550756931305
0,published,1.0,0.10513044893741608
0,prevalence,1.0,0.1558399796485901
0,permissions,1.0,0.01313965953886509
0,older,1.0,0.14530479907989502
0,observed,1.0,0.08740169554948807
0,objective,1.0,0.01818794757127762
0,methods,1.0,0.024640876799821854
0,longer,1.0,0.0349513441324234
0,log,1.0,-0.07369421422481537
0,karolinska,1.0,0
0,iqr,1.0,0
0,inflammatory,1.0,0.17046239972114563
0,hr,1.0,0.037340112030506134
0,hospitalisation,1.0,0
0,hf,1.0,0.1109897643327713
0,group,1.0,0.05019131675362587
0,fifteen,1.0,0.006569189950823784
0,female,1.0,0.05358291417360306
0,fdr,1.0,0
0,employer,1.0,0.03903285413980484
0,conclusions,1.0,0.07628431916236877
0,commercial,1.0,0.08596912771463394
0,ci,1.0,0.06607142090797424
0,bmj,1.0,0
0,aimed,1.0,0.0894685834646225
0,95,1.0,0
0,71,1.0,0
0,7,1.0,0.005520308390259743
0,56,1.0,0
0,4,1.0,-8.371472358703613e-05
0,3,1.0,0.019742561504244804
0,12,1.0,0
0,0,1.0,0.04786166548728943
0,specific goals without explicitly programming,25.0,0.04552177786827087
0,compromised cardiovascular system potentially associated,25.0,0.17510272115468978
0,tissue doppler imaging among others,23.0,0.20548518598079682
0,still challenging mainly due,16.0,0.00848001497797668
0,computer science discipline focused,14.5,0.11208346672356129
0,evaluate fetal cardiac structure,13.714285714285715,0.2446069410070777
0,primary acquired images,9.0,0.06630608687798183
0,optimizing image acquisition,9.0,0.11049925784269969
0,including conventional 2,9.0,0.06155302748084068
0,different ultrasound approaches,9.0,0.169826560964187
0,several fetal conditions,8.714285714285715,0.12636536111434302
0,fetal cardiac remodeling,8.714285714285715,0.3410065571467082
0,help extract measurements,8.0,0.054217755794525146
0,fetal cardiac function,7.714285714285714,0.32386235644419986
0,fetal echocardiography,4.714285714285714,0.42160068452358246
0,fetal cardiology,4.714285714285714,0.6208091229200363
0,cardiac abnormalities,4.5,0.4284811317920685
0,fetal heart,4.214285714285714,0.2731611877679825
0,© 2020,4.0,0.024751247838139534
0,small size,4.0,0.03336895443499088
0,prenatal diagnoses,4.0,0.2724864035844803
0,new technologies,4.0,0.1495411954820156
0,machine leaning,4.0,0.04164375178515911
0,karger ag,4.0,0.10048235952854156
0,involuntary movements,4.0,-0.0018107164651155472
0,great importance,4.0,0.08173215016722679
0,especially echocardiography,4.0,0.34955567494034767
0,currently used,4.0,0.03261781856417656
0,brief overview,4.0,0.04755626153200865
0,perform tasks,3.5,0.054614048451185226
0,optimal assessment,3.5,0.0816216841340065
0,ml techniques,3.5,0.07294395938515663
0,imaging,3.0,0.4709222614765167
0,computer,2.5,0.10320991277694702
0,help,2.0,0.016909226775169373
0,function,2.0,0.11069313436746597
0,perform,1.5,0.09922076761722565
0,ml,1.5,0.06590283662080765
0,heart,1.5,0.30470412969589233
0,assessment,1.5,0.08391694724559784
0,abnormalities,1.5,0.23768657445907593
0,well,1.0,0.09099400043487549
0,use,1.0,0.0033735278993844986
0,therefore,1.0,0.024225328117609024
0,teaching,1.0,0.20083385705947876
0,task,1.0,-0.009650083258748055
0,sonographers,1.0,0.39366966485977173
0,segmentation,1.0,0.13467922806739807
0,rules,1.0,-8.914992213249207e-05
0,review,1.0,0.06275224685668945
0,quantification,1.0,0.12732118368148804
0,provide,1.0,0.01998533308506012
0,potential,1.0,0.06813585013151169
0,monitoring,1.0,0.158101424574852
0,mode,1.0,0.00429178960621357
0,lack,1.0,0.0400080606341362
0,improving,1.0,0.09750453382730484
0,improve,1.0,0.08507965505123138
0,however,1.0,-0.011453256011009216
0,fetuses,1.0,0.11941638588905334
0,fetus,1.0,0.07748453319072723
0,expertise,1.0,0.15745125710964203
0,evaluation,1.0,0.14135286211967468
0,diagnosis,1.0,0.24688632786273956
0,demonstrated,1.0,0.0564635805785656
0,basel,1.0,0.17127791047096252
0,aid,1.0,0.07422354817390442
0,using optical diffraction tomography,16.0,0.12309156730771065
0,high mannose receptor specificity,14.5,0.09038802608847618
0,free living foam cells,12.5,0.04732429841533303
0,living foam cells,9.5,0.05638390965759754
0,related metabolic diseases,9.0,0.2114840696255366
0,refractive index measurement,9.0,0.19930221140384674
0,foam cells based,9.0,0.04959558633466562
0,explore new drugs,9.0,0.11309101432561874
0,cellular imaging techniques,9.0,0.22896581888198853
0,performed quantitative morphological,8.5,0.1657244066397349
0,dimensional fluorescence imaging,8.5,0.22630095730225244
0,based image analysis,8.5,0.0926242545247078
0,demonstrated therapeutic evaluation,8.333333333333334,0.15497295434276262
0,foam cells,6.0,0.03180879261344671
0,free manner,5.0,0.016464997082948685
0,quantitative methods,4.5,0.08229988999664783
0,dimensional dynamics,4.5,0.07924415543675423
0,biophysical analysis,4.5,0.1587689220905304
0,therapeutic intervention,4.333333333333334,0.16369031369686127
0,therapeutic effects,4.333333333333334,0.1536182351410389
0,targeted delivery,4.0,0.07152660563588142
0,quantitatively evaluated,4.0,0.09302292764186859
0,promising tool,4.0,0.04861261323094368
0,polyethylene glycol,4.0,0.03416683338582516
0,"odt ),",4.0,0.10110154002904892
0,lipid droplet,4.0,0.1454672645777464
0,limited application,4.0,0.016728481277823448
0,lapse monitoring,4.0,0.09469330869615078
0,key feature,4.0,0.06383324414491653
0,identified lds,4.0,0.054314942099153996
0,glycol chitosan,4.0,0.014412125572562218
0,fluorescein isothiocyanate,4.0,0.10863730311393738
0,findings suggest,4.0,0.12938952632248402
0,exploiting machine,4.0,0.03374647442251444
0,despite advances,4.0,0.04775756783783436
0,current noninvasive,4.0,0.16675288416445255
0,cell level,4.0,0.08076799660921097
0,attractive target,4.0,0.06326460093259811
0,mannose,2.5,0.1157321035861969
0,verifying,1.0,0.04014786332845688
0,time,1.0,0.05442593991756439
0,three,1.0,0.07735734432935715
0,single,1.0,0.015469912439584732
0,precisely,1.0,-0.023628994822502136
0,nanodrug,1.0,0
0,mmr,1.0,0
0,lobeglitazone,1.0,0
0,lobe,1.0,0.07261361926794052
0,learning,1.0,0.027504589408636093
0,ld,1.0,0.035696856677532196
0,label,1.0,0.08488131314516068
0,however,1.0,-0.011453256011009216
0,furthermore,1.0,-0.04380498453974724
0,designed,1.0,0.028855949640274048
0,constitutes,1.0,0.004307400435209274
0,atherosclerosis,1.0,0.29730460047721863
0,affect,1.0,0.0651945173740387
0,accumulation,1.0,0.033634718507528305
0,"), licensee aims press",16.0,0.07115261008342107
0,heart disease data respectively,13.5,0.16462429612874985
0,test data based,9.5,0.09176261723041534
0,receiver operating characteristic,9.0,0.08752081419030826
0,principal component regression,9.0,0.06541918342312177
0,prediction accuracy using,9.0,0.02866014465689659
0,heart disease,6.0,0.233869731426239
0,© 2019,4.0,0.024751247838139534
0,work analyses,4.0,0.06322342157363892
0,random forest,4.0,0.0022971369326114655
0,predictive ability,4.0,0.07631609216332436
0,important variables,4.0,0.038391283713281155
0,best performance,4.0,0.04327479936182499
0,also studied,4.0,0.12316841818392277
0,causes cancer,3.666666666666667,0.16430209577083588
0,breast cancer,3.666666666666667,0.24374888837337494
0,ml algorithms,3.0,0.07741449773311615
0,cancer,1.6666666666666667,0.23309507966041565
0,ml,1.5,0.06590283662080765
0,algorithms,1.5,0.08892615884542465
0,roc,1.0,0.02677847445011139
0,rf,1.0,0.04890134930610657
0,provides,1.0,0.014026330783963203
0,prognosis,1.0,0.23093095421791077
0,predict,1.0,0.029006652534008026
0,pcr,1.0,0
0,diagnosis,1.0,0.24688632786273956
0,curve,1.0,-0.04778170958161354
0,compute,1.0,0.02463405579328537
0,compare,1.0,0.09237030148506165
0,author,1.0,0.1725224107503891
0,analyzing,1.0,0.0660758689045906
0,primary human airway smooth muscle,25.0,0.07278229594230652
0,g protein estrogen receptor antagonists,20.5,0.08759976997971534
0,genomic camp signaling modality contributes,19.5,0.13971583247184755
0,gene expression changes induced,15.5,0.030620187520980835
0,time camp dynamics using,15.0,0.03098862525075674
0,24 hours treated hasm,14.5,0.12532460317015648
0,gαs virtually eliminated glucocorticoid,13.666666666666666,0.042618626107772194
0,diverse cell signaling effects,13.333333333333334,0.07683578133583069
0,requires gαs signaling,9.666666666666666,0.004757272079586983
0,immortalized cell lines,9.0,0.05235208570957184
0,faseb journal published,9.0,0.14419320970773697
0,camp difference detector,9.0,0.07630204906066258
0,48 genes represent,9.0,0.11444021761417389
0,stimulated camp responses,8.0,0.04693424825867017
0,gene budesonide signature,8.0,0.09470000738898914
0,camp production via,8.0,0.012308869510889053
0,g protein,7.0,0.04946049489080906
0,coupled receptor,5.5,0.047781556844711304
0,glucocorticoid treatment,5.0,0.2028777152299881
0,genomic signature,5.0,0.13813412748277187
0,cell surface,5.0,0.02518053911626339
0,camp levels,5.0,0.03949127532541752
0,genomic actions,4.5,0.11979828402400017
0,small effects,4.333333333333334,0.03572089411318302
0,© 2019,4.0,0.024751247838139534
0,without knockdown,4.0,-0.041687896475195885
0,wiley periodicals,4.0,0.04755686596035957
0,widely used,4.0,0.02890646457672119
0,swiftly increase,4.0,0.031050567515194416
0,situ assay,4.0,0.1062611322849989
0,sirna knockdown,4.0,-0.06241370365023613
0,seq analysis,4.0,0.1043926551938057
0,measuring real,4.0,0.0665376391261816
0,little effect,4.0,0.009360174415633082
0,leading us,4.0,0.048748016357421875
0,important class,4.0,0.04684542864561081
0,experimental biology,4.0,0.2464067041873932
0,drugs exerts,4.0,0.06017414107918739
0,drugs activate,4.0,0.09366906061768532
0,american societies,4.0,0.06495580892078578
0,glucocorticoids tested,3.666666666666667,0.11622970551252365
0,glucocorticoids alone,3.666666666666667,0.1052679717540741
0,camp,3.0,0.03433322533965111
0,gαs,2.6666666666666665,0
0,hasm,2.5,0
0,genomic,2.5,0.27172142267227173
0,effects,2.3333333333333335,0.04013404995203018
0,responses,2.0,0.050901129841804504
0,production,2.0,0.043551042675971985
0,budesonide,2.0,0.1438724398612976
0,glucocorticoids,1.6666666666666667,0.16443267464637756
0,view,1.0,0.01284804381430149
0,variety,1.0,0.07650606334209442
0,unappreciated,1.0,0.03765837103128433
0,third,1.0,0.03900638222694397
0,suppression,1.0,0.06901815533638
0,suggesting,1.0,0.051274579018354416
0,shifts,1.0,0.060013603419065475
0,rna,1.0,0
0,reported,1.0,-0.00021066516637802124
0,rapid,1.0,0.0760050043463707
0,progesterone,1.0,0.16972224414348602
0,prednisone,1.0,0.1314448118209839
0,one,1.0,0.060579702258110046
0,non,1.0,0.06398928165435791
0,membrane,1.0,0.1149565726518631
0,initiated,1.0,0.01000182330608368
0,inflammation,1.0,0.16907447576522827
0,inc,1.0,0.007824641652405262
0,implying,1.0,0.02828078530728817
0,identified,1.0,0.10330121219158173
0,hypothesize,1.0,-0.003548344597220421
0,growing,1.0,0.11825673282146454
0,found,1.0,0.03727259859442711
0,fluticasone,1.0,0.14957857131958008
0,federation,1.0,0.031218651682138443
0,evidence,1.0,0.05816628411412239
0,estradiol,1.0,0.13791009783744812
0,collectively,1.0,-0.011590112000703812
0,cells,1.0,0.06259886920452118
0,behalf,1.0,0.003146544098854065
0,authors,1.0,0.21598771214485168
0,analyzed,1.0,0.13667140901088715
0,140,1.0,0
0,creatinine ratios indicating organ protection,24.0,0.11339896842837334
0,pkcδ inhibition decreased leukocyte influx,20.416666666666664,0.06183050386607647
0,identified protein kinase c,16.0,0.09526320360600948
0,exhibit direct bactericidal properties,16.0,0.05096401087939739
0,reduced blood urea nitrogen,14.5,0.07309034373611212
0,pkcδ inhibition increased survival,13.583333333333334,0.08105698972940445
0,pkcδ inhibition improved survival,13.083333333333334,0.08620442698399226
0,decreased organ injury,10.666666666666666,0.09755001341303189
0,decreased endothelial permeability,9.666666666666666,0.07348190620541573
0,increased phagocytic activity,9.5,0.08044477303822835
0,© 2019 federation,9.0,0.02798494976013899
0,intensive care units,9.0,0.1665316546956698
0,improved gas exchange,9.0,0.09494644403457642
0,enhanced pathogen clearance,9.0,0.07967336475849152
0,effectively clear pathogens,9.0,0.028308877410988014
0,peritoneal macrophages isolated,8.666666666666666,0.14240561425685883
0,peritoneal chemokine levels,8.666666666666666,0.13704270124435425
0,24 hours post,8.0,0.09420297294855118
0,pkcδ inhibition,6.75,0.03232728689908981
0,improved survival,6.333333333333334,0.11314299702644348
0,pkcδ inhibitor,5.0,0.08326785266399384
0,peritoneal cavity,4.666666666666666,0.14553747326135635
0,neutrophil numbers,4.0,0.03045535460114479
0,macrophage phenotypes,4.0,0.137033149600029
0,leading cause,4.0,0.06677581369876862
0,kidney dysfunction,4.0,0.1721501424908638
0,inflammatory therapeutics,4.0,0.24545498192310333
0,inflammatory response,4.0,0.11321571096777916
0,important regulator,4.0,0.09456070140004158
0,important issue,4.0,0.08771714940667152
0,experimental biology,4.0,0.2464067041873932
0,cecal ligation,4.0,0.16161786019802094
0,american societies,4.0,0.06495580892078578
0,administered intra,4.0,0.06133175268769264
0,induce sepsis,3.5,0.19450661540031433
0,pkcδ,3.0,0
0,blood,2.5,0.15856775641441345
0,post,2.0,0.10225207358598709
0,sepsis,1.5,0.3236554265022278
0,tracheally,1.0,0
0,thus,1.0,-0.023273250088095665
0,surgery,1.0,0.3447723090648651
0,study,1.0,0.2376001477241516
0,spleen,1.0,0.07567166537046432
0,risk,1.0,0.19420234858989716
0,puncture,1.0,0.05333371460437775
0,previously,1.0,0.015059597790241241
0,pbs,1.0,0.015961237251758575
0,organs,1.0,0.16247545182704926
0,mortality,1.0,0.27426618337631226
0,morbidity,1.0,0.32470452785491943
0,lung,1.0,0.2565838694572449
0,kg,1.0,0.09757691621780396
0,inability,1.0,-0.021751757711172104
0,importantly,1.0,0.0019238665699958801
0,immunosuppression,1.0,0.1757732629776001
0,evidence,1.0,0.05816628411412239
0,development,1.0,0.1793753206729889
0,delta,1.0,0.029204435646533966
0,clp,1.0,0
0,associated,1.0,0.10097402334213257
0,anti,1.0,0.10541997849941254
0,altered,1.0,0.00029489025473594666
0,200µg,1.0,0
0,).,1.0,0
0,3 new promising groups,14.5,0.06768338708207011
0,maximal tolerated doses,9.0,0.11074847479661305
0,hughe clinical research,9.0,0.3878527879714966
0,renin angiotensin blockade,8.666666666666666,0.14708236729105315
0,angiotensin receptor blockers,8.166666666666666,0.1153479553759098
0,others perspective drugs,8.0,0.07522831112146378
0,ace inhibitors intolerance,7.5,0.07948057353496552
0,heart failure treatment,7.0,0.22965233027935028
0,angiotensin receptor,5.166666666666666,0.15015103667974472
0,heart failure,5.0,0.2074820026755333
0,ace inhibitors,4.5,0.09943026676774025
0,špinarová l,4.0,0.02060166746377945
0,špinar j,4.0,0.010428212583065033
0,vítovec j,4.0,0.010428212583065033
0,symptoms relieve,4.0,0.12563420832157135
0,pharmacological treatment,4.0,0.26631876826286316
0,omecamtiv mecarbil,4.0,0.31335264444351196
0,neprilysin inhibitor,4.0,0.08962647616863251
0,main goal,4.0,0.06793928891420364
0,hf trial,4.0,0.11598029732704163
0,glucose co,4.0,0.1349470354616642
0,especially improvement,4.0,0.11350113525986671
0,diabetes mellitus,4.0,0.22472551465034485
0,selected patients,3.5,0.24646209739148617
0,acei according,3.5,0.03558759391307831
0,3,2.5,0.019742561504244804
0,treatment,2.0,0.27399298548698425
0,inhibitors,2.0,0.12478162348270416
0,drugs,2.0,0.16310197114944458
0,patients,1.5,0.4592966139316559
0,acei,1.5,0
0,valsartan,1.0,0.3132857382297516
0,transporter,1.0,0.08719346672296524
0,sodium,1.0,0.11925020068883896
0,sglt2,1.0,0
0,sacubitril,1.0,0
0,results,1.0,0.0652550756931305
0,replace,1.0,0.0772906020283699
0,quality,1.0,0.11005230993032455
0,pmid,1.0,0
0,paradigm,1.0,0.11544345319271088
0,oedema,1.0,0
0,mra,1.0,0
0,mortality,1.0,0.27426618337631226
0,morbidity,1.0,0.32470452785491943
0,medline,1.0,0
0,life,1.0,0.07387976348400116
0,innovations,1.0,0.1336166262626648
0,indicated,1.0,0.047450292855501175
0,indexed,1.0,0.00026863813400268555
0,hospitalisations,1.0,0
0,given,1.0,0.014340896159410477
0,dyspnoe,1.0,0
0,done,1.0,0.023701651021838188
0,diuretics,1.0,0.21879620850086212
0,digoxin,1.0,0.22319909930229187
0,decrease,1.0,0.07778903841972351
0,cornerstone,1.0,0.0026033464819192886
0,case,1.0,0.09149735420942307
0,betablockers,1.0,0
0,arni,1.0,0
0,arb,1.0,0.03499434143304825
0,added,1.0,0.07914778590202332
0,31906682,1.0,0
0,2,1.0,0.03300613537430763
0,1,1.0,-0.001867588609457016
0,proposed model showed significant improvement,21.0,0.07173480018973351
0,"mmrc ), copd assessment test",18.333333333333336,0.08392896875739098
0,modified medical research council,16.0,0.21932038920931518
0,chronic obstructive pulmonary disease,15.333333333333334,0.23184162378311157
0,chronic obstructive lung disease,15.333333333333334,0.17300859093666077
0,top 10 global causes,15.0,0.0657731331884861
0,incorporates previously proposed parameters,15.0,0.040034666657447815
0,previously reported pa models,14.666666666666666,0.04339719098061323
0,copd patients within 30,11.333333333333334,0.26192525774240494
0,"cat ), 6",9.333333333333334,-0.004790199920535088
0,worn wearable devices,9.0,0.12437052341798942
0,positive prediction rate,9.0,0.06270675361156464
0,minute walking distance,9.0,0.04606260359287262
0,16 copd patients,9.0,0.4592966139316559
0,0 million lives,9.0,0.046121989687283836
0,readmission prediction criteria,8.5,0.14118045568466187
0,ranked 3rd among,8.5,0.04270237311720848
0,physicians cannot predict,8.0,0.18083805094162622
0,day readmission risk,8.0,0.16073491548498473
0,continuous pa monitoring,7.666666666666666,0.07097375268737476
0,existing diagnosis methods,7.5,0.14337464794516563
0,proposed model,6.0,0.054264677688479424
0,copd patients,6.0,0.4592966139316559
0,test subjects,5.5,0.11057605221867561
0,clinical assessment,5.5,0.29115190356969833
0,"qoa ),",5.333333333333334,0
0,chronic diseases,5.333333333333334,0.2243969812989235
0,statistical model,5.0,0.08372131921350956
0,readmission risk,5.0,0.23771753162145615
0,global initiative,5.0,0.03046402893960476
0,especially within,5.0,0.08104106411337852
0,prevention methods,4.5,0.1263566929847002
0,potential readmission,4.5,0.1746842823922634
0,highest among,4.5,0.06573433242738247
0,new parameter,4.0,0.08210638165473938
0,daily living,4.0,0.06507956236600876
0,claimed 3,4.0,-0.0013971682637929916
0,airflow obstruction,4.0,0.0615088976919651
0,adopted currently,4.0,0.045376935973763466
0,30 days,3.8333333333333335,0.03250393271446228
0,regularity index,3.75,0.04345167800784111
0,mass index,3.75,0.06871355697512627
0,physical activity,3.666666666666667,0.020183337852358818
0,based wrist,3.666666666666667,0.05970970541238785
0,based indices,3.666666666666667,0.09765568003058434
0,activity index,3.416666666666667,0.06239112466573715
0,proposed,3.0,0.053893283009529114
0,hospital discharge,3.0,0.2782559171319008
0,copd,3.0,0
0,pa,2.6666666666666665,0.05034612491726875
0,30,2.3333333333333335,0
0,predict,2.0,0.029006652534008026
0,monitoring,2.0,0.158101424574852
0,diagnosis,2.0,0.24688632786273956
0,index,1.75,0.10827754437923431
0,based,1.6666666666666667,0.08516917377710342
0,activity,1.6666666666666667,0.01650470495223999
0,hospital,1.5,0.4200267195701599
0,discharge,1.5,0.13648511469364166
0,days,1.5,0.03250393271446228
0,sensitivity,1.0,0.0724399983882904
0,ri,1.0,0.030980270355939865
0,quality,1.0,0.11005230993032455
0,predicting,1.0,0.043349962681531906
0,paper,1.0,0.07484385371208191
0,moreover,1.0,0.01877431571483612
0,introduced,1.0,0.0400276780128479
0,gold,1.0,0.0385880172252655
0,found,1.0,0.03727259859442711
0,exercise,1.0,0.1012873649597168
0,dyspnea,1.0,0.19185543060302734
0,discharged,1.0,0.13826555013656616
0,diagnosed,1.0,0.1202194094657898
0,death,1.0,0.12083880603313446
0,data,1.0,0.1061776876449585
0,compared,1.0,0.10162706673145294
0,collected,1.0,-0.03091895952820778
0,body,1.0,0.014940984547138214
0,bode,1.0,0.05985786393284798
0,ai,1.0,0.07966839522123337
0,accelerometer,1.0,0.0423012413084507
0,78,1.0,0
0,63,1.0,0
0,37,1.0,0
0,2019,1.0,0
0,2016,1.0,0
0,bone marrow hematopoietic stem cell,25.0,0.10978166311979294
0,cd200 +/ cd206 +) associated,22.0,0.10097402334213257
0,exhibited decreased splenic expansion,14.2,0.12433300912380219
0,hsc )- derived mo,13.25,0.039984219086666904
0,mice exhibited increased mrna,13.166666666666666,0.07916917403539021
0,inflammatory cytokine gene expression,13.083333333333334,0.11162370862439275
0,yolk sac origin drive,13.0,0.01964195165783167
0,flow cytometry studies showed,13.0,0.1460544615983963
0,dependent transcription factors involved,11.333333333333334,0.07021418306976557
0,cd80 +/ cd64,10.0,0
0,κb transcriptional activity,9.0,0.09117141366004944
0,focal adhesion kinase,9.0,0.10769765079021454
0,downstream transcription factors,9.0,0.08452703058719635
0,150 days post,9.0,0.06737800315022469
0,tissue inflammatory response,8.416666666666666,0.13381063689788184
0,α >> arg,8.0,0.010040659457445145
0,fak inhibitor abrogated,8.0,0.03980506956577301
0,cultured mφ confirmed,8.0,0.04626263026148081
0,proinflammatory cytokines response,7.666666666666666,0.08711581180493037
0,causes chagas disease,7.5,0.12196000168720882
0,infected mice treated,6.866666666666667,0.1014980102578799
0,chronically infected mice,6.866666666666667,0.07014989604552586
0,transcription factors,6.0,0.10666237957775593
0,derived cd11b,5.0,-0.011859389953315258
0,infected mice,4.866666666666667,0.06999934837222099
0,inflammatory phenotype,4.75,0.14123701304197311
0,inflammatory pathology,4.75,0.33089689910411835
0,dependent increase,4.666666666666667,0.04945408180356026
0,mφ response,4.666666666666666,0.05596902221441269
0,chagas mice,4.666666666666666,0.09806038811802864
0,chagas disease,4.5,0.13518544659018517
0,splenic mo,4.45,0.17343458533287048
0,surface expression,4.333333333333334,-0.02629269380122423
0,notch1 involved,4.333333333333334,0.03122086077928543
0,proinflammatory mo,4.25,0.10686515271663666
0,splenic compartment,4.2,0.1608849000185728
0,splenic cd11b,4.2,0.2681081295013428
0,infected mφ,4.2,0.05121348053216934
0,6 mice,4.166666666666666,0.051602981984615326
0,trypanosoma cruzi,4.0,0.07082304358482361
0,sinusoidal compartment,4.0,0.05503897927701473
0,regulatory role,4.0,0.07001019828021526
0,proinflammatory phenotype,4.0,0.12349044531583786
0,proinflammatory activation,4.0,0.10917668044567108
0,progenitor lineage,4.0,0.0636040698736906
0,pathogen stimulus,4.0,0.024714428931474686
0,mφ proliferation,4.0,0.16025876998901367
0,mφ contributing,4.0,0.00862792506814003
0,myocardial infiltration,4.0,0.16267641633749008
0,latin america,4.0,0.06314825732260942
0,inherent capability,4.0,0.024718476459383965
0,infection ).,4.0,0.1787572205066681
0,heart failure,4.0,0.2074820026755333
0,functional activation,4.0,0.11878135055303574
0,frequent cause,4.0,0.07947275415062904
0,chronic phase,4.0,0.11103755049407482
0,also detected,4.0,0.07311824522912502
0,agonistic effects,4.0,0.0391689408570528
0,acute parasitemia,4.0,0.30777977406978607
0,"10 ),",4.0,0
0,srt1720 reprogrammed,3.666666666666667,0.05110195279121399
0,srt1720 dampened,3.666666666666667,0.027375388890504837
0,induced fak,3.666666666666667,-0.006984012201428413
0,sirt1 agonist,3.5,0.06754408031702042
0,chronic cd,3.5,0.13787981867790222
0,induced increase,3.3333333333333335,0.027806519530713558
0,associated,3.0,0.10097402334213257
0,yolk,2.5,-0.04447002336382866
0,studies,2.5,0.24976284801959991
0,showed,2.5,0.048222288489341736
0,sac,2.5,0.054907120764255524
0,increased,2.5,0.07228505611419678
0,involved,2.3333333333333335,0.03122086077928543
0,expression,2.3333333333333335,0.0005566496402025223
0,mo,2.25,0.0787610411643982
0,splenic,2.2,0.2681081295013428
0,infected,2.2,0.05121348053216934
0,α,2.0,0.06381849944591522
0,treated,2.0,0.1644953340291977
0,proinflammatory,2.0,0.13496926426887512
0,mφ,2.0,0
0,fak,2.0,0
0,chronically,2.0,0.07045099139213562
0,chagas,2.0,0.10733556002378464
0,srt1720,1.6666666666666667,0
0,induced,1.6666666666666667,-0.006984012201428413
0,increase,1.6666666666666667,0.06259705126285553
0,sirt1,1.5,0
0,cd,1.5,0.06606568396091461
0,6,1.5,0.014420747756958008
0,vs,1.0,0.08122316002845764
0,untreated,1.0,0.11393826454877853
0,tnf,1.0,0
0,tc,1.0,0.0335920974612236
0,study,1.0,0.2376001477241516
0,runx1,1.0,0
0,results,1.0,0.0652550756931305
0,respond,1.0,0.04464415833353996
0,pu,1.0,0.07325270771980286
0,protein,1.0,0.07616645097732544
0,phosphorylation,1.0,0.07472814619541168
0,nf,1.0,0.0131322480738163
0,myocardium,1.0,0.27229008078575134
0,myb,1.0,0
0,monocytes,1.0,0.02856728993356228
0,monitored,1.0,0.10678759217262268
0,modulating,1.0,0.09799468517303467
0,migration,1.0,0.050750430673360825
0,methods,1.0,0.024640876799821854
0,maturation,1.0,-0.006207987666130066
0,markers,1.0,0.03814179450273514
0,macrophages,1.0,0.10670876502990723
0,instead,1.0,0.039980120956897736
0,inflammation,1.0,0.16907447576522827
0,il,1.0,0.06259879469871521
0,however,1.0,-0.011453256011009216
0,f4,1.0,0.021830834448337555
0,examined,1.0,0.1701224148273468
0,determined,1.0,-0.03170712664723396
0,controlling,1.0,0.041483066976070404
0,control,1.0,0.05591680109500885
0,conclusions,1.0,0.07628431916236877
0,cells,1.0,0.06259886920452118
0,c57bl,1.0,0
0,c,1.0,0.04119548946619034
0,background,1.0,0.03833860531449318
0,anti,1.0,0.10541997849941254
0,alter,1.0,-0.003222196362912655
0,acutely,1.0,0.11704602837562561
0,80,1.0,0
0,1,1.0,-0.001867588609457016
0,examined whether prevalent mood disorders,21.583333333333332,0.12869693860411643
0,"obesity ), chronic kidney",16.0,0.23452904323736826
0,"57 ), incident multimorbidity",14.0,-0.008581696078181267
0,mortality risk following multimorbidity,13.2,0.1781585564215978
0,adult hiv clinic cohort,13.0,0.1789909154176712
0,mood disorders documented,9.583333333333334,0.11178286870320638
0,mood disorder diagnosed,9.25,0.0940139393011729
0,bipolar affective disorder,9.0,0.07190846403439839
0,adjusted subhazard ratios,9.0,0.04736204072833061
0,adjusted subhazard ratio,9.0,0.04382872208952904
0,≥ 2 ncds,8.4,0.08460040576756
0,ncds may reduce,8.4,0.03972076065838337
0,2588 incident ncds,8.4,-0.008581696078181267
0,particularly metabolic syndrome,8.0,0.1289055198431015
0,experience high rates,8.0,0.06256085634231567
0,≥ 1 year,7.75,0.054301721354325615
0,≥ 1 ncd,7.25,0.06716354377567768
0,mood disorders,6.583333333333334,0.16552762687206268
0,incident ncds,5.4,-0.008581696078181267
0,metabolic syndrome,5.0,0.1439461186528206
0,first year,4.5,0.02394421212375164
0,risk group,4.2,0.12219683267176151
0,increased risk,4.2,0.13324370235204697
0,competing risk,4.2,0.13580424711108208
0,study period,4.0,0.12990714237093925
0,people living,4.0,0.10212717577815056
0,major depression,4.0,0.10543613135814667
0,liver disease,4.0,0.19786392897367477
0,general population,4.0,0.14119073003530502
0,focused prevention,4.0,0.14420075342059135
0,first ncd,4.0,0.019310347735881805
0,defining cancers,4.0,0.10799512825906277
0,cumulative incidence,4.0,0.08749265782535076
0,confidence interval,4.0,0.0899096429347992
0,communicable disease,4.0,0.10335621982812881
0,cardiovascular disease,4.0,0.3688889145851135
0,64 ).,4.0,0
0,140 adults,4.0,0.051906388252973557
0,ci 1,3.75,0.032101916149258614
0,conclusively associated,3.5,0.044794896617531776
0,ashr ranging,3.5,-0.015200847759842873
0,multimorbidity,3.0,0
0,hiv,2.5,0.14575514197349548
0,clinic,2.5,0.32195553183555603
0,ncds,2.4,0
0,1,2.25,-0.001867588609457016
0,risk,2.2,0.19420234858989716
0,ncd,2.0,0
0,high,2.0,0.06070782244205475
0,ci,1.5,0.06607142090797424
0,associated,1.5,0.10097402334213257
0,ashr,1.5,0
0,treatment,1.0,0.27399298548698425
0,three,1.0,0.07735734432935715
0,tennessee,1.0,0.0342380553483963
0,setting,1.0,0.04959516599774361
0,results,1.0,0.0652550756931305
0,plwh,1.0,0
0,non,1.0,0.06398928165435791
0,nashville,1.0,0.010575555264949799
0,methods,1.0,0.024640876799821854
0,included,1.0,0.029688812792301178
0,hypertension,1.0,0.364623486995697
0,hyperlipidemia,1.0,0.2624513506889343
0,follow,1.0,0.08601848781108856
0,diabetes,1.0,0.31405115127563477
0,dementia,1.0,0.18816161155700684
0,death,1.0,0.12083880603313446
0,conclusions,1.0,0.07628431916236877
0,care,1.0,0.26734086871147156
0,calculated,1.0,-0.0013035684823989868
0,burden,1.0,0.07514367252588272
0,baseline,1.0,0.05839666724205017
0,background,1.0,0.03833860531449318
0,assessed,1.0,0.06162751466035843
0,aids,1.0,0.0020779240876436234
0,accumulation,1.0,0.033634718507528305
0,95,1.0,0
0,51,1.0,0
0,42,1.0,0
0,4,1.0,-8.371472358703613e-05
0,29,1.0,0
0,24,1.0,0
0,2015,1.0,0
0,1998,1.0,0
0,06,1.0,0
0,04,1.0,0
0,02,1.0,0
0,statistically significant differences,9.0,0.10447552551825841
0,logistic regression model,9.0,0.07161387925346692
0,conditional inference tree,9.0,0.012389281143744787
0,adjusted odds ratios,9.0,0.05823785811662674
0,acute myocardial infarction,9.0,0.3220969835917155
0,ventricular arrhythmia hospitalizations,8.666666666666666,0.3152106702327728
0,higher among patients,8.5,0.2236365800102552
0,found among drugs,8.5,0.09962361678481102
0,prior cardiac arrhythmia,8.166666666666666,0.32735601905733347
0,atrial fibrillation hospitalizations,8.0,0.28927744428316754
0,cardiac arrhythmia,5.166666666666666,0.48549817502498627
0,atrial fibrillation,5.0,0.26550570130348206
0,study found,4.5,0.13743637315928936
0,higher risk,4.25,0.15365959703922272
0,study period,4.0,0.12990714237093925
0,study outcomes,4.0,0.23542963713407516
0,study aimed,4.0,0.16353436559438705
0,respectively ).,4.0,0.08458003401756287
0,relevant predictors,4.0,0.1270303875207901
0,relevant predictor,4.0,0.10312579944729805
0,new users,4.0,0.0782760214060545
0,medical history,4.0,0.28095812164247036
0,data sources,4.0,0.06687838211655617
0,danish registers,4.0,0.012088241055607796
0,90 days,4.0,0.03250393271446228
0,risk stratification,3.75,0.16070245951414108
0,increased risk,3.75,0.13324370235204697
0,ci 2,3.5,0.04953877814114094
0,ci 1,3.5,0.032101916149258614
0,risk,1.75,0.19420234858989716
0,2,1.5,0.03300613537430763
0,1,1.5,-0.001867588609457016
0,used,1.0,0.010911919176578522
0,unadjusted,1.0,0.13189849257469177
0,triazolam,1.0,0.16294308006763458
0,secondly,1.0,-0.0010252296924591064
0,results,1.0,0.0652550756931305
0,promethazine,1.0,0.17892049252986908
0,perform,1.0,0.09922076761722565
0,patient,1.0,0.4149835705757141
0,p,1.0,0.11820723116397858
0,objectives,1.0,0.043118979781866074
0,methods,1.0,0.024640876799821854
0,loratadine,1.0,0.20007756352424622
0,investigation,1.0,0.0926906168460846
0,identify,1.0,0.04736902192234993
0,hospitalization,1.0,0.25800377130508423
0,fractures,1.0,0.19541451334953308
0,followed,1.0,0.06544908136129379
0,domperidone,1.0,0.17249611020088196
0,conclusion,1.0,0.03420025110244751
0,compute,1.0,0.02463405579328537
0,compare,1.0,0.09237030148506165
0,betahistine,1.0,0
0,95,1.0,0
0,94,1.0,0
0,78,1.0,0
0,7,1.0,0.005520308390259743
0,69,1.0,0
0,63,1.0,0
0,58,1.0,0
0,5,1.0,0.010449972003698349
0,4,1.0,-8.371472358703613e-05
0,31,1.0,0
0,3,1.0,0.019742561504244804
0,22,1.0,0
0,2016,1.0,0
0,2015,1.0,0
0,14,1.0,0
0,12,1.0,0
0,07,1.0,0
0,01,1.0,0
0,0001,1.0,0
0,0,1.0,0.04786166548728943
0,"),",1.0,0
0,altman analysis suggested strong correlation,25.0,0.05678745824843645
0,dataset included 48 vois taken,23.0,0.07844765996560454
0,part requires full attribution,16.0,0.0022889776155352592
0,intravascular optical coherence tomography,16.0,0.2140582539141178
0,following segmentation noise cleaning,16.0,0.058252427726984024
0,creative commons attribution 4,16.0,0.027785959653556347
0,performing percutaneous coronary interventions,15.5,0.24217879585921764
0,inhibit proper stent deployment,14.0,0.1109986703377217
0,manually annotated ivoct volumes,13.0,0.0784776359796524
0,automatically determined calcification depth,12.833333333333334,0.0726599944755435
0,deployment calcification scores,9.333333333333334,0.07477511713902156
0,deployment calcification score,9.333333333333334,0.08377153426408768
0,two expert analysts,9.0,0.09502685690919559
0,keeping vois intact,9.0,0.04027108599742254
0,fujino et al,9.0,0.08752741664648056
0,convolutional neural network,9.0,0.09854805283248425
0,classification approach could,9.0,0.01804668332139651
0,34 clinical pullbacks,9.0,0.25725935958325863
0,coronary calcification lesions,8.833333333333334,0.2726018528143565
0,automatically obtained stent,8.666666666666666,0.14883502262334028
0,99 ± 0,8.6,0.10103905200958252
0,97 ± 0,8.6,0.10103905200958252
0,85 ± 0,8.6,0.10103905200958252
0,0 unported license,8.6,0.04783251881599426
0,automatically obtained lumen,8.0,0.07978673217197259
0,calcification attributes,5.0,0.10349067114293575
0,obtained sensitivities,4.666666666666666,0.0247585317119956
0,without lesions,4.333333333333334,0.07429851591587067
0,mixed lesions,4.333333333333334,0.05186578631401062
0,vascular lumen,4.0,0.3328341767191887
0,treatment planning,4.0,0.18590878695249557
0,tissue classes,4.0,0.12448721006512642
0,thickness attributes,4.0,0.029360875487327576
0,pretrained segnet,4.0,0
0,performed 10,4.0,0.1553603708744049
0,original publication,4.0,0.004803294315934181
0,impact using,4.0,-0.006068231537938118
0,great concern,4.0,0.09053497761487961
0,fold cross,4.0,0.11676701158285141
0,comprehensive software,4.0,0.11384642496705055
0,applied clinically,4.0,0.16154612600803375
0,segment calcifications,3.75,0.14111110381782055
0,major calcifications,3.75,0.15375930815935135
0,calcifications using,3.75,0.09604602307081223
0,vivo images,3.5,0.1461043357849121
0,segmented regions,3.5,0.09626410156488419
0,vois,3.0,0.1336328536272049
0,stent,2.6666666666666665,0.39394140243530273
0,0,2.6,0.04786166548728943
0,manually,2.5,0.020255818963050842
0,ivoct,2.5,0
0,determined,2.5,-0.03170712664723396
0,lumen,2.0,0.18679653108119965
0,calcifications,1.75,0.23382940888404846
0,segmented,1.5,0.09718252718448639
0,images,1.5,0.07014717161655426
0,©,1.0,0.024751247838139534
0,work,1.0,0.06322342157363892
0,whole,1.0,0.08689890801906586
0,validation,1.0,0.09198760986328125
0,total,1.0,0.003683900460600853
0,task,1.0,-0.009650083258748055
0,suggest,1.0,0.046784643083810806
0,spie,1.0,0
0,results,1.0,0.0652550756931305
0,respectively,1.0,0.08458003401756287
0,reproduction,1.0,0.09168039262294769
0,reported,1.0,-0.00021066516637802124
0,refined,1.0,0.0060292575508356094
0,published,1.0,0.10513044893741608
0,method,1.0,0.016362402588129044
0,lipidous,1.0,0
0,interest,1.0,0.08689615875482559
0,including,1.0,0.06332606077194214
0,good,1.0,0.0672173798084259
0,giving,1.0,0.0026437565684318542
0,four,1.0,0.06643542647361755
0,evaluated,1.0,0.1149546355009079
0,encouraging,1.0,0.04055313393473625
0,doi,1.0,0.055976808071136475
0,distribution,1.0,0.11434805393218994
0,data,1.0,0.1061776876449585
0,created,1.0,-0.00517185777425766
0,consensus,1.0,0.04067409038543701
0,calculate,1.0,-0.0033954866230487823
0,calcified,1.0,0.14941717684268951
0,bland,1.0,-0.0012202747166156769
0,authors,1.0,0.21598771214485168
0,assessment,1.0,0.08391694724559784
0,annotations,1.0,0.0771874189376831
0,angle,1.0,0.03275878354907036
0,agreement,1.0,0.04792368784546852
0,2640,1.0,0
0,04,1.0,0
0,01,1.0,0
0,mechanics simulator using machine learning,25.0,0.039487116038799286
0,predict lv mechanics much faster,21.57142857142857,0.051101071387529375
0,used extreme gradient boosting,14.5,0.05170036666095257
0,simulation results show ml,13.75,0.066113056614995
0,ml results could capture,13.75,0.04391429200768471
0,obtain training fe models,11.083333333333334,0.06819514464586973
0,time left ventricular,9.0,0.11121451730529468
0,mean absolute errors,9.0,0.04038336997230848
0,predict lv behavior,8.904761904761905,0.037892408668994904
0,different material properties,8.8,0.014418844133615494
0,734 ± 0,8.75,0.10103905200958252
0,623 ± 0,8.75,0.10103905200958252
0,544 ± 0,8.75,0.10103905200958252
0,495 ± 0,8.75,0.10103905200958252
0,334 ± 0,8.75,0.10103905200958252
0,075 ± 0,8.75,0.10103905200958252
0,050 ± 0,8.75,0.10103905200958252
0,reinforced material model,8.666666666666666,0.006163677200675011
0,lv constitutive equation,8.571428571428571,0.02270826914658149
0,varied passive properties,8.3,0.022176596025625866
0,passive properties govern,8.3,0.011267357816298803
0,volume results obtained,8.25,0.05494770593941212
0,ml model based,8.166666666666666,0.06856936092178027
0,real world applications,8.0,0.04875158021847407
0,cross myofiber stress,7.833333333333334,0.11580562591552734
0,varied active properties,7.8,0.033767037093639374
0,stress predictions ).,7.0,0.05870144069194794
0,results predicted,5.25,0.061780449002981186
0,ml model,5.166666666666666,0.06026945449411869
0,ml ).,5.0,0.06590283662080765
0,passive behavior,4.833333333333334,0.01599915325641632
0,myofiber stress,4.833333333333334,0.0933484435081482
0,mechanical properties,4.8,0.06056681461632252
0,lv stresses,4.571428571428571,0.05859331041574478
0,lv pressures,4.571428571428571,0.025300887413322926
0,lv pressure,4.571428571428571,0.0867864266037941
0,shear stress,4.5,0.05624750070273876
0,passive tissue,4.5,0.08704498410224915
0,584 ml,4.5,0.06590283662080765
0,260 ml,4.5,0.06590283662080765
0,training set,4.333333333333334,0.06541751697659492
0,myofiber contractions,4.333333333333334,0.12142586708068848
0,active behavior,4.333333333333334,0.033384814858436584
0,fe method,4.25,0.014418970793485641
0,fe computations,4.25,0.02538616582751274
0,volume loops,4.0,0.05239192955195904
0,pressure predictions,4.0,0.07293277233839035
0,large group,4.0,0.06074954383075237
0,hyperelastic fiber,4.0,0.01226314902305603
0,heart resulting,4.0,0.14859699178487062
0,finite element,4.0,-0.04499960597604513
0,298 mmhg,4.0,0
0,228 kpa,4.0,0
0,191 mmhg,4.0,0
0,032 kpa,4.0,0
0,024 kpa,4.0,0
0,xgboost volume,3.666666666666667,0.1002674475312233
0,xgboost pressure,3.666666666666667,0.12181110680103302
0,cubist volume,3.666666666666667,0.07493147253990173
0,cubist pressure,3.666666666666667,0.0857033021748066
0,0,2.75,0.04786166548728943
0,lv,2.5714285714285716,0.051761746406555176
0,used,2.5,0.010911919176578522
0,obtain,2.5,0.024071499705314636
0,ml,2.5,0.06590283662080765
0,training,2.3333333333333335,0.1278398334980011
0,fe,2.25,0.01247553899884224
0,volume,2.0,0.1002674475312233
0,real,2.0,0.02762891724705696
0,predictions,2.0,0.02405443787574768
0,active,2.0,0.03386080265045166
0,xgboost,1.6666666666666667,0
0,cubist,1.6666666666666667,0.04959549754858017
0,well,1.0,0.09099400043487549
0,volumes,1.0,0.07075798511505127
0,tool,1.0,-0.026759788393974304
0,systole,1.0,0.2340625375509262
0,subjects,1.0,0.13721111416816711
0,smoother,1.0,0.04971789941191673
0,simulations,1.0,0.05079309642314911
0,similar,1.0,0.08377962559461594
0,shape,1.0,0.05461088567972183
0,provide,1.0,0.01998533308506012
0,prediction,1.0,0.07748128473758698
0,predictability,1.0,-0.0036656539887189865
0,paper,1.0,0.07484385371208191
0,myocardium,1.0,0.27229008078575134
0,improve,1.0,0.08507965505123138
0,goal,1.0,0.06500711292028427
0,follows,1.0,0.03413863107562065
0,experiments,1.0,0.11820036172866821
0,diastole,1.0,0.2708514630794525
0,describe,1.0,-0.011884354054927826
0,conducted,1.0,0.055469855666160583
0,added,1.0,0.07914778590202332
0,1,1.0,-0.001867588609457016
